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ABSTRACT 
Necrotic enteritis (NE) is an important enteric disease in poultry production that has 
re-emerged as a major problem following an EU wide ban on the use of in-feed 
antimicrobials. Although the primary aetiological agent of disease is Clostridium 
perfringens type A, a commensal in the gastrointestinal tract (GIT) of chickens, numerous 
additional influential factors have been reported that can predispose chickens to NE. These 
precipitating factors mainly include diet, co-infection with other pathogens particularly 
coccidia, as well as environmental and management factors. Despite being first described 
almost more than 50 years ago, a reliable, consistently reproducible experimental model for 
NE induction is still lacking. Here, a series of experiments were conducted to investigate 
the importance of the various potential predisposing factors, in isolation and in 
combination, that are believed to play a role in sub-clinical NE development: feed 
withdrawal, dietary protein sources, co- infection with coccidia, C. perfringens dose and 
contact with reused litter. In addition, chicken breed sensitivity to NE was assessed, and 
last, but not least, blood and gut tissue samples were used to identify novel biochemical 
markers for sub-clinical NE. 
Chapter 3 reports an experiment showing that feed withdrawal up to 24 hrs in 
experimentally challenged birds did not result in NE specific lesions. Chapter 4 shows that 
replacing dietary soyabean meal with potato protein concentrate or canola meal or adding 
synthetic trypsin inhibitor to the soyabean meal control diet did not induce sub-clinical NE 
in birds housed on reused litter, a natural source of C. perfringens challenge. Chapter 5 
describes that in vitro growth of C. perfringens on in vitro digested grower diets was 
prolonged following the addition of fishmeal, suggesting that the role of fish meal as a 
predisposing factor for in vivo sub-clinical NE cannot be excluded. All subsequent diets 
therefore contained high levels of fish meal. When this was used in combination with high 
dose of coccidial vaccine, a repeated in-feed challenge for three days at 10
2
 colony forming 
units (cfu) C. perfringens per g feed did not result in sub-clinical NE, though at 10
9
 cfu/g 
resulted in 10% of challenged birds (3 out of 30) showing NE-specific lesions (Chapter 6). 
Further study is needed to determine if the two Ross birds with gross NE lesions compared 
to the one Hubbard bird (out of 15 birds each) was due to a lower level of NE resistance. 
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The failure to significantly induce sub-clinical NE in the previous experiments 
suggests that challenging the birds with C. perfringens in the isolated presence of suspected 
predisposing factors may not provide a suitable experimental model. Indeed, when birds 
were dosed twice daily with 10
8
 cfu C. perfringens for three days in the presence of high 
levels of fishmeal, canola meal as main protein source, coccidial and IBD vaccinations, and 
feed withdrawal prior to challenge, 40.6% of the challenged birds developed lesions of sub-
clinical NE without inducing mortality (Chapter 7). This concurred with reduced growth 
performance relative to the sham-infected control birds, and thus is a successful model for 
induction of sub-clinical NE. 
Finally this work has, for the first time provided novel information on potential 
biomarkers (Chapter 8). Whilst challenge did not impact on the expression of genes 
previously shown to be differentially expressed upon C. perfringens toxin exposure, the 
serum ceruloplasmin concentration increased, suggesting that monitoring this acute phase 
protein may indicate the presence of C. perfringens infection in poultry. However, as such 
markers generally lack specificity, further research confirming its role in response to sub-
clinical NE is needed to provide a fully effective diagnostic and prognostic marker for flock 
health and welfare, as well as ultimately helping to gain better understanding of the 
pathophysiology of sub-clinical NE.  
Improved knowledge of the effect of different dietary components on the growth of 
C. perfringens may help in the formulation of broiler diets to assist in further reducing the 
incidence of NE particularly in the absence of antimicrobial growth promoters. It is hoped 
that host responses in terms of acute phase proteins, and possibley gene expression, will 
also provide greater insight into the pathogenesis of NE. Provided that the developed 
experimental sub-clinical NE model is reproducible, this will benefit the understanding of 
this billion dollar disease and enable further investigation of various chemical and non-
chemical interventions to reduce its severity and impact on poultry production. 
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1 GENERAL INTRODUCTION  
Necrotic enteritis (NE) remains a major problem in the modern poultry industry, 
although in the past, it has been controlled by in-feed microbials, and ionophore anti-
coccidials (Collier et al., 2003). However it has re-emerged as a significant problem, 
causing reduced growth performance together with increased feed costs, following an 
EU wide ban on in-feed growth promoters. The sub-clinical form of NE is more 
disastrous since it can be more pervasive within the flock and mostly goes un-noticed 
and therefore undetected because of absence of evident clinical signs and/or symptoms 
(Kaldhusdal et al., 2001; Hofacre et al., 2003; Skinner et al., 2010; Timbermont et al., 
2009a). This usually results in condemnation of carcasses at time of slaughter 
(Kaldhusdal & Hofshagen, 1992). Although it is becoming progressively more apparent, 
the economic impact of sub-clinical NE has not been formally investigated (Skinner et 
al., 2010). Overall the main feature of the disease is the occurrence of necrotic lesions 
in the small intestine mostly in the jejunum and ileum but occasionally in the duodenum 
(Alsheikhly & Truscott, 1977b; Ficken & Wages, 1997). Decreased digestion and 
absorption, reduced weight gain and an increased feed conversion ratio are a direct 
result of the damage to intestinal mucosa caused by the sub-clinical form of the disease 
(Kaldhusdal et al., 2001). Poultry farms cannot afford to ignore the economic losses 
caused by this disease, despite its sporadic nature in developing countries as it is still 
causing large scale outbreaks in chicken production units. However, the total impact of 
fully developed NE on chicken production is difficult to determine accurately due to the 
nature of sub-clinical NE.  
The primary causative organism is a gram positive, anaerobic, spore forming 
bacterium, Clostridium perfringens, a commensal in the gastrointestinal tract (GIT) of 
poultry (Ficken & Wages, 1997) that has been isolated from feed, litter, dust, and faeces 
(Wages & Opengart, 2003). Despite identification of numerous factors that promote the 
development of sub-clinical NE, the exact field conditions that precipitate the out breaks 
of NE are still ambiguous. Together with a degree of co-infection with Eimeria, the 
predisposing factors are mainly dietary in nature. Currently, the only way to assess the 
degree of host response is by scoring gross pathological lesions within the intestine. 
Under experimental conditions it has proved difficult to induce sub-clinical NE, 
although C. perfringens has been identified as the disease’s primary etiological agent. 
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There is currently some understanding of the disease’s progression, but is still unclear 
as to the predisposing factor(s) that lead to the induction of NE following an overgrowth 
of C. perfringens in the GIT. Contradictory results from experiments have left the 
numerous predisposing factors still ill defined (Kaldhusdal et al., 1999). It is therefore 
essential to develop a reproducible experimental model for induction of sub-clinical NE 
in order to achieve more effective control of this costly disease as financial cost of NE 
has been estimated to be £1.6 billion per year to the world’s poultry industry (Van der 
Sluis, 2000). This will enable control of strategies and exploration of new methods to 
allow testing of a variety of factors, such as feed additives, vaccines and a range of new 
approaches. The focus of this thesis is: 
1) To clarify the role of the different, conflicting predisposing factors, in order to 
develop a model for induction of sub-clinical NE. The predisposing factors being 
considered are: feed withdrawal, diet, contact with reused litter, genotype of chickens 
and co-infection with other pathogens in isolation and/ or in combination as well as 
testing breed sensitivity to disease induction.  
2) To identify novel biochemical markers for sub-clinical NE in broiler chickens. It 
is anticipated that such additional markers will help to identify the presence of sub-
clinical NE, and to increase our understanding of the nature of host responses to C. 
perfringens infection. 
The major focus of the work described in this thesis is to prioritize the risk 
factors that purportedly expose birds to an increased risk of sub-clinical NE whilst also 
contributing to an advance in new preventative strategies to enable control of this billion 
dollar disease in a post anti-biotic era. This will be through developing a model for 
induction of sub-clinical NE based on an improved understanding of the involvement 
and relevance of the many anecdotal and research identified potential risk factors for 
NE both in isolation and/or in combination. 
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2 LITERATURE REVIEW 
Necrotic enteritis (NE) is an enteric disease caused by overgrowth of a commensal 
C. perfringens. This overgrowth also results in changes not only of the digestive tract 
environment, but also its bacterial ecology and histopathology. In order to adequately 
understand (sub-clinical) NE itself, it is therefore essential to briefly review the anatomy 
of a chicken’s digestive tract, its histomorphology and microbial ecology. 
 STRUCTURE AND FUNCTION OF THE 2.1
GASTROINTESTINAL TRACT OF POULTRY 
The GIT acts as a gateway for various nutrients to gain access to the circulatory 
system. The major function of the digestive system is to assimilate nutrients that are 
required for maintenance, growth, and reproduction of the organism. Intake of feed is 
accompanied by quick development of the GIT and its associated organs (Uni et al., 
1998). Early development of the digestive tract is crucial for achieving better growth 
and performance in chickens (Tako et al., 2004). 
 Different components of Gastrointestinal Tract: 2.2
The anatomy of the chicken GIT is unique. Main components of digestive system 
of birds are beak, mouth, oesophagus, crop, proventriculus or glandular stomach, 
Gizzard or muscular stomach, small intestine and large intestine (North & Bell, 1990). 
The general structure of the digestive tract of fowl is illustrated in Figure 2.1. 
2.2.1 Mouth and Oesophagus 
Chickens have no lips, soft palate, cheeks or teeth, but there are an upper and 
lower horny mandible referred to as beak (also known as rostrum) to enclose the mouth 
(Turk, 1982). The oesophagus starts from mouth along the neck enters thoracic cavity 
and into the glandular stomach (Bradley & Grahame, 1960). The oesophagus acts as 
passage for food from the mouth to the glandular stomach. 
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2.2.2 Crop 
The crop is a thin-walled storage pouch on the ventral end of the oesophagus 
(Hill, 1976). While the crop is well known for its storage function, along with some 
bacterial fermentation (Turk, 1982). Although the crop is a non-secretary organ, it 
contains enzymes and secretions from saliva, feed and microbes. Bacterial fermentation 
in the crop results in lactic acid production (Fuller & Brooker, 1974). 
 
 
Figure 2.1: The general structure of Chickens digestive tract. 
(Sturkie, 1976). 
2.2.3 Proventriculus 
The crop enters the proventriculus, sometimes called the “glandular stomach” or 
“true stomach”, that is lined with a glandular mucus membrane. Gastric juices like 
pepsin (the enzyme for protein digestion) and hydrochloric acid are secreted by 
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glandular cells of the proventriculus. Ingested feed passes quickly through the 
proventriculus so there is little digestion of ingested particles here. However, most 
digestive enzyme action takes place in the next portion of the GIT, “the gizzard”, (North 
& Bell, 1990). 
2.2.4 Gizzard (Muscular stomach or ventriculus) 
The gizzard lies between the proventriculus and the upper limit of the small 
intestine (duodenum). In the gizzard larger food particles are ground and reduced to 
small particles capable of being taken into the intestinal tract for further digestion and 
absorption (North & Bell, 1990). 
2.2.5 Small intestine 
The small intestine starts from the posterior end of the gizzard and ends at the 
ileo-caecal junction. The small intestine is about 62 inches long in the average adult 
chicken and is divided into the duodenum, jejunum, and ileum. The duodenum is the 
proximal portion of the intestine, extending from the gizzard to the pancreatic and 
biliary ducts, and encloses the pancreas to form a U-shaped structure also known as the 
“duodenal loop”. The duodenum is the principal site of nutrient absorption in the 
chicken (Duke, 1986). Next to the duodenum lies the jejunum, the segment extending 
from the pancreatic ducts to the Meckel’s diverticulum or yolk sac diverticulum 
(sometimes also known as the yolk stalk). Meckel’s diverticulum is used as a land mark 
to separate the jejunum and ileum (Denbow, 2000). The ileum extends from Meckel’s 
diverticulum to the ileo-caecal junction. Quantitatively, most digestion and absorption 
takes place in the small intestine (Turk, 1982), where chemical action by pancreatic 
enzymes aids digestion, also helped by bile, intestinal secretions and various microbes 
harbouring gut lumen (Darel and Duke, 2004).  
The small intestine of newly hatched chickens is relatively immature and 
undergoes significant morphological development during the first few days of life (Uni 
& Argov, 2006). The intestine of a newly hatched chicken increases in weight more 
rapidly than its body mass during the first 10 days (Noy & Sklan, 1999) with the highest 
growth rate at 5-7 days of age (Dibner et al., 1996; Uni et al., 1999; Uni & Argov, 
2006). A two to four fold increase in intestinal length has been observed up to 12 days 
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of age, while the weight of three intestinal segments (duodenum jejunum and ileum) 
increased seven to ten fold 
2.2.6 Caeca 
At the junction of the small and large intestine there are two blind pouches 
known as caeca (Denbow, 2000). Each caecum is about 6 inches long, it is the largest 
part of the large intestine and is the main site of bacterial fermentation in poultry. Caeca 
are also assumed to have a role in the mixing of digesta and absorption of nutrients as 
well as fermentation (Ewing, 2008). The majority of obligatory anaerobes such as 
clostridia are present in the caeca (Barnes et al., 1972). 
2.2.7 Large Intestine or Colon  
The large intestine is relatively short in the chicken, being only 4 inches. It 
extends from the end of the small intestine to the cloaca. The main function of the large 
intestine is water re-absorption (North & Bell, 1990).  
2.2.8 Cloaca and Accessary organs  
At the end of the digestive tract of birds there is the cloaca that serves as a 
common pathway for excretory, reproductive and digestive wastes (Denbow, 2000). 
The Bursa of Fabricious, one of the main lymphoid organs in poultry is located in the 
cloaca. 
Certain organs, such as the pancreas, liver and gall bladder are directly 
associated with digestion as their secretions empty into the intestinal tract and aid the 
digestion of ingested food material (North & Bell, 1990). 
Digestion consists of a number of physical and chemical processes. Feed is 
ingested, broken down into smaller particles, acted upon by digestive secretions, and 
propelled through the GIT by the muscular activities of the tract. Salivary, gastric, 
pancreatic, biliary, and intestinal secretions collectively provide mucus for protection 
and lubrication of the tract. Enzymes from the GIT and its associated organs aid in the 
hydrolysis of carbohydrates, protein, and lipids into smaller compounds for absorption. 
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Commensal microflora ferment and break down certain complex carbohydrates that are 
not digested by endogenous enzymes, thus providing additional nutrients. The 
microflora of the GIT also synthesizes some amino acids and vitamins essential to the 
host animal. Bacterial enzymes not only help in digestion of carbohydrates but also 
encourage digestion of protein and lipids that ultimately contribute to the nutrition of 
the host (North & Bell, 1990). 
  HISTOMORPHOLOGY OF THE SMALL INTESTINE 2.3
The whole GIT consists of four layers or tunics as does the intestinal wall. As 
such, the intestine is a multi-layered tube containing a serosal layer, a longitudinal 
muscular layer, a sub mucosal layer and a mucosal layer (Turk, 1982; Denbow, 2000). 
 
Figure 2.2: Photomicrograph of duodenum showing different layers.  
(a) Villi (b) Muscular layer (c) crypt. Haematoxylin and Eosin (x4). 
2.3.1 Intestinal Mucosa 
The mucosa of the GIT is a functional boundary between the environment and 
the internal physiological compartments of any organism. Intestinal mucosa consist of 
three layers: epithelium, lamina propria and a muscular layer (Denbow, 2000). The 
epithelium of the intestine is not only a highly specialized site for absorption but it also 
provides a good environment for various microbes harboured in the gut (Figure 2.3). 
Absorption takes place principally through the mucosa of the small intestine. Within the 
a 
b 
c 
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mucosa the main site of nutrient digestion and absorption is the epithelial layer (Turk, 
1982).  
 
Figure 2.3 : Epithelial layer of intestine (columnar epithelium). 
The interior surface of an avian intestine lacks the macroscopic mucous 
membrane folds that are usually seen in large mammals although it is folded into 
numerous structures called villi (Figure 2.2; Turk, 1982). Villi increase in size and 
number as progress down to duodenum giving them a greater absorptive surface per unit 
of intestine. The duration of villous growth varies: duodenal villous growth is almost 
complete by day 7, although jejunum and ileum villi development continues beyond 14 
days of age (Uni et al., 1995; Uni et al., 1999). Villi are present throughout the length of 
both the small and large intestines, but length is not consistent between the small and 
large intestines. There is a steady decrease in the height along the way, being longer in 
the duodenum at 1.5mm but decreasing in length to 0.4-0.6 mm in the ileum and rectum 
(Denbow, 2000). Over time, the number of villi increases in both the duodenum and 
jejunum but not in the ileum (Geyra et al., 2001a). 
Between the villi are the Crypts of Lieberkhuhn (Figure 2.2), in which there is a 
continuous renewal of cell populations called stem cells (crypt cells). These cells have a 
life cycle of 48 to 96 hours under normal conditions (Uni et al., 1998). Stem cells 
proliferate by mitosis and then migrate to the top of the villi (Turk, 1982). During this 
migration process, the enterocytes (intestinal epithelial cells) differentiate into principal 
(absorptive), or goblet (secretory) cells. Upon reaching the tip of the villus these cells 
are sloughed into the lumen of the intestine. In this way epithelial cells are continuously 
replaced by new epithelial cells (Turk, 1982; Uni & Argov, 2006). The crypts contain 
the undifferentiated cells, goblet cells, endocrine cells and lymphocytes. Paneth’s cells 
and globular leukocytes are present at the base of the crypts (Denbow, 2000). 
Enterocytes migrate from the crypt up the villi until they are exfoliated into the lumen 
and are sloughed into the lumen from the villi tip (Turk, 1982). An increase in the total 
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number of enterocytes is observed with age, due to a dramatic increase in villi length 
(Uni et al., 1998).  
The surface of the villi is covered by enterocytes that have tiny cylindrical 
projections on their luminal borders. These microvilli further increase the surface area 
available for absorption. In the inner wall of the villi, just underneath the epithelial cells, 
is the lamina propria. The lamina propria consists of connective tissue, capillaries, 
smooth muscle, and nerve fibres. The capillaries bring the blood stream to the base of 
the epithelial cells so that only one cell layer separates the lumen of the intestine from 
the blood (Turk, 1982). This facilitates the absorption of nutrients from the lumen of the 
intestine and their release into the blood stream.  
Goblet cells are highly exocrine cells that produce acidic and neutral mucins in 
similar proportions. There are many goblet cells present between the columnar cells of 
the surface epithelium and in the superficial parts of the simple glands (Figure 2.4). The 
goblet cells are scattered over the surface of villi interspersed with absorptive cells. 
Goblet cells are distributed along the villi (Uni et al., 2003). Goblet cells are short lived 
and continuously undergo replacement (Uni et al., 2003). They are produced from 
pluripotent stem cells at the base of the crypt from where they migrate towards the villi 
tip where they are sloughed off into the lumen. This process takes 2-3 days (Geyra et 
al., 2001b), and the number of goblet cells increases with chicken age in all regions of 
the intestine. 
 
Figure 2.4 : Goblet cells. 
The goblet cells synthesize and secrete a mucopolysaccharide called mucin 
(Turk, 1982). Upon secretion, the mucin hydrates and gels, which generates a protective 
Chapter 2  29 
 
mucus layer over the epithelial surface. This layer undergoes continuous degradation 
and renewal. Other components that reside within the mucus layer include water, 
electrolytes, sloughed epithelial cells and secreted immunoglobins. This produces a 
physical and chemical barrier that protects the epithelium from luminal agents such as 
enteric bacteria, bacterial and environmental toxins and some dietary components that 
pose a threat to the mucosa (Uni, 2006). The mucus layer also plays a crucial role in 
nutrient transport between the lumen and brush border membrane (Uni et al., 2003).  
It has long been believed that mucin, which is the major component of the 
mucus layer, has a function that is largely associated with lubrication of bolus 
movement (Moran, 1985). This mucin layer is also believed to be capable of 
aggregating several bacterial species and modulating their adherence to the intestinal 
epithelium, and thus plays an important role in the maintenance of normal microflora. 
Additional protective factors provided by the mucin are accumulation of bactericidal 
and bacteriostatic compounds, and secretary immunoglobulin A, all compounds capable 
of neutralizing or killing toxic bacteria (Robert et al., 1991; Thompson & Applegate, 
2005). However, mucin also serves a protective function by discouraging the 
translocation of harmful micro organisms, binding chemical irritants, establishing the 
unstirred water layer, protecting the underlying epithelial cells, providing a medium for 
the colonization of favourable microflora, and interacting with the intestinal immune 
system (Ferket et al., 2005; Thompson & Applegate, 2005). Thus, it is generally agreed 
that the mucin layer is an important factor in maintaining a strong intestinal barrier 
against pathogen invasion (Thompson and Applegate, 2005). 
Early functionality of the GIT is vital for the growth performance of chickens, 
making it crucial to achieve optimal intestinal development and functional capacity. The 
small intestine of a newly hatched chicken is immature and undergoes dramatic changes 
during the first few days post-hatch. The extensive changes in the morphological 
development of the small intestine close to immediate-post-hatch includes the 
differentiation of enterocytes and the definition of crypts as well as the multi- fold 
enlargement of the intestinal absorptive surface (Uni & Argov, 2006). 
Most of the digestion in a bird’s intestinal tract occurs in the lumen of the 
intestine under the influence of the digestive enzymes secreted by the pancreas and 
intestinal wall as well as the bile secreted by the liver. Digestion of sugars and peptides 
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into absorbable monomers, however, takes place within the brush border by the 
enterocytes, facilitated by membrane bound enzymes (Turk, 1982).  
 MICROBIAL ECOLOGY OF THE DIGESTIVE TRACT 2.4
The GIT supports an ecosystem that harbours a large and diverse population of 
bacteria, which create symbiotic relationships with the host (Apajalahti, 2005). There 
are more bacterial cells residing within the intestinal tract than there are cells of the host 
organism (Mead, 2000). The microflora of the intestinal tract of broiler chickens 
influences digestion, gut morphology, immune responses and health. The gut flora
 
is 
also believed to both protect against intestinal colonization of pathogens and to 
stimulate the immune response (Mead, 2000). The microbes in the intestinal tract can 
become attached to mucosal surfaces or food particles, or remain free-living in the 
lumen (Gabriel et al., 2006). The major sites of microbial activity in the GIT are those 
in which conditions are relatively stable and the digesta is retained long enough for 
significant microbial growth to occur (Mead, 2000). 
Most of the work on avian gut flora has been done using domestic chickens 
rather than the commercial poultry currently used in the industry (Fuller, 1984). 
Intestinal bacteria evolve with age; at hatch, the GIT is a sterile environment after which 
the flora grows rapidly (Gabriel et al., 2006) and maximum densities of bacteria are 
reached within the first 5 days post hatch (Apajalahti et al., 2004). During the following 
weeks the composition of flora changes rapidly, taking 30 or more days in the caeca to 
develop a stable and dynamic population (Barnes et al., 1972; Lu et al., 2003). Many 
factors can affect the composition
 
of the avian gut flora, including species, strain, age, 
diet, sex; environmental stressors, performance enhancers, antibiotic administration and 
infection with
 
pathogenic organisms (Smith, 1965a; Knarreborg et al., 2002; Hume et 
al., 2003; Pedroso et al., 2006).  
The intestinal microflora is an integral part of the digestive system of all 
animals, and in common with all living organisms they have nutritional and 
environmental requirements. Microflora harbouring the gut derives most of its energy 
for reproduction and growth from dietary compounds that are either resistant to 
digestion or absorbed too slow (Apajalahti et al., 2004). Since bacterial species differ 
from each other in relation to their substrate preferences and growth requirements, the 
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chemical composition and structure of the digesta largely determines the species 
distribution of the microbial community in the GIT. Therefore, microflora size, 
composition and activity can be altered by changes in diet (Hume et al., 2003). The 
structure and function of the digestive tract determines the sites of the intestine in which 
physiochemical and nutritional requirements for bacterial growth are fulfilled. Despite 
variations there are no sites in the GIT in which bacterial growth is entirely missing 
with over-all activity varying in different GIT sections (Apajalahti, 2005). Not 
surprisingly, different species of bacteria are harboured by different GIT sections on the 
basis of their preferred predilection sites as various intestinal segments function 
differently. There are several factors that restrict bacterial growth in the proximal GIT, 
including chemical inhibition (e.g. acid and bile), highly competitive rate of nutrient 
absorption (large absorptive surface and active transport), passage rate of digesta, 
continuous sloughing of both epithelial cells and mucus, and immunological defence 
mechanisms. 
The microbiota residing in the GIT consist of approximately 400 known species, 
of which 20 - 40 % can be cultured. There are different methods for determining and 
quantifying the bacteria in digesta or on the epithelial lining. Basic knowledge of 
intestinal bacterial populations is based on culture-based techniques. Since Muzyer et 
al. (1993) first used denaturing gradient gel electrophoresis (DGGE) to study complex 
microbial populations, it has become an attractive alternative to culture-based 
techniques. Many studies have used DGGE as a tool to investigate intestinal microbiota 
(Hume et al., 2003; Lu et al., 2003; Pedroso et al., 2006). The availability of molecular 
techniques for identifying non-culturable species has opened new avenues of research 
into the factors that affect this complex mix of organisms and offers new opportunities 
for analysing the structure and species composition of intestinal microbial communities 
(Lu et al., 2003; Apajalahti et al., 2004; Dibner et al., 2007).  
2.4.1 The crop 
Lactobacilli, enterococci and coliforms are dominant species in the crop, and 
Lactobacillus salivarius is the dominant species during the first week of life. 
Lactobacilli are attached to epithelium and form an almost continuous layer (Fuller, 
1978; Dibner et al., 2008). Lactobacillus spp is the major species of bacteria that 
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produces lactic acid, reducing the crop lumen pH to about 5.0 once feeding begins 
(Fuller, 1977). 
2.4.2 The proventriculus and ventriculus (Gizzard) 
Both the proventriculus and gizzard appear to be unfavourable for the growth of 
various bacteria resulting in a bacterial population that is lower than that found in other 
parts of the GIT (Smith, 1965a; Smith, 1965b). This is likely due to a low pH (range 1 
to 4), requiring any surviving microorganisms to show a high degree of acid tolerance 
(Gabriel et al., 2006). Despite this unfavourable environment, earlier studies have 
observed bacterial populations in the ventriculus: Lactobacillus at (up to 10
8
 cfu/g of 
ventricular contents) and low numbers of E. coli, Streptococcus/Enterococcus and 
yeasts have also been found in the gizzard (Smith, 1965a; Smith, 1965b). 
2.4.3  Small intestine  
Large and diverse populations of bacteria inhabit the lumen of the proximal part 
of the small intestine. In the duodenum microflora are relatively sparse compared to the 
lower small intestine (Smith, 1965a). The environment of the ileum is more favourable 
to bacterial growth because of the lower oxygen pressure, and lower enzyme and bile 
salt concentrations (Gabriel et al., 2006). 
The majority of organisms isolated from the duodenum and ileum are gram 
positive (Salanitro et al., 1978). The predominant organisms in the small intestine are E. 
coli and Streptococcus spp, Enterococcus spp, Staphylococcus spp and Lactobacillus 
spp at about 10
9
cfu/g of ingesta. Lu et al. (2003) and Gong et al. (2002b) used the 
molecular analysis technique on 16S rRNA amplification to corroborated the previous 
culture-based results with lactobacilli predominating in the small intestine as well as 
smaller numbers of
 
streptococci and enterobacteria.  
Anaerobes comprised 39% of the total number of isolates obtained with the 
greatest range of types occurring in the duodenum (Salanitro et al., 1978). Obligate 
anaerobes including anaerobic cocci and species of Eubacterium, Propionibacterium, 
Clostridium, Gemmiger and Fusobacterium are also present (Salanitro et al., 1978). In 
Chapter 2  33 
 
the ileum Apajalahti et al. (1998) found bacterial numbers were typically between 10
7 
and 10
9
 per gram of digesta. 
2.4.4 The ceca 
In simple stomach animals, bacterial fermentation is concentrated in the upper 
large intestine. The bacteria in these sections of the GIT utilize dietary compounds that 
have escaped pre-caecal host digestion and absorption, so these bacteria do not compete 
with the host when they ferment the entering substrate. In poultry, the most intense 
bacterial fermentation occurs in the caeca (Apajalahti, 2005). The caeca are evacuated 
only 1-2 times per day, thus providing relatively stable conditions for microbial 
proliferation (Gabriel et al., 2006). As a result of these favourable conditions, the 
resultant microbial community tends to be both large and diverse (Gong et al., 2002a; 
Lu et al., 2003). 
The bacterial population in the caeca is significantly more diverse than that in 
the ileum, although the bacterial population in both regions is predominantly Gram-
positive. This difference between caeca and ileum bacterial distribution is likely to due 
to the variation of their functional and environmental properties. The main function of 
the ileum is purely nutrient absorption, while that of the caecum is extensive bacterial 
fermentation, resulting in further nutrient absorption as well as detoxification of 
substances harmful to the host (Gong et al., 2002a; Gong et al., 2002b). 
At least 38 different types of
 
anaerobic bacteria of different strains have been 
isolated from chicken caeca
 
(Barnes et al., 1972; Mead, 1989). Using culture based 
techniques Barnes et al. (1972) found strict/obligatory anaerobes such as 
Bacteroidaceae, Gemmiger formicilis, Fusobacterium and Bifidobacterium gallinarum, 
all of which are highly sensitive to oxygen, at levels of ~10
11
 cfu/g of caecal content and 
are predominantly culturable bacteria. Mead (1989) found that 28% of the total caecal 
culturable bacteria consisted of gram-positive cocci such as Peptostreptococcus
 
spp. 
Other bacteria
 
included Bacteroidaceae (20%), Eubacterium spp. (16%), 
Bifidobacterium
 
spp. (9%), cocci (6%), Gemmiger formicilis (5%), and
 
Clostridium spp. 
(5%). Facultative anaerobes such as Streptococci and Peptostreptococci spp occur in 
lower numbers with yeasts, moulds and protozoa generally at low levels or absent 
(Barnes et al., 1972; Salanitro et al., 1974).  
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Using new molecular methodologies, based on 16S rRNA bacterial genes 
analysis, Gong et al. (2002a; 2002b) observed that butyrate-producing bacteria 
(including those related to Fusobacterium prausnitzii), ruminococci, Clostridia spp and 
E. cecorum were the predominant groups of bacteria on the caecal mucosa. 25% of the 
sequences cloned from the caecal samples studied were found to be un-reported species, 
closely related to unidentified butyrate-producing bacteria from the human caecum and 
bovine rumen (Gong et al., 2002b). Using the same technique, Lu et al. (2003) reported 
that 65% of sequences were related to Clostridia spp, Fusobacterium spp (14%), 
Lactobacillus spp (8%) and Bacteriodes spp (5%). Apajalahti et al. (2001) analysed 
diet-related
 
differences in the caecal intestinal microbial communities using G+C% 
profiling of 16S
 
ribosomal DNA (rDNA) sequences and found most of the
 
genes 
detected were not from well-known bacterial species. This finding was later confirmed 
by Gong et al. (2002a) who found that many of the 16S rDNA sequences retrieved
 
from 
a caecal library exhibited low sequence similarity to the
 
genes of known bacterial 
genera. 
Caecal flora changes from simple to a more complex and increasingly diverse 
population with the age of the chicken. Hume et al. (2003) examined changes in 
digestive microbial communities by using DGGE and found that caecal amplicon 
profiles changed from 8 major bands in chicks of 2 days of age to more complex 
mixtures of 26 major bands in chicks of 32 days of age. The composition of caecal 
microflora can vary between flocks, between birds within a single flock, and even 
within an individual bird examined at different times (Salanitro et al., 1974). During the 
development of chickens and turkeys, microbial populations take longer to develop in 
the caeca than they do in other parts of the GIT, and may take up to six weeks after 
hatching to fully develop (Barnes et al., 1972). 
It must be noted that variation in the composition of intestinal microbial 
communities in different published reports may be partly due to the large diversity of 
gut flora as well as the method being used for enumeration.  
 NECROTIC ENTERITIS 2.5
One of the most clinically dramatic disease amongst enteric bacterial diseases is 
necrotic enteritis (NE), first described in broiler chickens by Parish more than fifty 
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years ago in England (1961). Since then, it has been perceived as a major global threat 
to the poultry industry, as it is the most common disease throughout all poultry-growing 
areas of the world (Songer, 1996a). The condition occurs almost exclusively in broilers 
(Long, 1973; Bernier et al., 1974), although layers are also affected (Kwatra & 
Chaudhury, 1976; Dhillon et al., 2004) with outbreaks reported in 3-6 month old 
chickens (Broussard et al., 1986). In addition to broiler chickens it has also been 
identified in turkeys (Gazdzinski & Julian, 1992). Free living birds like quail and wild 
crows can also develop NE (Droual et al., 1995; Gazdzinski & Julian, 1992; Asaoka et 
al., 2004). However NE is of major concern to the poultry industry due to the 
economical impact of the disease through lost productivity. 
2.5.1 Epidemiology 
Outbreaks of NE are sporadic, but have a high mortality with severe economic 
losses (Dahiya et al., 1995a). The disease has been reported from various countries, 
including United Kingdom (Parish, 1961), Canada (Helmbold & Bryant, 1971; Long, 
1973), France (Casewell et al., 2003) and Australia (Nairn & Bamford, 1967). 
Epidemiological data on the incidence of NE are limited although a global survey found 
NE as a commonly occurring disease throughout the world (Van der Sluis, 2000). A 
cross sectional survey conducted by Hermans & Morgan (2007) among 857 farms in the 
UK indicated cases of NE in at least one flock during 2006 with a prevalence of NE in 
the recently reared flock at 12.3%. 
Necrotic enteritis usually occurs in broiler chicks at 2-6 weeks of age and is 
characterized by a sudden onset of diarrhoea and mucosal necrosis (Long, 1973; Fukata 
et al., 1991). The disease can occur more than once a year on any particular farm. In 
Canada it mostly appears in July, August, September and October (Long, 1973), whilst 
in the UK the frequency of NE is at its highest in the winter months (Hermans & 
Morgan, 2007). Norway was similar to the UK with a peak incidence of NE during the 
winter and a lower incidence of NE during the warmer season (Hermans & Morgan, 
2007; Kaldhusdal & Skjerve, 1996). It is generally recognised that the disease is not 
seasonal, although discrepancies in occurrence between different lattitudes that appear 
to contradict this are as yet unexplained. 
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2.5.2 Aetiology 
The primary cause of NE is Clostridium perfringens type A (Long & Truscott, 
1976; Alsheikhly & Truscott, 1977b; Alsheikhly & Truscott, 1977a) and type C 
(Thompson et al., 2006; Prescott et al., 1978b), although reference to type C in the 
literature is sparse.  
 CLOSTRIDIUM PERFRINGENS 2.6
Clostridium perfringens is a ubiquitous bacterium found in poultry houses and its 
surroundings, including water, poultry faeces, feed, soil and air (Arbuckle, 1972; 
Craven, 2000; Arbuckle, 1972), as well as in a wide variety of raw and processed foods 
particularly meat and poultry (Dahiya et al., 2005a). C. perfringens is believed to be the 
cause of variety of economically significant diseases in domestic animals (Songer, 
1996b). Genetically C. perfringens is a diverse organism and has successfully been 
isolated from the GIT of animals and humans. It is a member of the normal gut 
microbiota and is non-pathogenic in low concentrations (Kondo, 1988; McDevitt et al., 
2006a). Particularly in poultry, C. perfringens is present throughout almost the full 
length of the GIT; it has been isolated from the crop, gizzard and caeca (Nauerby et al., 
2003; Gholamiandekhordi et al., 2006). 
In healthy birds several different types of C. perfringens are present, whereas not 
all isolates of C. perfringens from diseased birds are pathogenic (Van Immerseel et al., 
2009). This indicates that different strains of C. perfringens may vary in their virulence 
and only specific strain(s) have the ability to produce NE, with outbreaks usually caused 
by a massive proliferation of some of these specific types (Nauerby et al., 2003; Cooper 
& Songer, 2009). 
2.6.1 Morphology 
C. perfringens was previously known as Clostridium welchii. It is a Gram-
positive, rod shaped, anaerobic, toxin producing bacterium that is able to form 
endospores under unfavourable conditions such as environmental stress, nutrient 
restriction and overpopulation (Stephenson & Lewis, 2005). Although C. perfringens is 
classified as an anaerobe, it can occasionally survive and grow in the presence of 
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oxygen (Quinn et al., 1994). Colonies of C. perfringens are smooth, round and 
glistening surrounded by an outer zone of complete hemolysis with an inner zone of 
incomplete hemolysis (Quinn et al., 1994). Optimal temperature for the growth of C. 
perfringens is 43-45ºC (maximum 50-51ºC) with a generation time of 8-10 minutes and 
an optimum pH of 5-8 (Bryant & Stevens, 1997). However, C. perfringens can grow at 
temperatures between 15-50°C and its endospores can tolerate 100ºC for 2hrs (Williams 
et al., 2003; Williams, 2005). It requires 13 amino acids for its optimum growth (Cato et 
al., 1986). 
2.6.2 Growth characteristics  
C. perfringens can grow on a wide variety of culture media (Table 2.1), 
including Shahidi Ferguson perfringens agar (SFPA), Tryptose Sulphite Cycloserine 
(TSC) agar, blood agar (incubated anaerobically at 37ºC for 24hrs) and cooked meat 
medium. Byrne et al. (2008) compared a range of agars and reported that TSC and 
reinforced clostridial agar (RCA) are the best media for culturing C. perfringens. 
However TSC media with or without the addition of egg yolk is best for culturing C. 
perfringens as black colonies can be observed after 24 hrs of anaerobic incubation. For 
recovery of C. perfringens spores, RCA was the most effective agar (Mead, 1995; 
Byrne et al., 2008). On the surface of agar plates C. perfringens forms large, regular, 
round, slightly opaque but shiny colonies (Brynestad & Granum, 2002). 
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Table 2.1: Different types of media used for diagnosis of Clostridium perfringens 
Media Reference 
Blood agar  Long & Truscott, 1976; Kaldhusdal et al., 1995; 
Branton et al., 1997; La Ragione & Woodward, 
2003; Olkowski et al., 2006a; Drew et al., 2004; 
Nairn and Bamford, 1967 
Cooked Meat Medium Shane et al., 1985 
Sulphite polymyxin sulfadiazine 
agar 
Bradley and Radhkrishnan, 1972;  
Fastidious anaerobe agar  Engstrom et al., 2003 
Lecithin – Clostridium welchii 
agar plates 
Baba et al., 1997 
Brain Heart Infusion Agar 
(BHI) 
Barbara et al., 2007; Kaldhusdal et al., 1999; 
Cooper & Songer, 2009 
2.6.3  Toxins of Clostridium perfringens  
C. perfringens produces at least 17 different types of exotoxins, although 
individual strains only produce a subset of these (Songer, 1996b). Bacterial toxins play 
an important role in the pathogenesis of NE (Arbuckle, 1972). C. perfringens strains are 
classified into five types A, B, C, D and E (Table 2.2) depending upon the major 
extracellular toxin produced, i.e. alpha (α), beta (β), epsilon(ε) and iota (ι) (Miclard et 
al., 2009; Losada-Eaton et al., 2008). Type-A C. perfringens produces α-toxin, type B 
produces α, β and ε toxins, type C produces α and β toxins, type D produces α and ε 
toxins and type E produces α and ι toxins. This means that α-toxin is produced in 
varying amounts by almost all strains of C. perfringens although different strains of C. 
perfringens produce varying amounts of α-toxin with type-A strain producing the 
highest amount of α-toxin (Titball et al., 1999). Molecular typing of the major toxins 
produced by C. perfringens has been done by many researchers (Engstrom et al., 2003; 
Nauerby et al., 2003). 
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Table 2.2: Major toxins used for typing C. perfringens as well as the enterotoxin and their genetic location 
Type  α-toxin   β-toxin  Epsilon toxin Iota toxin Enterotoxin Major diseases/ Host 
A + - - - + NE in poultry 
GIT diseases in humans/ 
human food poisoinig 
Intestinal clostridiosis in horses 
 
B + + + - + Dysentery in lambs 
Chronic enteritis in lambs 
enterotoxaemia in neonatal 
pigs, calves, goats and foals 
 
C + + - - + NE in poultry, 
EN in humans 
D + - + - + Enterotoxaemia in sheep 
(pulpy kidney disease) 
E + - - + + Enterotoxaemia in lambs, 
calves and rabbits 
Gene  plc Cpb1 
Cpb2 
etx iap 
ibp 
cpe  
Genetic 
location  
Chromosome  Plasmid Plasmid Plasmid Plasmid/ 
chromosome  
 
Biological 
activity 
Cytolytic 
Haemolytic, 
Dermonecrotic  
Lethal  
Cytolytic,  
Lethal 
Oedema of various 
organs  
kidneys, liver 
CNS 
Disruption of actin 
cytoskeleton and cell 
barrier integrity  
Cytotoxic, Lethal  
Causesdiarrhoea 
by leakage of 
water and ions 
 
CNS: Central nervous system; NE: Necrotic enteritis; EN: Enteritis necroticans. 
(Modified from (Brynestad & Granum, 2002). 
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Table 2.3: Different methods for molecular diagnosis and/or Genetic diversity of 
clostridium perfringens 
Method  Reference 
Pulsed –field gel electrophoresis 
(PFGE) 
Nauerby et al., 2003; Engstrom et al., 2003; 
Chalmers et al., 2007; Barbara et al., 2008 
Polymerase chain reaction (PCR) Engstrom et al., 2003; Saito et al., 1992;   
Kalender & Ertas 2005 
Real time/ Quantitative PCR 
(qPCR) 
Collier et al., 2003; Collier et al., 2008; Zhou et 
al., 2009 
Amplified fragment length 
polymrphism (AFLP) 
Engstrom et al., 2003 
2.6.4 Pathogenesis of necrotic enteritis and associated 
toxins  
Despite the clinical and economic significance of NE, the pathogenesis of C. 
perfringens and the associated disease in poultry is still not fully understood (Van 
Immerseel et al., 2009; Timbermont et al., 2009a). The jejunum is the predilection site 
for C. perfringens (Arbuckle, 1972), although it is normally present in the intestinal 
tract of healthy chickens (Smith, 1965a; Van Immerseel et al., 2009). However 
successful progression of the disease may involve a number of different factors as 
described in section 2.8. It is believed that a key event in the pathogenesis of NE is 
associated with the adherence of C. perfringens to the intestinal villi, as once it has 
become attached it starts to proliferate and produce the toxins that induce gut necrosis 
(Alsheikhly & Truscott, 1977a; Alsheikhly & Truscott, 1977b; Cooper et al., 2009). 
Mostly a sudden onset of the disease is quickly followed by death. The disease usually 
occurs in broiler chicks at 2-6 weeks of age and is characterized by sudden diarrhoea 
and mucosal necrosis (Fukata et al., 1991). 
2.6.4.1 Αlpha -toxin  
α-toxin is a multifunctional zinc metalloenzyme produced in varying amounts by 
nearly all isolates of C. perfringens (Songer, 1996b; Sato et al., 1978). It possesses both 
phospholipase C and sphingomyelinase activities. The α-toxin is believed to be the first 
bacterial toxin to be identified as an enzyme (Naylor et al., 1998) and is considered as 
the principal lethal toxin of C. perfringens (Songer, 1996b; Sato et al., 1978). The 
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structure of α-toxin consists of two domain proteins: The α-helical amino-terminal 
domain (N-terminal domain or N-domain) containing the active site and the β-sandwich 
carboxy-terminal domain (C- terminal domain or C-domain). The C-domain interacts 
with the phospholipid content of the cell membrane, thus creating toxicity (Titball et al., 
1999; Titball et al., 1993; Flores-Diaz et al., 2004). Alpha toxin has haemolytic, 
cytotoxic, necrotic properties, so has a direct effect on host metabolism including 
inhibition of neutrophil chemotaxis, vasoconstriction and platelet aggregation. Alpha 
toxin causes hydrolysis of the phosphotidylcholine and sphingomyelin portions of the 
membrane phospholipids, thus promoting membrane disorganization (Titball et al., 
1999; Bullifent et al., 1996). Both zinc and calcium ions are essential co-factors 
required for both the activity and stability of α-toxin. Moreover, zinc makes the α-toxin 
molecule rigid and stable with little conformational change. α-toxin activity is lost by 
EDTA, a zinc chelating agent (Sato et al., 1978; Titball et al., 1999). 
The gene for α-toxin is known as cpa or plc and has been both cloned and 
sequenced / expressed in Escherichia coli (Okabe et al., 1989). It is present in all strains 
of C. perfringens. The α-toxin gene is situated near the putative origin of replication, 
one of the most stable regions within the C. perfringens chromosome (Titball et al., 
1999). Some variation in the α-toxin sequence has been found but these did not 
significantly affect its activity (Abildgaard et al., 2009). The quantity of plc produced 
by different strains varies considerably, reflecting differences in the regulation of the plc 
gene. α-toxin is produced during the exponential or growth phase of C. perfringens and 
its mRNA expression is at maximum during this phase. At higher concentrations α-toxin 
is cytotoxic. At lower concentrations it disturbs phospholipids metabolism and 
deregulates different signal transduction processes (Bullifent et al., 1996). 
The α-toxin has phospholipase C activity and the regulation of α-toxin 
production is considered to be a critical pathogenicity factor of the type A strain of C. 
perfringens (Engstrom et al., 2003). Although there is controversy (see below) about the 
role of α-toxin in NE, the α-toxin is believed by many to play a vital role in the severity 
of NE primarily because of its ability to impair the intestinal mucosal barrier 
(Alsheikhly & Truscott, 1977b; Alsheikhly & Truscott, 1977a; Rehman et al., 2009). It 
causes hydrolysis of the phosphotidylcholine and sphingomyelin into diacyglycerol or 
ceramide respectively (Figure 2.5). These products promote membrane disorganization 
by activation of the protein kinase C with later stimulation of arachadonic acid cascade. 
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The activation of arachidonic acid cascade induces production of inflammatory 
mediators including leukotriens, thromboxane, platelet agglutinating factor and 
prostacyclin all products that are responsible for membrane damage and the 
inflammatory process (Van Immerseel et al., 2004; McDevitt et al., 2006a) which 
results in lysis or other forms of cytotoxicity (Songer, 1997; Titball et al., 1999). 
   
 
Figure 2.5: Mode of action of α-toxin. 
(Modified from McDevitt et al.2006a). 
For more than three decades α-toxin was considered to be the main virulent 
factor in the pathogenesis of NE. But, although a number of mechanisms have been 
described the importance of α-toxin in the pathogenesis of NE is still questionable. 
Some studies showed that whether α-toxin is given through intra-duodenal infusion or 
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oral inoculation it induced necrosis of the epithelium of the small intestine (Alsheikhly 
& Truscott, 1977b). In one in vitro study a significantly higher amount of α-toxin was 
noted in isolates from birds with NE than isolates from healthy birds (Hofshagen and 
Stenwig, 1992). Against these positive findings a later in vitro study demonstrated no 
difference in α-toxin production between the strains of C. perfringens isolated from NE 
outbreaks and those isolated from clinically healthy broilers (Gholamiandekhordi et al., 
2006). Studies have shown that induction of NE lesion was independent of the amount 
of α-toxin produced in vitro, and even that immunization with recombinant α-toxin gave 
partial protection against experimental challenge with C. perfringens (Cooper & 
Songer, 2009), These findings questioned the proposed role of α-toxin in the disease, 
demonstrated that α-toxin may have limited implications in NE (Keyburn et al., 2006) 
and was not an essential virulence factor in induction of the disease. In their experiment 
the inactivation of α-toxin gene (plc) did not affect the virulence of the resultant strain 
and that an α-toxin negative mutant produced the same type of lesions as that of a wild 
type strain. In contrast a more recent in vitro study concluded that α-toxin can impair 
the intestinal mucosal barrier function (Rehman et al., 2009). Furthermore, 
immunization with recombinant α-toxin stimulated the production of anti-α-toxin IgG, 
giving partial protection to broiler chicks against experimental challenge with C. 
perfringens (Cooper & Songer, 2009) suggesting α-toxin does play a possible role in 
NE. 
2.6.4.2 NetB Toxin  
In the past few years some studies have cast doubt on the role of α-toxin as the 
primary cause of NE by demonstrating that instead of conferring complete immunity, 
vaccination with alpha toxoid partially protected the birds against NE (Cooper & 
Songer, 2009; Lovland et al., 2004). Some studies indicated that besides α-toxin other 
proteins can confer immunity against experimentally induced NE (Kulkarni et al., 
2007), suggesting that there are additional factors, other than α-toxin, that are important, 
or perhaps even more important, in NE pathogenesis. Keyburn et al. (2006) reported 
that α-toxin negative mutants of C. perfringens type A were able to produce NE in an 
experimental model. Later a novel pore-forming toxin of C. perfringens named NetB 
was identified in the NE strains of C. perfringens. Literature information on Net B is 
scarce. It has a similar molecular size to β-toxin, hence the name NetB (necrotic 
enteritis toxin B-like). Its amino acid sequence has limited similarity with other pore 
forming toxins similar to the β-toxin of C. perfringens (38% identity) and the α-toxin of 
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Staphlococcus aureus (31% identity). It has cytotoxic activity against chicken leghorn 
male hepatoma cell line (LMH) including karyorehexis and karyolysis (Keyburn et al., 
2008). Although the evidence of involvement of NetB toxin in the pathology of NE is 
convincing there is still ambiguity about the role of NetB toxin in NE (Martin & Smyth, 
2009). Keyburn et al. (2008) isolated the NetB gene from isolates from chickens 
infected with NE but did not find the NetB gene in isolates from uninfected chickens. 
Martin & Smyth, (2009) in contrast found the NetB gene in isolates from chickens both 
with and without NE. Interestingly, NetB negative isolate was able to produce the 
disease in experimental model of Cooper & Songer (2009). 
Although immunogens other than α-toxin have been identified that give 
protective immunity against NE (Kulkarni et al., 2006; Kulkarni et al., 2007) this does 
not necessarily indicate they have a role in the development of NE. These studies also 
indicated that the alpha toxoid offered significant protection against NE (Kulkarni et al., 
2007) suggesting that it does have some role in the pathogenesis of the disease. It is 
clear that the importance of α-toxin in relation to NE can not be predicted from studies 
using purified toxin, which reinforces the importance of using the natural infection 
process to dissect the role of this toxin as an etiological agent of the disease. The 
sometimes contradictory evidence for the role of α-toxin and NetB toxin argues for the 
role of another, as yet unidentified, virulence factor(s) that allows C. perfringens to 
compete effectively in the chicken gut to produce the disease. 
2.6.5 Disease transmission 
During outbreaks of NE the major source of C. perfringens may be either 
contaminated feed or litter (Frame & Bickford, 1986; Songer, 1996a: Branton et al., 
1997; Ficken & Wages, 1997). In the 1960s out breaks of NE in Australia were 
associated with one commercial brand of feed (Nairn & Bamford, 1967). Sometimes 
feed components contaminated with bacteria may have also been a source of C. 
perfringens in NE outbreaks (Wijewant & Senevira, 1971a; Eleazer & Harrell, 1976) 
There is a possibility that C. perfringens may be able to transmit vertically as bacteria 
have been found in the yolk sac of an embryonated egg (Shane et al., 1984). Craven et 
al. (2003) suggested that C. perfringens may be transmitted within the integrated broiler 
chicken operation. C. perfringens has also been reported to be transmitted mechanically 
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and or biologically through house flies in poultry houses, resulting in the development 
of NE (Dhillon et al., 2004). 
2.6.6 Types of necrotic enteritis  
Under field conditions the disease occurs in two forms: an acute clinical form 
and a mild subclinical form. The acute form of NE is characterized by visible clinical 
signs like watery diarrhoea and sudden increase in flock mortality but often without any 
premonitory signs. 
Birds that do not succumb to clinical signs, may develop a sub-clinical 
clostridial infection. In the sub-clinical form of the disease there is often no peak 
mortality. Intestinal damage as a consequence of disease leads to a reduction in 
performance noticeable as reduced weight gain and an increased feed conversion ratio 
(Kaldhusdal & Hofshagen, 1992; Timbermont et al., 2010). The prevalence of sub-
clinical NE is not known, as the lesions can only be revealed by post mortem 
examination of randomly sampled birds (Engstrom et al., 2003). The sub-clinical form 
of NE is more important than the acute phase as it persists in broiler flocks without any 
obvious clinical signs, allowing it to remain undetected and untreated resulting in huge 
economic losses (Skinner et al., 2010). In the past few years the sub-clinical form of NE 
has become increasingly prevalent with no overt clinical signs and no peak mortality 
(Timbermont et al., 2011). 
2.6.7 Clinical signs  
Sick birds affected with NE are depressed, anorectic with ruffled feathers and 
huddle together. In the advanced stage of the disease the bird becomes limp/moribund, 
lying in lateral recumbency as they are unable to stand, relatively immobile, and very 
quickly die (Long, 1973; Alsheikhly & Alsaieg, 1980; Kaldhusdal et al., 1995). Mostly 
the course of the disease is short, with no clinical signs before the birds are just found 
dead (Songer, 1996a; Williams, 2005). Acute symptoms of the disease are severe 
depression, decreased appetite, reluctance to move, ruffled feathers and diarrhoea 
(Ficken & Wages, 1997). The period of illness is usually short (1- 2 hrs) so, again, most 
of the birds are just found dead (Nairn & Bamford, 1967; Helmbold & Bryant, 1971).  
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Birds that have died of NE have a foetid odour, are usually dehydrated with 
dark, dry pectoral musculature and pale kidneys (Long et al., 1974). The unopened 
intestinal wall is darker in colour than normal and distended due to the presence of large 
amounts of bile stained contents. In an affected flock the mortality rate can be anything 
from 1% to as high as 50% (Shane et al., 1985; Craven et al., 1999; Craven et al., 
2001b). 
By definition, sub-clinical NE does not manifest any clinical signs, and mostly 
under field conditions, only detected at the processing plant(s) by the rejection of 
carcasses (Lovland & Kaldhusdal, 2001; McDevitt et al., 2006b). It is usually 
associated with hepatitis and cholangiohepatitis. In some cases bile-stained fluid and 
some times blood-stained fluid filled the lumen of the intestine with sloughing of the 
intestinal epithelium, as well as greyish and thickened mucosa particularly in the 
duodenum and ileum (Lovland & Kaldhusdal, 1999). 
2.6.8 Gross lesions 
The small intestine is the principal site of tissue damage (Arbuckle, 1972) with 
gross lesions seen primarily in the jejunum and ileum, although these can also been 
extended to the duodenum (Helmbold & Bryant, 1971; Long et al., 1974; Broussard et 
al., 1986; Kaldhusdal & Hofshagen, 1992). Lesions may also be present in the caeca 
and liver (Long et al., 1974; Alsheikhly & Truscott, 1977a; Alsheikhly & Truscott, 
1977b;). Under invasive experimental conditions, such as direct administration of C. 
perfringens or purified toxin administered intra-duodenally, the first appearance of signs 
of damage to the chickens’ intestine have been reported as early as 6 hrs after 
administration of the challenge (Alsheikhly & Truscott, 1977a; Alsheikhly & Truscott, 
1977b).  
Typically an intestinal wall is friable and easily torn. There is a marked 
distension of the intestine with the lumen usually filled with gas and dark brown fluid 
material. Ulcers can occur either singly or as aggregates in the mucosa of the intestine. 
In very severe cases, the intestinal mucosa is covered with a layer of fibrino-necrotic 
material, or a diphtheritic membrane covering the mucosa in segments of variable 
length usually involving two thirds of the small intestine, the jejunum and ileum (Nairn 
& Bamford, 1967; Long et al., 1974; Kaldhusdal et al., 1995; McDevitt et al., 2006a). 
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Lesions of sub-clinical NE are usually present in one or more areas of the intestine 
(Long et al., 1974). In addition to small intestinal lesions C. perfringens is also 
associated with liver abnormalities; mostly enlargement (Riddell & Kong, 1992; 
Kaldhusdal et al., 1995; Lovland & Kaldhusdal, 2001). Sometimes severe congestion 
can be found in the liver (Shane et al., 1985).  
2.6.9 Histopathological changes 
Microscopically lesions of NE from field cases consist of coagulation necrosis at 
the intestinal villous apices. A clear line of demarcation is visible between necrotic and 
viable cells. In some cases cellular degeneration may reach the sub-mucosa (Nairn & 
Bamford, 1967; Ficken & Wages, 1997). An apparently visible psuedomembrane is 
made up of necrotic/ distorted villi, inflammatory cells and clumps of bacteria 
(Gholamiandehkordi et al., 2007; Olkowski et al., 2008). From field cases, regeneration 
of the intestinal tract is characterized by a proliferation of epithelial cells, production of 
connective tissue network, decreased numbers of goblet, columnar and epithelial cells. 
Overall regenerative changes leave the affected region with short, flat villi that have a 
reduced absorptive surface (Long et al., 1974; Ficken & Wages, 1997).  
In the sub-clinical form of the disease microscopic changes are mostly seen in the 
small intestine, sometimes in liver but rarely in the caecum (Kaldhusdal & Hofshagen, 
1992). Larger areas of the intestine are affected in the sub-clinical compared to clinical 
form of the disease. Necrosis starts from the apical villous epithelium (Kaldhusdal et 
al., 1995). Lesions typically develop from the tips of the villi. Histopathological 
examination of tissues from the field cases reveal small demarcated areas of 
degeneration merged with areas of normal unaffected intestine. Degenerative changes 
begin with congestion of blood vessels followed by diffuse oedema. Later the epithelial 
cells of the villi become enlarged, with pale vacuolated cytoplasm, and an indistinct 
homogenous deposit in place of the striated border. The degenerative process progresses 
down the villi in regular manner that many villi are equally affected. At this stage 
necrotic tissue is clearly differentiated from normal by a clear sharp line. In some cases 
stroma of the villi are sloughed off. There is fibrin with amorphous basophilic deposits 
in the majority of blood vessels. 
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Other significant changes include dissolution of the nuclei, with nuclear material 
flowing out of the individual cells in the form of irregular deposits that disappear when 
all layers of the intestine, from mucosa to serosa, are affected in the final stage of the 
degenerative process. Regenerative changes of the intestinal tract in field cases are 
characterized by a proliferation of the epithelial cells of the crypts to replace necrosed 
cells (Parish, 1961; Long et al., 1974), production of connective tissue in the 
inflammatory area, and a decreased number of goblet and epithelial cells. In the lumen 
of an affected intestine, disintegrated necrotic villi, degenerated epithelial cells, goblet 
and inflammatory cells can be found, leaving the intestinal villi shortened and flattened 
with a reduced absorptive surface (Long et al., 1974). Large numbers of gram-positive 
rod-shaped bacteria can be seen in the sloughed epithelium (Parish, 1961; Alsheikhly & 
Truscott, 1977a; Alsheikhly & Truscott, 1977b; Kaldhusdal et al., 1995). 
When NE occurs in association with an Eimeria infection, coccidial oocytes are 
apparent at the base of the intestinal villi (Nairn & Bamford, 1967). Gross and 
histopathological lesions in turkeys are the same as that of chickens; however in turkeys 
the duodenal part of the small intestine is more affected than in chickens. Alsheikhly & 
Truscott, (1977b) observed changes in the morphology of erythrocytes and attributed 
this to a direct effect of C. perfringens toxin on erythrocytes. 
 EXPERIMENTAL MODELS OF NECROTIC 2.7
ENTERITIS  
A consistent experimental induction of (sub-clinical) NE has proved difficult. 
One the one hand, many workers have reported successful experimental induction of 
NE (Long et al., 1974; Truscott & Alsheikhly, 1976; Alsheikhly & Truscott, 1977b; 
Pedersen et al., 2008). Approaches to reproduce the disease include intraduodenal 
inoculation of C. perfringens broth cultures (Alsheikhly & Truscott, 1977b; Kaldhusdal 
et al., 1999), intra-duodenal administration of bacteria free crude toxins of C. 
perfringens (Alsheikhly & Truscott, 1977a), Long & Truscott (1976) used a pure culture 
challenge model to reproduce NE in broiler chickens. Other methods of introducing C. 
perfringens to induce disease include the mixing of C. perfringens cultures in feed 
(Alsheikhly & Alsaieg, 1980; Pedersen et al., 2008), oral gavage (Olkowski et al., 
2006a), and intravenous challenge with C. perfringens cultures (Williams et al., 2003), 
rearing birds on reused litter from NE infected flocks (Hamdy et al., 1983b; Baba et al., 
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1997) and even use of reused litter from flocks without having any clinical signs of NE 
(Palliyeguru et al., 2010). 
On the other hand, a more detail analysis of the literature shows that the results 
for experimental induction of the disease are indeed controversial (Table 2.4). Cowen et 
al. (1987) conducted five trials and tried 3 different methods: feeding a C. perfringens 
broth culture-feed mixture, exposure to NE- infected litter and combination of these two 
yet had variable results and was only able to produce disease in three out of five trials. 
 
 
 
 
 
Chapter 2           50 
 
 Table 2.4: Experimental reproduction of disease 
Challenge Route  Reference: 
 
Bacteria free crude toxin Intra-duodenally Disease produced Alsheikhly & Truscott, 1977a 
C. perfringens (10
7 
/ gram) Orally Disease produced Long & Truscott, 1976 
C. perfringens type A (dose not mentioned) Feed Disease produced Alsheikhly & Alsaieg, 1980 
C. perfringens 10
8
 cfu/ gram  Feed  Disease produced Shane et al., 1985 
 C. perfringens pure  culture  Orally  
Intravenous injection  
Disease produced Bernier et al., 1975 
C. perfringens  Feed   Unable to produce disease Cowen et al., 1987 
-   Litter  Unable to produce disease  Cowen et al., 1987 
4 x 10
6
 - 2x 10
9
  Feed  Disease produced Riddell & Kong, 1992 
C. perfringens 10
5-
-10
10 
 per chicken
 
 Feed  Kaldhusdal et al., 1999 
C. perfringens 10
2-
-10
03 
  Drinking water Unable to produce disease Takeda et al., 1995 
Dose not mentioned Gavage Unable to produce disease Takeda et al., 1995 
C. perfringens 10
01 
-10
10
 Feed Unable to produce disease Pedersen et al., 2003 
C. perfringens 10
8
 Feed  Disease produced Timbermont et al., 2008 
NE: Necrotic enteritis; C. perfringens: Clostridium perfringens 
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Although C. perfringens is major aetiological agent of NE there are other 
contributory factors (see section 2.6.4) that are required to predispose birds to the 
disease. Sufficient numbers of C. perfringens and damage to intestinal mucosa are two 
major factors that are known for the production of the disease (Alsheikhly & Truscott, 
1977a). Some experimenters have tried to induce NE with concurrent infection of 
coccidiosis. Shane et al. (1985) suggested that infection of broiler chicks with Eimeria 
acervulina prior to inoculation of C. perfringens at the levels of 2.5 x 10
8
 organisms/ 
gram of feed produced characteristic lesions of the disease and also resulted in increased 
mortality, from 8% in birds receiving C. perfringens alone, to 35 % in birds receiving 
Eimeria acervulina as well as C. perfringens. On the contrary, Baba et al. (1992) 
despite inoculation of higher number of coccidia and C. perfringens was unable to 
induce disease. Therefore inoculation of broiler chickens with C. perfringens does not 
always result in successful induction of disease (Shane et al., 1984; Pedersen et al., 
2003). 
To facilitate experimental induction of the disease some experimenters used 
opium to decrease intestinal peristalsis and sodium bicarbonate to neutralize acidity in 
the gut (Bernier et al., 1977). Some supplemented the diet with dietary Zinc along with 
Eimeria and C. perfringens (Baba et al., 1997). McReynolds et al. (2004b) used IBD 
vaccine to induce immunosuppression for successful induction of disease. 
Despite these frequent attempts, there is no generally established disease model 
for the experimental induction of NE in broiler chickens as constant reproduction of the 
disease is difficult to achieve so there is a need to develop an experimental model of the 
disease that can be applied to test products known to have a protective effect against C. 
perfringens. Therefore there is urgent need to identify factors that play crucial role in 
induction and pathogenesis of NE. 
 PREDISPOSING FACTORS FOR NECROTIC 2.8
ENTERITIS 
Although C. perfringens is documented as a causative agent of NE other 
contributory factors are essentially required that predispose birds to the disease. A 
documented key predisposing factor for the development of NE is an intestinal 
environment that favours the growth of C. perfringens in the gut. Favourable conditions 
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include, a decrease in intestinal motility and a, decrease in intestinal pH (Bernier et al., 
1974). 
The presence of predisposing factors are as important as the presence of C. 
perfringens and its virulence factors for disease production. Factors that predispose the 
bird to NE are management, nutrition, overcrowding of birds kept on litter, and 
inadequate hygiene routines (Kaldhusdal et al., 1999; McDevitt et al., 2006a). Reported 
factors that predispose the bird to NE can be divided into three major categories (Table 
2.5): 
 Infectious  
 Non-infectious/ Nutritional  
 Management 
2.8.1 Infectious predisposing factors for NE  
Different diseases that commonly occur amongst poultry have been identified as 
predisposing factors for NE. Among parasitic diseases, coccidiosis and the resultant 
intestinal damage may be a major predisposing factor for NE (Van Immerseel et al., 
2004). Experimental evidence regarding other parasitic infestations as predisposing 
factors that can lead to NE are scarce: C. perfringens was isolated from intestinal 
scrappings of turkeys from two commercial farms that experienced an outbreak of NE 
together with Ascaridia dissimilis (Norton et al., 1992). 
2.8.1.1 Coccidiosis 
Concurrent intestinal diseases like coccidial infection may be a potential risk 
factor for the development of NE; especially under field conditions. When sufficient 
numbers of C. perfringens are present coccidial infection can play a crucial role in the 
occurrence of NE.  
The precise mechanism of coccidial infection in the pathogenesis of NE is not 
clear. There are different theories that suggest coccidia play a major role in inciting the 
disease, however mucosal damage resulting from coccidiosis is a possible cause that 
predisposes birds to NE (Gazdzinski & Julian, 1992; Williams et al., 2003). The sexual 
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stage in the life cycle of the coccidian parasite results in extensive damage to the 
intestinal mucosa (Shane et al., 1985; Van Immerseel et al., 2004) and it is 
hypothesized that intestinal damage due to coccidiosis along with sufficient numbers of 
C. perfringens are prerequisites for NE, therefore it is perhaps the best known 
predisposing factor (Shane et al., 1985; Van Immerseel et al., 2004). In particular the 
Eimeria species that colonize the small intestine, such as Eimeria maxima and Eimeria 
acervulina, are known to predispose birds to NE (Alsheikhly & Alsaieg, 1980). Bradley 
and Radhkrishnan, (1972) observed that the growth of C perfringens also increased 
during infection with E. tenella. Baba et al. (1997) found that concurrent infection with 
E. nacatrix increased the clostridial population in the intestine of the chickens (Baba et 
al., 1997). 
Mucosal damage in turn facilitates the loss of protein in the intestinal lumen 
with the subsequent degradation of protein into amino acids by proteolytic enzymes in 
the GIT that may cause an increase in the acidity of digesta. An acidic pH (5.6 or lower) 
affects the permeability of the cell membrane and will ultimately suppress intestinal 
motility all of which favours C. perfringens growth. In addition to mucosal damage, 
coccidial infection also induces a host mucogenic response that results in increased 
mucus production. C. perfringens has a unique ability to utilize mucus as its substrate so 
increasing the amount of mucus provides a growth advantage for C. perfringens 
(Deplancke et al., 2002; Collier et al., 2008). 
Coccidiosis and NE are usually linked as they both have similar symptoms but 
coccidiosis is usually observed just prior to or during an outbreak of NE (Verleyen, 
2009). Some reports suggest that supplementation with anticoccidial preparations may 
reduce the incidence of NE (Alsheikhly & Alsaieg, 1980; Shane et al., 1985; Riddell & 
Kong, 1992; Williams, 2005). Some of the experimental evidence does not have reliable 
results so it has been argued that it was unlikely that coccidial infection plays any 
significant role in NE. This was because at that time coccidiostats were used during the 
most susceptible stage of NE (Nairn & Bamford, 1967). 
In contrast all the experiments that have successfully claimed reproduction of 
the disease included an overdose of coccidial vaccine or feeding live coccidia to cause 
intestinal damage during the progress of the experiments (Pedersen et al., 2003; 
McReynolds et al., 2005; Pedersen et al., 2008). Alsheikhly & Alsaieg (1980) and 
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Shane et al. (1985) suggested that supplementation with anticoccidials preparations may 
reduce the incidence of NE. Anticoccidial drugs like narasin, salinomycin lasalocid and 
maduramicin have been shown to have a beneficial effect on the control of NE in 
broilers (Elwinger et al., 1992; McReynolds et al., 2007; Timbermont et al., 2009b; 
Lanckriet et al., 2010; Lee et al., 2011). 
2.8.1.2 Viral disease / immunosuppression 
Some viral diseases like Infectious Bursal Disease (IBD), Chick Anemia Virus 
and Marek’s Disease have been suggested to promote the development of NE under 
field conditions (Williams et al., 2003; McReynolds et al., 2007; Timbermont et al., 
2009b; Lee et al., 2011). As these diseases can cause immunosuppression, they can 
increase the severity of NE (Lee et al., 2011). Indeed, in most of the experiments to 
induce NE, IBD vaccination has been used as predisposing factor (McReynolds et al., 
2004a). 
Table 2.5 : Various predisposing factors for NE 
Risk factor Reference 
Infectious   
Coccidiosis  
(Eimeria infection) 
Long, 1973; Alsheikhly & Alsaieg, 1980; Baba et al., 1992; 
Baba et al., 1997; Hofacre et al., 1998a  
Immunosuppression  McReynolds et al., 2004b 
Non-infectious   
Fish meal Wijewant & Senevira, 1971b 
Barley  Riddell & Kong, 1992; Kaldhusdal & Skjerve, 1996; Annett 
et al., 2002 
Wheat  Branton et al., 1987; Riddell & Kong, 1992; Kaldhusdal & 
Skjerve, 1996 Annett et al., 2002  
Increased digesta 
viscosity (NSPs) 
Kosher, 2003 
Lipids Dahiya et al., 2006 
Dietary protein  Truscott & Alsheikhly, 1977; Kaldhusdal & Skjerve, 1996; 
Drew et al., 2004; Dahiya et al., 2005a; Wilkie et al., 2005;  
Managment  
Litter  Cowen et al., 1987; Droual et al., 1994; Williams, 2005; 
Hermans & Morgan, 2007; Mikkelsen et al., 2009; 
Palliyeguru et al., 2010 
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2.8.2  Non infection predisposing factors for NE  
Non infectious predisposing factors for NE include a variety of 
management/environmental factors, such as poor management, overcrowding, 
inadequate hygiene routines, wet litter as well as nutritional factors such as inclusion of 
high levels of wheat, barley, fish meal, imbalance in the diet, the form of feed (see 
below). Any of these, or a combination have been shown to have a major effect on the 
incidence of NE (Wijewant. & Senevira., 1971c Long, 1973; Drew et al., 2004; Van 
Immerseel et al., 2004; Dahiya et al., 2006; Hermans & Morgan, 2007; Hofacre et al., 
1998b). 
2.8.2.1 Nutrition and dietary factors  
It is now widely recognised that diet has a strong influence on the incidence of 
NE in broilers (Baba et al., 1992; Annett et al., 2002; Drew et al., 2004; Kaldhusdal et 
al., 1999). Not only the chemical balance but also the physical quality of the diet can 
influence the microbes present in GIT (Smith & Macfarlane, 1998). Roller-mill ground 
wheat reduced NE related mortality compared to hammer ground wheat (Branton et al., 
1987). 
Diets enriched in cereals such as barley and wheat lead to an increased incidence 
of NE compared with a corn-based diet. This may be due to an increased proliferation 
of C. perfringens in the wheat and barley diets (Riddell & Kong, 1992; Branton et al., 
1997; Annett et al., 2002). Cereals like wheat and barley contain high levels of 
indigestible, water soluble non starch polysaccharides (NSPs) e.g. arabinoxylans and β-
glucans, that are not utilized by the bird but can act as a potential substrate for the 
microflora, so enhancing the growth of pathogenic bacteria within the GIT (Choct et al., 
1996; Iji & Tivey, 1998). The NSPs are also hydrophilic, increasing the viscosity of the 
intestinal contents, predisposing the bird to NE. Van Immerseel et al. (2004) gave a 
possible explanation of this as wheat or barley may contain certain substances that 
promote the proliferation of C. perfringens. Another possible explanation of the 
association of wheat, meat meal and fish meal with NE could be the higher zinc 
concentration (Leeson and Summers, 2001), as production of alpha toxin is increased by 
zinc which has also been shown to protect α-toxin from destruction by trypsin (Baba et 
al., 1992). 
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Poor quality wheat at levels above 50% corn-replacement can increase 
susceptibility to NE (Dekich, 1998). Some researchers have observed an association 
between NE and a specific brand of poultry feed (Nairn & Bamford, 1967). 
The other predisposing factor for NE is a diet with an high protein content, or a 
diet rich in animal protein such as fish meal or meat/bone meal (Wijewant & Senevira., 
1971d; Hafez, 2003). The level of crude protein, the protein source, and the amino acid 
content of a diet all have a significant affect on the intestinal population of C. 
perfringens. Genome sequence analysis of C. perfringens showed that it lacks many 
enzymes required for amino acid biosynthesis making it necessary to obtain this 
essential material from its host. Consequently a diet high in protein provides an 
exceptional amino acid source for C. perfringens proliferation thus predisposing the 
bird to increased risk of NE (Shimizu et al., 2001; Drew et al., 2004). Poorly digested 
protein diets act as a substrate for the C. perfringens in the lower gut, thus enhancing 
the growth of the organism (Verleyen, 2009). Another possible explanation of the 
association between wheat or fish/meat meal and NE could be the higher zinc 
concentration; since production of the alpha toxin associated with C. perfringens is not 
only increased in the presence of zinc but also the zinc protects the toxin from 
destruction by trypsin (Baba et al., 1992). Recently potato protein has become an 
additional risk factor due to its higher antitrypsin activity (Palliyeguru et al., 2010). The 
role of fish meal in the production of NE has also been recognised as being of 
importance. Most of the experimental models referred to in the literature used fish meal 
at concentrations from 18% - as high as 50% (Cowen et al., 1987; Cooper & Songer, 
2009). It is hypothesized that fish meal contains higher Zinc levels and, as α-toxin is 
zinc metallozyme it requires zinc for its activity. However, it has also been recognised 
that higher levels of Zinc in the feed also have a boosting effect on the immune status of 
the chicken. The dietary fat source is also known to have an effect on the incidence of 
NE, since animal fat (a mixture of lard and tallow) can lead to higher counts of C. 
perfringens when compared  to vegetable/ soya oil (Knarreborg et al., 2002). 
Not only the dietary content, but also its actual form can also affect the 
incidence of NE. An increased risk of NE has been also associated with pelleted feed 
compared to mash. Some researchers have observed the association of NE with a 
specific brand of poultry feed although they omitted to mention the name or its 
composition (Nairn & Bamford, 1967). In addition to all these dietary factors that 
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indirectly lead to proliferation of C. perfringens in the gut of birds, poultry feed is 
generally considered to be the major source of infected spores (Wijewant and Senevira., 
1971). 
2.8.2.2 Anti-nutritional factors  
Anti-nutritional factors such as protease inhibitors, lectins, tannins and 
mycotoxins may also affect the incidence of NE. For example, trypsin inhibitors found 
in soyabean meal reduce the digestibility of proteins, leaving higher concentrations of 
undigested proteins in the lower gut thus providing more suitable conditions for the 
growth of proteolytic bacteria like C. perfringens (Clarke & Wiseman, 2005; McDevitt 
et al., 2006a). Trypsin inhibitor activity (TIA) may also play a role in creating 
conditions favourable to a poor litter quality that indirectly can lead to NE (Clarke & 
Wiseman, 2010). 
Lectins are proteins and glycoproteins present in cereal grains such as wheat, 
barley, oats and rye as well as in legumes such as soya and kidney beans. Lectins may 
facilitate bacterial attachment to the gut epithelium which can facilitate the rate and 
extent of pathogen growth (Giovannini et al., 1996; Calderon et al., 1997; McDevitt et 
al., 2006a). Tannins are present in many dietary ingredients such as rapeseed meals and 
beans and can act strongly with protein leading to tissue damage that may predispose 
birds to NE (Robins & Brooker, 2005; McDevitt et al., 2006a). Although there are 
numerous diet related factors described in the literature it has not yet been agreed which 
dietary factors actually influence the disease due to variable results from different 
experiments.  
2.8.3 Management  
2.8.3.1 Litter 
Last but not least, wet litter has been demonstrated to be further significant risk 
factor for NE. Wet litter is a frequent condition with prevalence as high as 56% in UK 
broiler farms (Hermans & Morgan, 2007). There are a wide variety of causes of wet 
litter, such as climate conditions in the poultry house and leaky drinkers. In recent years 
the incidence of NE has been increasingly associated with NE. There is a direct 
correlation between sticky droppings and a poor litter condition with higher nitrogen 
Chapter 2  58 
levels. Moist and crusty litter allows proliferation of C. perfringens (Kaldhusdal et al., 
1995). Rough litter has also been suggested as the cause of intestinal damage which, 
together with increased colonization of C. perfringens, may result in a higher incidence 
of NE. There is conflicting information in the literature whether NE leads to wet litter 
and/or coccidiosis or whether these two conditions are risks factor leading to NE 
(Hermans & Morgan, 2007).  
Other poorly referenced and ill-defined factors known to increase the incidence 
of NE are increased farm size, a raised number of chicks placed in the last flock, a 
greater number of hatcheries supplying the chicks as well as a higher number of feed 
lorries entering the farm (Hermans & Morgan, 2007). 
To summarise the wide ranging literature, it is clear that almost anything that 
causes stress and results in an imbalance of the microflora of the GIT is a potential risk 
factor for NE. Despite substantial research efforts there is still a lack of full 
understanding of the actual mechanisms underlying the effect of the many predisposing 
factors as experimentation on predisposing factors does not always lead to induced 
disease. 
For many years, poultry producers have prevented and treated NE by routine 
inclusion of antimicrobial growth promoters (AGPs), such as bacitracin, lincomycin, 
avoparcin, avilamycin, amoxicillin and tylosin in poultry feed (Ficken & Wages, 1997; 
Craven et al., 1999; McDevitt et al., 2006a; Lanckriet et al., 2010). There has been 
growing public concern about the risk of bacterial resistance associated with the routine 
use of AGP in poultry production, as bacteria may become resistant to antibiotics, and 
the resistant genes may be transferred easily among and between different bacterial 
species. This may lead to risk of making antibiotic therapy ineffective in treating animal 
as well as human diseases. This may be the reason, of European Union wide ban on the 
use of AGP in poultry feed in January, 2006, (Van Immerseel et al., 2009). In the 
absence of in-feed antibiotics, alternative strategies require to be explored to protect 
against the outbreak of NE. However, to assess the efficacy of such strategies an 
infection model is required, which leads to the aim of this thesis. 
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PhD OBJECTIVES  
As discussed earlier, in the past few decades NE in poultry has been prevented 
and treated with the addition of in-feed antimicrobials. Rising concerns from 
consumers, about the negative effects of antimicrobials in animal feed, led many 
countries to ban their use. This in turn led to a resurgence of NE in poultry, with major 
economic and social effects globally. The resurgence of NE caused leading researchers 
to seek alternatives for the initial treatment and ultimately the prevention of this 
damaging disease.  
Despite of the fact that NE has being described almost five decades ago, the key 
aetiology agent that leads to the pathogenesis of the disease is still controversial, 
pathogenesis of NE is still poorly understood for a number of reasons. The main 
virulent factors are debatable as are the predisposing factors of disease, reflecting gaps 
in our understanding. Another gap in NE research is that to this date no reproducible 
and reliable disease model has been discovered. Unfortunately NE appeared to be very 
difficult to induce under control environmental conditions, most likely due to the 
potential presence of numerous ill-defined predisposing factors, and until now there has 
been no well established experimental disease model able to effectively and consistently 
produce the disease.  
Different species of broilers can differ in their susceptibility to different infectious 
diseases. Resistance to diseases could be due to genetic differences between the species 
(Lamont, 1998; Zekarias et al., 2002). There have been anecdotal reports of a variation 
between different broiler species (Ross vs Hubbard) in their susceptibility to enteric 
infectious diseases. Any variation in disease-resistance might be the result of underlying 
inter-species differences (Zekarias et al., 2002). Having already experimentally 
considered a wide range of factors associated with this disease, this researcher felt it 
was important to determine if there might be any validity in the anecdotal reports of 
species variation.  
The aims of this PhD are therefore: 
1. To develop a working infection model that enables experimental induction of 
sub-clinical NE in broiler chickens with special reference to prioritize nutrition 
related risk factors that purportedly predispose birds to sub-clinical NE. 
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2. To test breed sensitivity to disease induction, two chicken breeds, Ross and 
Hubbard, with varying degrees of susceptibility to the induced infection. 
3. To identify the novel biochemical markers for sub-clinical NE.  
To achieve these aims, the main focus of the work for this thesis has been: 
1. To establish a disease model for sub-clinical NE,  
2. Investigate the importance of the various factors that are believed to play a 
role in the development of sub-clinical NE, such as high proteins levels in 
diets, co- infection with coccidia, the level of C. perfringens in inoculum and 
contact with re-used litter  
3. Use the results to identify novel bio-chemical markers of the host for sub-
clinical NE.  
Thesis will provide a better understanding of the factors involved in the 
pathogenesis of sub-clinical NE thereby enabling development of new treatment and 
preventative strategies for restricting the damage inflicted on the global poultry industry 
by this terrible disease. 
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EXPERIMENTS 
3 EXPERIMENT ONE:  
CAN FEED WITHDRAWAL ASSIST EXPERIMENTAL 
INDUCTION OF SUB-CLINICAL NECROTIC ENTERITIS? 
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 Introduction 3.1
Necrotic enteritis in poultry was first described by Parish (1961) in a flock of 6-
7 weeks old cockerels, since then it has been reported world wide (Nairn & Bamford, 
1967; Long, 1973; Kaldhusdal et al., 1999; Brennan et al., 2003; Johansson et al., 
2004). Its primary cause is over-growth of C. perfringens type A (Alsheikhly & 
Truscott, 1977b), which is a normal inhabitant of the GIT of healthy birds (Flores-Diaz 
& alape-Giron, 2003). Necrotic enteritis is most common in broiler chickens 2-6 weeks 
of age (Helmbold & Bryant, 1971; Bernier et al., 1974). The clinical form of NE result 
in high mortality rates (Songer, 1996b; Van Immerseel et al., 2004; Thompson et al., 
2006) whereas sub-clinical NE remains a major problem in broiler flocks as this form of 
disease is not manifested by any signs or symptoms (Skinner et al., 2010) and mostly 
result in reduced weight gain and poor feed conversion (Kaldhusdal & Hofshagen, 
1992; Kaldhusdal et al., 1999; Engstrom et al., 2003). 
There are numerous suggested predisposing factors of NE, though most of them 
are ill defined. Possible factors that are associated with higher incidence of NE include 
increasing the amount of dietary crude protein which may increases the number of C. 
perfringens in caecum and thus predispose birds to NE (Drew et al., 2004). Diets based 
on rye, wheat oat and barley have been reported to have resulted in higher incidence of 
NE compared to corn based diets (Riddell & Kong, 1992). Occurrence of NE may also 
be affected by changes in feeding programmes (Craven et al., 1999; Craven, 2000), 
including temporarily cessation of feeding and other perturbation resulting from diet 
change over. 
Feed withdrawal has been shown to cause alterations in intestinal morphology 
and changes in mucus characteristics that in turn affect pathogen colonization in the gut 
(Deplancke et al., 2002; Thompson & Applegate, 2006). Results of Bilgili (1988) 
showed that the shear strength of duodenum was reduced in birds with 18 or 24 hrs of 
feed withdrawal compared to those with only 6 or 12 hrs of feed withdrawal. Later 
Northcutt et al. (1997) confirmed that integrity of intestines declined after 12-14 hrs of 
feed withdrawal. Feed withdrawal reduces the natural ability of broilers to inhibit the 
growth of several harmful bacteria like Salmonella and Enterobacteriacae. This was 
shown by the increased incidence of Salmonella in broiler crops (Corrier et al., 1999) 
and caeca of market age broilers challenged experimentally with high doses of 
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Salmonella enteritidis after 18hrs of feed withdrawal (Ramirez et al., 1997). It is known 
that starvation causes enlargement of goblet cells as well as causing an increase in 
mucin protein concentration in the small intestine (Uni et al., 2003; Smirnov et al., 
2004). Deplancke et al. (2002) showed that C. perfringens has an acidomucolytic 
potential, since it utilizes mucin as a substrate, shown by its rapid growth on a mucin 
containing medium that can subsequently result in NE. Thus, feed withdrawal could 
result in increased C. perfringens proliferation, and thus induce (sub-clinical) NE.   
Anecdotal field evidence indicates that NE can occur following a disruption in 
feeding (for example due to feeder mechanisms failing) as well as following feed 
change over. Therefore, patterns of occurrence of NE could be affected by dietary 
restriction or fasting. Moreover preliminary work together with evidential data gathered 
from a wide range of nutritional studies conducted at our lab supports the view that feed 
change over could be associated with the occurrence of subclinical NE (un-published 
work). Recent work has highlighted that a change of feed form (as happens at feed 
change over) causes birds to temporarily alter, in some cases entirely stop, their eating 
habits (un-published work). The interval between the end of feeding a starter diet and 
the beginning of feeding a grower diet is correlated with changes in GIT microflora 
which in turn may influence occurrence of sub-clinical NE. Therefore the objective of 
this experiment was to assess whether feed withdrawal assists the induction of sub-
clinical NE in broiler chickens inoculated with C. perfringens. 
 Materials and Methods 3.2
3.2.1 Treatment Groups and Experimental design 
A total of two hundred and forty, one-day-old male Ross 308 broiler chickens 
were randomly assigned to one of the three treatments, each replicated four times. All 
birds were given a standard starter diet until day 10, when they transferred to 12 floor 
pens adopting stratified randomization on body weight with 20 birds per pen. All the 
pens were equipped with plastic feeder hoppers and drinkers appropriate for the age and 
number of birds. On day 10 birds were divided into three treatment groups and grower 
diet was replaced after variable periods of feed withdrawal, i.e. no withdrawal (Group-
1, full fed control), 8 h of withdrawal (Group 2) or 15 hrs of withdrawal (Group 3). In 
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addition, on day 18, feed withdrawal time for Group-2 and Group 3 were 15 and 24 hrs 
respectively (Table 3.1).  
Table 3.1: Experimental design 
Groups Feed withdrawal Period 
Day 10 Day 18 
1 0 h 0 h 
2 8 h 15 h 
3 15 h 24 h 
Birds were reared in a solid floored pen (1.74m x 1.28 m) containing 10cm thick 
bedding material of wood shaving in an environmentally controlled house using a 
standard commercial management programme from day 0 to day 28. Birds were fed 
nutritionally complete standard commercial starter and grower diets (Table 3.2). No 
antibiotic growth promoter or anti-coccidial drugs were used in the diets. Both the diets 
were provided as mash.  
The research facility was thoroughly cleaned and disinfected prior to bird 
placement. Light was provided for 23 hours per day with controlled temperature and 
humidity. The three treatments were randomly allocated to pens with four positional 
blocks. Precautions taken to avoid accidental across pen contamination included 
changing of gloves and use of foot dipping tanks. All experimental procedures were 
approved by Scottish Agricultural College Animal Ethics committee (AE 15/2009) and 
carried out under Home Office authorization (PPL 60/3383). 
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Table 3.2: Ingredients and calculated composition (g/kg) of starter (days 0-10) 
and grower (days 10-28) experimental diets in experiment one 
Ingredient Starter (g/kg) Grower (g/kg) 
Wheat 621.9 668.9 
Soybean meal 216.6 165.6 
Rapeseed meal 41 40 
Soybean meal (ff) 34.5 38 
Vegetable oil 47 50 
Choline chloride 0.5 0.5 
Monodical 14.5 14 
Limestone 12 12 
Common salt 2.7 2.7 
Lysine 2 1.5 
Methionine 3.3 2.8 
Sodium bicarbonate 1.5 1.5 
Vitamin and mineral premix
1 
2.5 2.5 
   
Calculated nutrient composition   
Metabolizable Energy (MJ/kg) 13.2 13.5 
Crude protein 220 201 
Crude fiber 36 30 
Calcium 8.9 8.7 
Phosphorus 8 7.8 
Available phosphorus 4.7 4.6 
1
The vitamin and Mineral Premix (Target Feeds Ltd) contained vitamins and trace elements to 
meet the requirements specified by the breeder. The premix provided (units kg
-1
 diets  
supplement provided (units kg
-1
 diets): Vit A 16,000 iu; Vit D3 3,000 iu;  Vit E 75 iu;  Vit B1 3 
mg; Vit B2 10 mg; Vit B6 3 mg; Vit B12 15 µg;  Vit K3 5 mg; Nicotinic acid 60 mg; Pantothenic 
acid 14.5 mg; Folic acid 1.5 mg; Biotin 275 µg; Choline chloride 250 mg; Iron 20 mg; Copper 
10 mg; Manganese 100 mg; Cobalt 1mg; Zinc 82 mg; iodine 1 mg; Selenium 0.2mg;  
Molybdenum 0.5mg. 
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3.2.2 Bacterial Culture & Administration (Challenge) 
To ensure a standardized background level of C. perfringens all birds were 
gavaged at 7 days of age with 1 ml of broth containing 10
4
 cfu of C. perfringens. The C. 
perfringens strain 56 was isolated from the intestine of a broiler chicken with severe 
necrotic gut lesions that produce moderate amounts of α-toxin in vitro. This was a type 
A strain (no enterotoxin or beta-2 gene), netB positive and has been used previously to 
induce NE in an in vivo model (Gholamiandehkordi et al., 2007). The strain was stored 
in the form of frozen beads at -80°C. From the frozen culture, bacteria was grown 
overnight on Tryptose Sulphite Cycloserine (TSC) agar.  
The TSC agar was obtained as dehydrated media (Oxoid Ltd, UK) and 
reconstituted according to the manufacturer’s instructions. 23 gms of powdered TSC 
agar compound was weighed into a 500ml Schott Duran bottle, and diluted with 
distilled water to a volume of 500ml and fully mixed. When completed, the bottles of 
agar media were sterilized in an autoclave at 121°C for 10 minutes before being cooled 
to 50°C in a preheated water bath where the bottles were held until required for pouring 
onto plates. All supplements were removed from storage at 4°C about an hour before 
they were required, to allow acclimatisation to room temperature. Selective antibiotic 
supplements (SR-0088E, Oxoid Ltd, UK) were reconstituted with 2ml of sterile distilled 
water. Immediately before pouring, supplements were added to the agar one at a time in 
the water bath and the bottle mixed gently. Approximately 10-15ml TSC agar with egg 
yolk emulsion (25ml/500ml: SR-0088E, Oxoid Ltd, UK) was poured into each of the 
culture plates and allowed to spread evenly. When the agar solidified the plates were 
labelled. 
Frozen beads were streaked out onto the TSC agar plate with the help of sterile 
disposable loops to ensure an even distribution of the mixture across each agar plate. 
These plates were incubated invertedly in an anaerobic jar with CO2 generating gas 
packs (AnaeroGen™, AN0025A, Oxoid Ltd, UK). The jar was placed in an incubator at 
37°C for 24hrs. Before inoculation in the feed, the bacteria were cultured for 24hrs at 
37°C in Brain Heart Infusion (BHI) broth (CM 1032, Oxoid, Ltd, UK). 
After overnight incubation, 3 colonies (Figure 3.1) were taken from TSC agar 
plates and mixed with BHI broth. The BHI broth was obtained as dehydrated media and 
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reconstituted according to the manufacturer’s instructions. 37g of powdered BHI was 
weighed and dissolved in 1 litre of distilled water by mixing. When completed the 
bottles with the dissolved/mixed BHI were sterilized in an autoclave at 121ºC for 15 
minutes. When cooled down, 2ml of BHI broth was taken into sterile bijou bottles. 
 
Figure 3.1: Black colonies of C. perfringens on Tryptose Sulphite Cycloserine 
(TSC) agar medium. 
3.2.3 Growth performance 
Up to 3-4 colonies from overnight cultures of TSC plates were taken and 
inoculated into bijou bottles with BHI broth. Brain heart infusion broth was incubated at 
37ºC, shaking at 60rmp anaerobically overnight (18-24hrs). The concentration of C. 
perfringens in the inoculum was estimated spectrophoto-metrically at 600nm 
(Spectronic 301, Milton Roy) with the aid of a standard curve. Actual C. perfringens 
concentration in the inoculum was confirmed by plating on TSC agar plates, incubating 
the plates at 37°C overnight, and counting the number of black presumptive C. 
perfringens colonies. All birds were gavaged on 7 days of age with 1ml of BHI broth 
containing 10
4
 cfu/ml C. perfringens. Broth was orally delivered into the crop of each 
chick once only using a bottle equipped with vinyl tubing about 3-4cm long (Figure 
3.2). 
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Figure 3.2: Gavaging birds with Clostridium perfringens broth. 
3.2.4 Vaccinations 
All the birds were vaccinated with coccidial vaccine (Paracox
®
 -5) at day old. 
Each 0.004 ml dose of vaccine contains the following numbers of sporulated oocytes 
derived from precocious lines of coccidia: E. acervulina HP 500-650, E. maxima CP 
200–230, E. maxima MFP 100–130, E. mitis HP 1000-1300 and E. tenella HP 500–650) 
(Schering-Plough Animal health, Welwyn Garden City, UK). Birds were vaccinated at 
9 days old with infectious bursal disease (IBD) vaccine (Poulvac® Bursine2, Pfizer 
Animal Health) in drinking water following normal procedure of vaccination i.e. one 
hour prior to vaccination the water supply to the birds was stopped to ensure every bird 
was vaccinated. 
3.2.5 Data Collection  
3.2.5.1 Sampling of birds  
Birds were observed daily for any signs and symptoms of NE. On 12, 20 and 28 
days of age, five birds from each replicate pen were selected at random and euthanized 
by an intravenously administered overdose of barbiturate. Total ileum content/digesta 
were collected in sterile containers to enumerate total coliforms, Lactobacilli and C. 
perfringens. Samples of digesta were also taken in a separate sterile container for toxin 
determination. 
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3.2.5.2 Lesion scoring 
Three sections of small intestine (duodenum, jejunum and ileum) were identified 
from the removed GIT, immediately incised, washed with phosphate buffer saline 
(PBS) and the whole length of tissue was inspected for evidence of lesions (clostridial 
or coccidian). A scoring system was used to score intestinal lesions for NE on a scale 0-
3 (adapted from Shane et al., 1985) (see Figure 7.2 to Figure 7.4).  
 score 0: absence of gross lesions or no lesions; 
 score 1: focal necrosis or focal ulceration; 
 score 2: focal ulceration coalesced to form discrete patches; 
 score 3: extensive diffuse mucosal necrosis; 
3.2.5.3 Histopathology 
Following post-mortem examination, a 1.5-2cm of tissue sample from small 
intestine, particularly those showing lesions were taken and washed with phosphate 
saline to ensure that intestinal samples were completely covered by fixative. Tissue 
samples were then stored in 10% buffered formalin for histopathology. The amount of 
fixative was 10 times the volume compared with the amount of tissue sample. Tissues 
were stored in fixative solution until required for processing. 
For processing the intestinal samples were dehydrated by transferring the 
sections into a series of progressively increasing concentrations of ethanol (50, 60, 70, 
80, 90, and 100%) for 2 hrs. Subsequently the sections were immersed in xylene to 
remove ethanol before being placed in blocks and filled with molten paraffin wax. This 
is necessary to prevent collapse and distortion of tissue during sectioning. When the 
wax is cooled or hardened the block of wax containing the processed tissue was 
sectioned into 3-5µm sections using a microtome. Thin sections were then placed in a 
warm water bath to remove wrinkles before being taken up onto a glass slide. The slides 
were place in an oven at 55°C for 15 minutes for the sections to adhere onto glass slide. 
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The paraffin was removed by quickly immersing the slides through xylene. The 
deparaffinised tissues were then rehydrated in water. The samples on the slides were 
stained with Haematoxylin and Eosin (Appendix-A). Haematoxylin was used to stain 
the nuclear material dark blue, while the eosin was used to stain the cytoplasm pink. 
After the staining procedure, the glass slides were carefully blotted dry and 
mounted by placing a drop of DPX mounting medium (synthetic resin mounting media) 
onto a cover slip and arranging it over the top of the sections on the slide, Excess DPX 
was wiped and the slide was allowed to dry. The prepared tissue sections were later 
examined using a binocular setero-microscope (Olympus BX 41, U-LH100HG, 
Olympus optical Co. Ltd) connected to a camera (spot idea™ 28.2-5MP) to computer 
software (Spot idea, Version 4.7), using different magnifications (x4, x10, x40 and 
x100). 
3.2.5.4 Enumeration of C. perfringens, total coliforms and lactobacilli 
For enumeration of C. perfringens, total coliforms and lactobacilli, ileal contents 
(digesta content from the Meckel’s diverticulum to ileo-caecal-colon junction) were 
taken into sterile screw capped bottles and transferred immediately to our microbiology 
laboratory. For C. perfringens enumeration, dilutions were plated on Tryptose Sulphite 
Cycloserine agar (TSC, Oxoid UK CM0587) containing supplements (Oxoid, UK, 
SR0088) and incubated anaerobically overnight. TSC agar plates were prepared as 
previously described in section 3.2.2 of this thesis. Presumptive lactobacilli and total 
coliforms were enumerated on Man Rogosa Sharpe agar (MRS, Oxoid CM0361) and 
Membrane Lactose Glucoronide agar (MLGA, Oxoid CM1031), respectively.  
The MRS and MLGA media were especially chosen for their selectivity. 
Powdered MRS compound (62 g) and MLGA agar compound (88 g) were weighed into 
one litre Schott Duran bottles, diluted to a volume of 1000ml and mixed well prior to 
sterilization by autoclaving at 121°C for 15 minutes. The MRS agar was boiled before 
sterilization. After autoclaving the media were cooled down. Then around 15-20ml 
volume of media were poured into sterile Petri dishes and allowed to settle. All plates 
were inverted, sealed and stored at a temperature below 4ºC until required for 
enumeration of the respective bacteria. 
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Maximum Recovery Diluent (MRD) was used for serial dilutions of the digesta 
samples. The media was obtained as dehydrated media (Oxoid Ltd, UK), reconstituted 
according to the manufacturer’s instructions through dissolving 9.5 g MRD powder 
(CM0733) in 1 litre of distilled water, which was then sterilised by autoclaving at 121°C 
for 15 minutes.  
Each digesta sample was vortexed for 15 seconds in order to ensure adequate 
mixing. One g of ileal contents were weighed and well mixed with 9 ml MRD. Serial 
dilutions of 1ml in 10 were prepared for each sample tested down to 10
-7 
to give a total 
of 7 tubes in the dilution series (10
-1
, 10
-2
, 10
-3
, 10
-4
, 10
-5
, 10
-6
, and 10
-7
). From each 
dilution to be plated, 100µl were applied to the centre of a selected agar plate using a 
sterile spreader to ensure distribution of the mixture across the agar plate. Time was 
allowed for the liquid to be soaked up before 15ml of TSC overlay (without egg yolk) 
was spread. The plate was then incubated invertedly, in an upright position, in a jar 
providing anaerobic growing conditions. The jar was placed in an incubator at 37°C for 
24 hrs. After incubation the number of colonies was counted on the most appropriate 
dilution, i.e. on plates with 30-300 colonies. This figure was then used to calculate the 
number of colony forming units per gram of original sample. 
For enumeration of C. perfringens, dilutions were plated on TSC and were 
incubated at 37°C in jars containing gas generation kits (Anaerogen: AN0025 and 
AN0035, Oxoid). Lactobacilli were enumerated on MRS after incubation at 37°C for 48 
hrs. For enumeration of total coliforms, dilutions were plated on MLGA and typical 
colonies were counted following incubation at 35°C for 24 hrs. Each sample was plated 
in duplicate. Morphological characteristics of C. perfringens were further confirmed 
with a Gram stain (Appendix B).  
3.2.5.5 Quantification of α-toxin in intestinal digesta 
For detection of α-toxin in intestinal digesta, C. perfringens α-toxin ELISA kit 
(Cypress diagnostics, Belgium, Ref. VB040) was used according to the instructions of 
the manufacturer. The test used 96 well micro titration plates sensitized by specific 
monoclonal antibodies for the α-toxin to coat the well with antigen. Digesta samples 
were diluted volume per volume with dilution buffer and 100 µl aliquots of digesta 
samples were added to the duplicate wells. The plates were covered with lids and 
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incubated at room temperature (18-24ºC) for 1 hr prior to three successive cleanings 
with a washing solution using the concentrated washing solution provided with the kit 
that had been diluted 20 fold with a concentrated dilution buffer in distilled water. The 
plates were further incubated for 1 hr at room temperature with 100 µl of peroxidase 
labelled anti-alpha-toxin monoclonal antibody. After this second incubation the plates 
were washed again and a volume of 100 µl of chromogen (tetramethyl benzidine, TMB) 
was added to each well and incubated for further 10 min at room temperature. The 
reaction was stopped with 50 µl of stop solution. The optical density (OD) at 450nm 
was recorded with a microplate reader (Dynex, ICXE0072). Positive and negative 
controls were included, where positive control consisted of pure α-toxin and negative 
control of incubation buffer only.  
3.2.5.6 Growth parameters  
Body weight (BW) was measured on days 10, 14, 21, 28. Average feed intake 
(FI), average weight gain (WG) and feed conversion ratio (FCR) were calculated for the 
period days 10-14, 14-21 and 21-28. To determine feed intake, the feed offered was 
recorded and refusals weighed back on days 10, 14, 21 and 28. Feed conversion ratio 
was derived by dividing average feed consumed per pen by average weight gain of birds 
per pen.  
The birds were inspected daily within the experimental period and the birds that 
died or were culled were recorded, weighed and post-mortemed. When calculating feed 
conversion the body weight of dead birds was taken into account. 
3.2.6 Statistical Analysis 
The effect of feed withdrawal on counts of different bacteria (C. perfringens, 
total coliform and lactobacilli and growth parameters (average FI, WG and FCR) were 
compared using randomized complete block analysis of variance (ANOVA). The pens 
were treated as the experimental unit, and pen position used as block. Data are 
presented as means. Days 0-10 was initially used as covariate, but omitted from final 
model used when it did not contribute significantly in growth parameter analysis.  
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Because of the skewed nature of their distribution, C. perfringens, total 
coliforms and lactobacillus counts were transformed according to log (n + 1) to 
normalize the data before statistical analysis. Comparison contrasts were used to 
separate treatment means. Significance of the test was determined `at P<0.05. All 
statistical procedures were performed using Genstat 11 for Windows (VSN 
International Ltd, Hemel Hempstead, UK). 
 Results 3.3
The birds did not show any signs of clinical abnormalities (i.e. depression and 
ruffled feathers) in any of the treatment groups subsequent to C. perfringens challenge. 
Only one bird died (0.42%) during the course of the experiment. 
3.3.1 Lesion score  
On day 12 of the experiment, necropsy findings did not show any gross lesions 
in the intestines (duodenum, jejunum and ileum) in any of the treatment groups. 
However on day 20, lesions like mild focal changes and/ or small necrotic patches were 
seen in two birds from Group-3. On day 28, lesions similar to sub-clinical NE were 
found in two, three and one birds from Groups 1, 2 and 3 respectively.  
The intestinal gross lesions in most of the birds were very mild and inconclusive 
of NE (e.g. intestinal wall was very friable thin and hyperaemic with mesenteric vessels 
engorged with blood).  
3.3.2 Histopathology 
Histopathological examination of formalin fixed intestinal tissue on different 
days was done to confirm these changes and the relation to sub-clinical NE. 
Microscopic examination of the tissue sections revealed no lesions specific to sub-
clinical NE. There was no necrosis or desquamation of epithelial cells in intestinal villi. 
There was no evidence of Gram-positive rod-shaped organisms attached to the intestinal 
mucosa. Polymorphonuclear cells infiltration was not seen in the lamina propria in any 
of the sections. Although mucosal scrapings did not show any coccidial oocytes 
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numerous coccidial oocytes were seen scattered in the villi and crypts of intestinal 
mucosa (Figure 3.3). 
 
Figure 3.3: Photomicrograph of the intestine of broilers, showing presence of 
coccidial macrogamete (arrow), the overall architecture of villi are preserved. 
Haematoxylin and Eosin (x40). 
3.3.3 Quantification of different bacteria and α-toxin in ileal 
digesta 
Figure 3.4 shows the effect of feed withdrawal on C. perfringens, total coliforms 
and lactobacilli concentrations in ileal digesta of the birds euthanized on day 28. Group 
3 birds had greater concentrations of C. perfringens than Group 1 and 2 birds (P = 
0.071). Conversely counts of lactobacillus were significantly lower in ileal digesta of 
Group 3 birds compared to Group 1 and 2 birds (P= 0.032; Figure 3.4). Total coliforms 
populations tended to have higher concentrations in digesta of Group 3 birds compared 
to Group 1 birds (P = 0.061; Figure 3.4). Alpha toxin was not detected in ileal samples 
of birds from any of the treatment groups on different dissection days. 
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Figure 3.4: Ileal digesta microflora of broilers chickens on day 28 post hatch 
subjected to different period of feed withdrawal: Group 1: full fed control; Group 
2: 8 and 15 hrs feed withdrawal on days 10 and 18, respectively; Group 3: 15 
and 24 hrs feed withdrawal on days 10 and 18, respectively. The error bar is the 
standard error of the mean (SEM). 
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3.3.4 Growth performance 
Table 3.3 shows the effect of feed withdrawal treatment on averaged feed intake 
(FI) and feed conversion ratio (FCR) during days 0-10, 10-14, 14-21 and 21-28. During 
days 10-14, Group 1 birds had significantly higher FI than Group 2 and 3 birds, but feed 
withdrawal did not significantly affect FI during days 14-21 (Table 3.3). However, 
during days 21-28, Group 2 birds had higher FI than Group 3 birds. Group 2 birds had 
significantly better FCR compared to Group 1 birds during days 10-14. There was a 
trend for FCR to be decreased in Group 2 birds during days 14-21 (Table 3.3) but there 
was no significant effect of feed withdrawal on FCR during days 21-28.  
Table 3.4 shows the effects of feed withdrawal on average body weight (BW) of 
broilers on days 10, 14, 21 and 28 as well as on average weight gain (WG) during days 
10-14, 14-21 and 21-28 of birds. On days 14 and 21, Group 3 birds had smaller BW 
than Group 1 and Group 2 birds. However, on day 28, Group 2 birds had significantly 
higher BW compared to Group 1 and 3 birds. During days 10-14 and 14-21, Group 2 
birds had significantly higher WG than Group 1 and 3 birds. However, feed withdrawal 
had no effect on the WG during 21-28 (Table 3.4).  
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Table 3.3: Average feed intake and feed conversion ratio of groups of broilers on different days in different treatment groups 
Feed withdrawal Feed intake (g/bird/period) Feed conversion ratio 
Groups Day 10 Day 18 0-10 10-14 14-21 21-28 0-10 10-14 14-21 21-28 
1 0 h 0 h 248 293
a 
690 820
ab 
1.30 2.16
a
 
 
1.87 1.89 
2 8 h 15 h 247 247
ab 
665 873
a 
1.26 1.64
b 
1.57 1.76 
3 15 h 24 h 244 216
b 
663 792
b 
1.23 1.94
a 
1.92 2.02 
           
Probability of treatment effect 0.935 0.025 0.829 0.051 0.499 0.029 0.088 0.362 
SEM
1 
9.7 16.3 34.4 18.1 0.03 0.11 0.10 0.12 
Means within a column without a common superscript differ significantly (P<0.05) 
1
SEM: Standard error of means 
2
Data represents the mean of four pens with 20 birds per pen 
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Table 3.4:  Average body weight and weight gain of groups of broilers on different days in different treatment groups 
Feed withdrawal Average body weight (g) Average weight gain (g)  
Groups Day 10 Day 18 10 14 21 28 0-10 10-14 14-21 21-28 
1 0 h 0 h 231 367
b 
735
b 
1174
a 
191 135
b 
369
a 
439 
2 8 h 15 h 237 387
a 
809
a 
1306
b 
196 150
b 
422
b 
497 
3 15 h 24 h 238 349
c 
695
c 
1096
a 
197 111
c 
346
a 
401 
           
Probability of treatment effect 0.266 0.001 <0.001 0.019 0.301 <0.001 <0.001 0.203 
SEM
1 
2.8 5.0 11.0 37.1 2.81 3.4 8.4 34.9 
Means within a column without a common superscript differ significantly (P<0.05) 
1
SEM: Standard error of means 
2
Data represents the mean of four pens with 20 birds per pen 
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 Discussion  3.4
Although the GIT constitutes only 1.5% of the body weight of chickens, it 
consumes 6-8% of the dietary energy (Spratt et al., 1990). Therefore short term feed 
withdrawal can cause rapid alterations in intestinal morphology and mucus secretion 
which in turn can dramatically reduce the integrity of the intestine (Thompson & 
Applegate, 2006). Loss of intestinal integrity may leave birds prone to intestinal 
diseases like sub-clinical NE. Although C. perfringens is commonly found in the 
intestinal tract of poultry, its population can vary considerably from a few to 10
4 
cfu/g 
of digesta and the occurrence of NE is sporadic (Cowen et al., 1987; Engberg et al., 
2002; McDevitt et al., 2006b). 
During the present experiment none of the treatment groups produced overt 
clinical signs of NE (depression and ruffled feathers) subsequent to C. perfringens 
challenge in any of the treatment groups. Typical gross lesions of NE consist of marked 
distensions of the small intestine, with necrotic lesions varying from 0.5-1.5cm in 
diameter, randomly distributed either singly or in the form of aggregates. In severe 
cases entire duodenal and jejunal mucosa were covered by a yellow-brown diphtheritic 
membrane, together with a bile stained fluid or a core of granular debris in the lumen of 
the intestine (Long, 1973; Shane et al., 1985). On day 12 of the experiment, necropsy 
findings did not show any gross lesions in the small intestines of any of the feed 
withdrawal treatment group. However on day 20, lesions like mild focal changes and/or 
small necrotic patches were seen in two birds from group-3. On day 28, lesions similar 
to sub-clinical NE were found in two, three and one birds from groups 1, 2 and 3 
respectively. In most of the birds gross lesions were very mild and inconclusive for NE 
(e.g. intestinal wall was very friable thin and hyperaemic with the mesenteric vessels 
engorged with blood). 
Microscopic lesions of sub-clinical NE are characterized by severe necrosis of 
intestinal mucosa, with fibrin that is mixed with cellular debris adherent to necrotic 
mucosa, as well as large clusters of C. perfringens present in the necrotic mucosa. 
Marked infiltration of heterophil granulocytes are also observed in the intestinal mucosa 
(Long et al., 1974; Kaldhusdal & Hofshagen, 1992). However, histopathological 
examination of microscopic slides confirmed that lesions observed in the current 
experiment were not typical of NE although some coccidial oocytes were seen in the 
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intestinal mucosa. Gram staining further confirmed the absence of Gram-positive rod-
shaped organisms in the intestinal mucosa. Although mucosal scrapings (done at the 
time of necropsy only from birds that exhibited lesions on different dissection days) did 
not show any coccidial oocytes, numerous coccidial oocytes were seen scattered in the 
villi and crypts of the intestinal mucosa (Figure 3.3). Shane et al. (1985) clearly 
demonstrated that concurrent or prior infection with E. acerulina exacerbated the lesion 
score, the severity of histological lesions and mortality in broiler chicks. coccidiosis has 
been used as factor that predisposes birds to NE (Alsheikhly & Alsaieg, 1980; Shane et 
al., 1985).  
Although feed withdrawal did not significantly affect the counts of different gut 
flora, overall the Group 2 birds showed a better bacterial profile in terms of lower 
numbers of C. perfringens, coliforms and higher counts of lactobacilli. In the present 
study, numbers of C. perfringens ranged between 1.8 x 10
4
 and 3.2 x 10
6
 cfu/ml of 
digesta. Some authors have found C. perfringens counts ranging from 10
5
 to 2 x 10
8
/g 
of small intestine contents of birds suffering from NE (Long et al., 1974; Cowen et al., 
1987). Increased number of C. perfringens as much as log 4.5 has been observed in 
ileum in the clinically healthy birds (Dahiya et al., 2005a). Necrotic enteritis is said to 
occur when the number of C. perfringens reaches above 10
8
 cfu/g of digesta 
(Kaldhusdal & Hofshagen, 1992). On the basis of that definition, the levels of C. 
perfringens were found in this study appear to suggest that any lesions observed could 
have indicated the initiation of sub-clinical NE. 
Much of what is currently known regarding the effect of feed withdrawal on gut 
microflora in broilers has been provided by experiments that have examined feed 
withdrawal near slaughtering age. Thompson et al. (2008) found that as feed withdrawal 
time increases, the uniformity of the microbial population of the intestine decreases. 
Many populations of bacteria have been shown to coexist with C. perfringens. One of 
the largest populations of bacteria found in intestine along with C. perfringens is 
coliform bacteria (McReynolds et al., 2004b; Collier et al., 2008). In the present study, 
there was tendency of Group-3 birds to have higher numbers of coliform and lower 
numbers of lactobacilli than Group-1 birds (full fed control). These results are similar to 
Hinton et al. (2000) who reported that feed withdrawal periods up to 24 hrs caused 
increase in counts of Enterobactericeae together with a decrease in lactobacilli in 
broilers. Our results also agree with those of Northcutt et al. (2003a; 2003b) who did 
Chapter 3  81 
not observe any significant effect of feed withdrawal on coliform, E. coli and 
Salmonella counts on carcasses after 12 hrs of feed withdrawal. 
Fukata et al. (1991) concluded that when changes in the intestinal environment 
take place, such as a reduction in major microflora like lactobacillus, this can result in 
an increase in the number of C. perfringens which in turn may result in increased 
production of α-toxin and the resultant breakout of NE. Although not statistically 
significant, the trend towards a numerical increase of C. perfringens should not be 
ignored. Coupled with other predisposing factors, this increase of C. perfringens may 
contribute to increasing the risk of clinical outbreaks or the development of subclinical 
NE in broiler chickens under intensive rearing conditions. Thompson et al. (2008) also 
found a reduction in the microbial population and diversity of ileum as feed withdrawal 
time increased from 0 hr to 24 hrs. Hinton et al. (2000) showed that feed withdrawal 
periods up to 24 hrs caused increases in caecal enterobacteriacae population as well as 
the aforementioned decreases in lactobacilli of broilers. The exact mechanism by which 
feed withdrawal alters the bacterial population is not fully understood (Thompson et al., 
2008). Individual host factors may be contributing to the shifts observed in response to 
feed withdrawal. 
The growth performance of the birds in the experiment was comparable with 
commercial levels (Aviagen, 2009). In the current study, C. perfringens challenge had 
not caused an inhibition of average BW at day 10 (i.e. compared to commercial 
expectations). We were expecting that there would be a trend for average FI to be lower 
during study days 10-14 in group-2 and group-3 birds, since both groups were subjected 
to feed withdrawal for 8hrs and 15hrs respectively. Unexpectedly, on days 21-28 group-
2 consumed more feed (Table 3.3) compared to group-1 (full fed control). During the 
study period between 10-14 and 14-21, feed withdrawal treatment did not affect the 
feed intake of the different groups, although feed was withheld for 8hrs and 15 hrs for 
group 2 and 3 respectively. Similar results were seen on study days 14-28, although 
interestingly on days 21-28 the birds of group-2 had significantly higher average FI than 
group-3. The reason for this may be that group-2 over consumed the feed after it had 
been returned. Short periods of feed withdrawal in fact act as a stimulus to consumption 
(Washburn & Bondari, 1978). Birds learn quickly to eat normal quantities of food after 
feed restriction by limiting the time of access to food (Lee et al., 1971). The increase in 
growth rate of birds of group-2 between 14-21 days is perhaps an example of better 
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protein utilization and accelerated growth. Birds with restricted access to feed can more 
efficiently utilize protein from the diet than unrestricted birds when feed is resumed 
after feed restriction (Fontana et al., 1992). Plavnik & Hurwitz (1990) suggested that 
growth could be promoted by using a mild feed restriction at an early age. The non-
significant results in average WG of birds at 21-28 days of age was expected in 
response to feed withdrawal on days 10 and 18 only. The numerically increased growth 
in group-2 at 21-28 days of age was associated with increased feed intake. 
Different feed withdrawal periods in the present experiment did not have an 
effect on the overall incidence of subclinical NE. This disease is not readily reproduced 
under experimental conditions. Parish, (1961) did not find any effect on the course of 
NE due to change of diet, including supplements of  vitamins and minerals, although 
some scientists (Shane et al., 1985) were able to successfully produce NE by giving 24 
hours of fasting prior to offering infected feed to the experimental birds. However, they 
gave considerably higher dosages of coccidial oocytes (3.5x 10
5
) orally
 
and very high 
numbers of C. perfringens (2.5 x 10
8 
cfu/g of feed) over many days. In the present study 
the coccidial vaccine was given at the prescribed dose rate of 3000 coccidial 
oocytes/0.1ml of vaccine and 10
4 
cfu of C. perfringens only once orally. 
To our knowledge, the current experiment is the first to have assessed the effect 
of feed withdrawal in isolation on sub-clinical NE in young broiler chickens. Although 
feed withdrawal has been applied in most of the previous controlled experiments 
(Pedersen et al., 2003; Jia et al., 2009), even when birds were challenged with very high 
numbers of C. perfringens, these experiments also failed to induce NE (Pedersen et al., 
2003). It is known that during short hours of starvation more digestive enzymes, such as 
trypsin are released with trypsin recognised as inactivating the α-toxin of C. perfringens 
(Baba et al., 1992). It may also be possible that paracox-5® used in the present 
experiment was unable to induce sufficient gut damage. Although mucin quantity was 
not measured in the present study it is not impossible that insufficient mucin was 
produced as a result of starvation. 
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 Conclusion  3.5
The apparent lack of expected results may indicate that, if fasting with C. 
perfringens challenge is indeed predisposing to sub-clinical NE, there must be some 
other critical variables involved. The findings of the current study appear to indicate 
that feed withdrawal of the duration used in the present study did not predispose birds to 
(sub-clinical) NE. Furthermore, as specific lesions were not observed and C. 
perfringens counts in digesta were also low we conclude that feed withdrawal alone 
does not predispose birds to sub-clinical NE. 
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4 EXPERIMENT TWO:  
INTERACTIVE EFFECTS OF DIET COMPOSITION AND 
LITTER CHALLENGE ON THE INCIDENCE OF SUB-
CLINICAL NECROTIC ENTERITIS IN BROILER 
CHICKENS 
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 Introduction 4.1
Over the last few years there has been growing interest in utilising soybean meal 
(SBM) and canola meal (CM) as the major, high quality vegetable protein source in 
poultry diets. In countries where high prices of various protein sources make their use 
limited for poultry diets, this results in changes to both the sources and quality of 
protein in poultry diets (Palliyeguru et al., 2010). A higher than recommended level of 
dietary protein is believed to be a major predisposing factor affecting the incidence of 
sub-clinical NE in poultry. High SBM prices limit its use, compared with CM which is 
available for a much lower cost. However, the nutritional value of CM is limited due to 
the presence of a number of anti-nutritive factors, including indigestible non-starch 
polysaccharides and a high phytate (3-6%) content (Bell, 1984; Slominski & Campbell, 
1990). Phytate is known to reduce amino acid digestibility (Selle et al., 2000) thus 
providing increased nutritional opportunities for C. perfringens to grow and release α-
toxin. On the other hand it also inhibits the activity of digestive enzymes like trypsin 
and so reduces the degradation of the α-toxin associated with NE. However, whilst there 
is some information available on the anti-nutritive effects of CM (Bell, 1984; Slominski 
and Campbell 1990), the literature is lacking detail regarding a possible effect of CM on 
C. perfringens proliferation and concurring incidence of (sub-clinical) NE. 
A recently identified dietary factor that may be responsible for NE is the presence 
of certain anti-nutritional factors, like trypsin inhibitors (TI), in feed. These TIs can vary 
between different poultry diets, and a concentration of 3µg/ml of TI could possibly 
occur in practical feed samples (Probert, 2004). Higher than normal levels of TI in a diet 
may help to stabilise the α-toxin that is responsible for NE, possibly by reducing the 
surplus of pancreatic trypsin so preventing possible degradation of α-toxin by trypsin, 
the main factor for induction of NE (Palliyeguru et al., 2011). Recently potato protein 
concentrate (PPC) has been shown to be an additional risk factor due to its higher 
antitrypsin activity (Palliyeguru et al., 2010; Fernando et al., 2011). Birds fed diets with 
a high potato protein content (417.2g/kg) had higher counts of C. perfringens when 
compared with birds fed diets based on other plant proteins (Wilkie et al., 2005). 
Palliyeguru et al. (2010) also found a higher incidence of NE in birds fed potato protein 
based diets compared to soy protein. 
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In addition to diet, the condition of litter is another overlooked factor that can be 
responsible for inducing (sub-clinical) NE. The litter used for the bedding in poultry 
houses can be composed of wood chips, sawdust, wheat straw, or peanut hulls, and may 
play a role in possible colonization of  microbes in birds’ guts since Clostridia species 
have frequently been isolated from poultry litter (Alexander et al., 1968). Poor litter 
quality often provides an excellent environment for C. perfringens spores to 
accumulate, leading to a potential source of infection (McReynolds et al., 2007). This 
directly provides an important additional factor by creating suitable conditions for 
sporulation and growth of C. perfringens, but also indirectly facilitates other 
predisposing factors such as the sporulation of coccidial oocytes (Williams, 2005). In 
addition, rough litter has been suggested to result in minor gut damage that in the 
presence of sufficient C. perfringens numbers may cause NE (Alsheikhly & Truscott, 
1977a). 
Therefore the objective of this experiment was to study the effect of three 
sources of vegetable proteins (SBM, PPC and CM) in nutritionally complete diets, with 
similar protein contents (crude protein 212 g/kg), on the incidence of NE in male broiler 
chickens with clean and reused litter. A fourth dietary treatment, with synthetic TI 
(6µg/ml) added to the SBM control diet, was used to study its impact on onset of sub-
clinical NE.  
Reused litter was used as challenge to aim to produce sub-clinical NE in order to 
mimic, as closely as possible, the naturally occurring infectious conditions, and so to 
avoid the need to frequently dose birds with extremely high levels of the pathogen 
(Figure 4.1 to Figure 4.4). 
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Figure 4.1: Broiler chickens reared as single flock during 0-16 days of 
experiment. 
 
Figure 4.2: Addition of reused litter. 
n  
Figure 4.3 : Broiler chickens reared in different experimental pens with clean 
and reused litter. 
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 Materials and Methods  4.2
4.2.1 Treatment Groups and Experimental Design  
A total of 144 one-day-old male Ross 308 broiler chickens were obtained from 
a commercial hatchery. The birds were reared in a solid floored room following a 
standard commercial environmentally controlled programme from day 0 to day 32. 
Adequate feeders and drinkers were provided for the age and number of birds. For the 
first 16 days birds were reared as a single flock and given a nutritionally complete 
broiler starter diet (without antibiotic growth promoter or anticoccidials). On day 16 
post hatch, the birds were weighed and stratified on body weight (BW) and 6 birds 
randomly allocated to each of the 24 pens with similarly averaged day 16 BW. The 
design of the experiment is shown in Table 4.2. 
4.2.2 Feeding treatments 
Four feeding treatments were designed for this study. Three experimental 
broiler grower diets were formulated to be nutritionally complete for broiler chickens 
between 16 to 30 days of age. Diets were wheat based although the major portion of the 
additional protein supply was provided by one of three protein sources, i.e. SBM, CM 
and PPC. A fourth dietary treatment consisted of the SBM treatment with added 
synthetic TI (Sigma-Aldrich; T9003), referred to as SBM+TI. A concentration of 
synthetic inhibitor at a level of 6µg/g of feed was added to the prepared feed – this is a 
higher concentration than would normally occur or be possible in practical feed samples 
(Probert, 2004). 
All diets were formulated to have similar contents of calculated metabolizable 
energy (13.4MJ/Kg) and crude protein (212g/kg) (Table 4.1). Vitamins and minerals 
either met or exceeded the breed-nutritional recommendations (Broiler Ross 308, 2009). 
No anticoccidial drugs or antibiotic growth promoter were added to the grower diets. 
The formulated diets were mixed at SAC, Ayr and provided as mash. In order to 
formulate diets with similar content of calculated crude protein (212 g/kg) and 
metabolizable energy (13.4MJ/kg), the diets were varied by adjusting the vitamin and 
mineral content. This was felt unlikely to  have influenced the result(s) since the effect 
produced was counter to that observed. Experimental grower diets were given from day 
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16 until the end of the study. Feed and water were provided ad-libitum during the 
experimental period. Light was provided for 23 hours per day and house temperatures 
and humidity were controlled to provide optimum growing conditions for the age and 
breed of birds used (Aviagen, 2009). 
4.2.3 Litter treatment (Challenge procedure) 
The floor area of (1.74m x 1.28m) per pen was covered with wood shavings. 
For half of the pens, litter consisted of 75% clean wood shavings and 25% reused litter 
material (reused litter). The reused litter material was obtained from a commercial 
poultry flock that did not have a history of clinical or sub-clinical NE although sub-
clinical coccidiosis was expected. The other half of the pens had 100% clean wood 
shavings (clean litter). All experimental procedures were approved by SAC Animal 
Ethics Committee (AE 27/2010) and carried out under Home Office authorization (PPL 
60/4097).   
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Table 4.1: Feed ingredients and calculated chemical composition (g/kg) of the 
experimental grower diets. 
 Dietary treatments 
 SBM
1
   PPC
2 
CM
3 
Ingredients    
    
Canola - - 217 
Soybean Meal-48% 207 - - 
Potato protein concentrate - 110 - 
Soybeans full-fat, cooked 143 170 212.2 
Wheat 557 620 460 
Soybean oil 55 60 69 
Dicalcium Phosphate 15 15.4 15.4 
Limestone 2 2 2 
Defluorinated Phosphorus 17 18.1 17 
Common Salt 1.5 1.5 1.5 
Vitamin & Mineral Premix
1 
1.8 3.0 3.3 
DL-Methionine 1 - 1.5 
L-Lysine HCl - - 1.5 
    
Calculated Chemical Composition 
Metabolisable energy (MJ/Kg) 13.4 13.4 13.4 
Dry Matter 868 872 876 
Crude Protein 212 212 212 
Calcium 10.6 10.6 11.7 
Total Phosphorus 9.7 9.3 11.2 
Available Phosphorus 4.4 4.2 4.6 
1
 Vitamin and Mineral supplement provided (units kg
-1
 diets): Vit A 16,000 iu;  Vit D3 
3,000 iu;  Vit E 75 iu (iu=mg);  Vit B1 3 mg; Vit B2 10 mg; Vit B6 3 mg; Vit B12 15 µg;  
Vit K3 5 mg; Nicotinic acid 60 mg;  Pantothenic acid 14.5 mg;  Folic acid 1.5 mg;  
Biotin 275 µg; Choline chloride 250 mg; Iron 20 mg; Copper 10 mg; Manganese 100 
mg; Cobalt 1 mg; Zinc 82 mg; Iodine 1 mg; Selenium 0.2 mg; Molybdenum 0.5 mg 
(Target feed, Whitchurch, Shropshire). 
SBM
1
: Soybean meal 
PPC
2
: Potato protein concentrate 
CM 
3:
 Canola meal 
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4.2.4  Experimental design 
A 4x2 factorial arrangement of the four feeding treatments and the two litter 
treatments was used in a randomized complete block design. Three replicate pens were 
used for each feeding-litter treatment combination with 6 birds per pen (Table 4.2). The 
24 floor pens used were within three adjacent environmentally controlled rooms (eight 
pens per room), and the eight feeding-litter treatment combinations were randomly 
allocated to the eight pens within each of the three rooms. 
Initially it was planned to collect the data for all feeding-litter treatment 
combinations on days 30, 31, and 32. However, to comply with HO regulations, it was 
necessary to change from the initial plan since at day 21 the birds in CM feeding 
treatment groups were found to suffer from stunted growth (see Results), and had to be 
culled. The birds on all other feeding treatments were kept alive until day 32. This 
inevitably resulted in two data sets; one for the CM fed birds to day 21 and a second for 
all other feeding treatment groups. 
Table 4.2: Experimental treatments used in the experiment 
 Litter treatment  Feeding treatment 
1 Clean SBM 
2 Reused SBM 
3 Clean SBM + TI 
4 Reused SBM + TI 
5 Clean PPC 
6 Reused PPC 
7 Clean CM 
8 Reused CM 
SBM: Soybean meal; SBM + TI: Soya with added synthetic trypsin inhibitor; PPC: 
Potato protein concentrate; CM: Canola meal. 
4.2.5  Sampling and data recording  
4.2.5.1 Clinical signs and lesion scoring 
Experimental birds were assessed daily for clinical signs and symptoms of NE, 
from the day reused litter was added to the litter pens. At day 21, all the birds from CM 
dietary treatment with both clean and reused litter were weighed and culled by 
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intravenously administered overdose of barbiturate. In contrast, for all other feeding 
treatment groups, two birds from each replicate pen were selected at random, weighed 
and killed by intravenously administered overdose of barbiturate on days 30, 31, and 32. 
These days were taken because it was not possible to sample and dissect all the birds 
within a single day. The intestines of all killed birds were removed and the ileal 
contents collected individually. The three sections of intestine (duodenum, jejunum and 
ileum) were identified, immediately incised, washed with phosphate buffer saline (PBS) 
and the mucosal surfaces inspected for evidence of lesions (Clostridial or coccidian). It 
was intended to use the scoring system established by Shane et al. (1985):  
 score 0: absence of gross lesions or no lesions;   
 score 1: focal necrosis or focal ulceration;  
 score 2: focal ulceration coalesced to form discrete patches;   
 score 3: extensive diffuse mucosal necrosis;   
The livers were also examined for the presence or absence of hepatitis or 
cholangiohepatitis, which are recognized as consistent with the pathological changes of 
NE. 
4.2.5.2 Histopathology  
Following post-mortem examination, samples from the small intestine, 
particularly those showing lesions were taken for histopathology. A 1.5-2cm tissue 
sample was taken, washed with PBS and then stored in 10% buffered formalin for 
histopathology. Histopathology was done according to the procedure described in 
section 3.2.5.3. Gram staining was also done to confirm the presence of Gram positive 
bacilli (Appendix- B). The prepared tissue sections were later examined using a 
binocular stereo-microscope (Olympus BX 41, U-LH100HG, Olympus optical, Co. Ltd) 
connected by camera (spot idea™ 28.2-5MP) to computer software (Spot idea, Version 
4.7) using different magnifications (10x, 40x and 100x). 
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4.2.5.3 Quantification of C. perfringens and α-toxin in digesta 
Ileal digesta samples were taken into labelled plastic containers with screw-
topped lids. Samples were immediately transferred to the microbiology laboratory and 
analysed to enumerate C. perfringens within 2hrs of collection. Enumeration of C. 
perfringens on Tryptose Sulphite Cycloserine (TSC) agar (Oxide) was performed 
according to the method described in section 3.2.2. 
Quantification of α-toxin in the intestinal digesta was done by an enzyme linked 
immunosorbent assay (ELISA) using α-toxin C. perfringens kit (Cypress diagnostics, 
Ref. Vb040) following the manufacturer’s recommendations as described in section 
3.2.5.5. 
4.2.5.4 Growth performance 
Starter feed was weighed in at day 0 and weighed back at day 16. Then grower 
feed was weighed in at day 16, and weighed back at day 21 (CM only), and day 30 
(SBM, SBM+TI, PPC). Averaged feed intake (FI) was recorded by subtracting feed 
weighed out from feed weighed in divided over the number of birds in the pen. At day 
0, all birds were weighed and individually tagged. At days 16 all birds were weighed 
individually again. The growth of the birds was subsequently recorded by weighing the 
birds at day 21 (CM only) or 30 (SBM, SBM +TI, PPC). Average weight gain (WG) 
was calculated as average live bird weight at the end of the period – average live bird 
weight at the beginning of the period.  Feed conversion ratio (FCR) was calculated by 
dividing the average feed consumed per pen by the average weight gain of birds per 
pen.  
4.2.5.5 Analysis of litter  
Litter was analysed for enumeration of C. perfringens and coccidial oocytes at 
days 16 and 21 (CM only) or 30 (SBM, SBM +TI, PPC). Sterilized gloves and plastic 
bags were used to collect litter samples from the pen centre, as well as mid way between 
the centre and each of the four corners of every pen. Litter samples collected were then 
combined and homogenized. 
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A representative sample of collected litter was enumerated for C. perfringens 
on TSC agar using the pour plating technique. Litter sample aliquots of approximately 
10g were weighed out and suspended in 90ml of Maximum recovery diluents (MRD). 
From this dilution further 10 fold dilutions were made. From each dilution to be plated, 
100µl of mixture was applied to the centre of each agar plate, allowed to be absorbed 
and then 15ml of TSC overlay was spread before the plate was incubated invertedly in a 
jar providing anaerobic conditions. The jar was placed in an incubator at 37°C for 
24hrs. After incubation the number of colonies was counted to calculate the number of 
colony forming units per gram of original sample. All samples were analysed in 
duplicate. 
For counting of coccidial oocytes in the litter, 30g of litter was weighed. The 
litter sample was placed in 200ml of water overnight. The mixture was then shaken and 
poured into an 8 inch diameter 425µ mesh sieve resting in a round bottomed copper 
bowl. Debris was then spread over the area of the sieve. Strained fluid was then swirled 
in the round bottomed bowl to ensure even mixing. The resultant fluid was then poured 
into a universal tube to almost fill it. Tubes were centrifuged at 1500rpm for 2 minutes. 
The supernatant was then discarded and the tubes shaken to loosen any sediment. After 
replacing the lids, the tubes were gently inverted several times. Both chambers (sides) 
of a McMaster counting chamber were filled using a pipette. The counting chamber was 
allowed to stand at room temperature for a minimum of 1hour for the oocytes to settle. 
The number of coccidial oocytes (all species: small, medium and large) were counted at 
10 x 10 magnification (Olympus microscope, BX 41, U-LH100HG, Olympus optical 
Co. Ltd). The sample preparation indicated that the number of oocytes counted needed 
to be multiplied by 22.5 to obtain the number of oocytes per g of original material.  
The litter pH was also determined at the end of the experiment on day 21 (CM 
dietary treatment group) and 30 (all other dietary treatment groups). Litter pH was 
determined by using a pH probe with a stainless steel penetration blade attached to 
Hanna HI 99163 meter (Hanna Instruments Ltd, Bedfordshire, UK). Litter pH was 
measured directly from the litter, from the centre of each pen. 
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4.2.5.6 Feed Analysis 
Feed samples were ground before chemical analysis. For amino acid analysis, 
Diet samples were oxidised with a hydrogen peroxide / formic acid / phenol mixture. 
Excess oxidation reagent was decomposed with sodium metabisulphite. The oxidised 
sample was hydrolysed with 6M hydrochloric acid for 24 hours. The hydrolysate was 
adjusted to pH 2.20, centrifuged and filtered. The amino acids were separated by ion 
exchange chromatography (Biochrom 20 analyser, Amersham Pharmacia Biotech, 
Pittsburgh, PA) and determined by reaction with ninhydrin using photometric detection 
at 570nm (440nm for Proline). 
Trypsin inhibitor activity of each diet was determined through extraction using 
dilute sodium hydroxide solution at pH 9.5 and incubating an aliquot of the unfiltered 
extract with a standard amount of trypsin. The amount of trypsin remaining in the 
sample was measured by reaction with the synthetic substrate Benzoyl-DL-arginine-P-
nitroanilide for a specific time and temperature, causing the formation of the yellow 
coloured p-nitroaniline. After filtration the colour intensity of the complex was 
measured spectrophotometrically at 410nm. Within the limits of the test there was a 
linear relationship between the quantity of p-nitroaniline released and trypsin inhibitor 
activity. 
 Statistical analysis 4.3
As mentioned earlier due to stunted growth and some signs of depression the 
birds from the CM dietary treatment were culled on day 21 of the experiment and their 
intestinal tracts examined for the presence of lesions. Therefore the CM dietary 
treatment could not be directly compared with the other feeding treatments. The CM 
data set was analysed for the effect of litter treatment only (i.e. clean vs reused litter) 
using analysis of variance (ANOVA) Genstat 11 for Windows, IACR Rothamstead, 
England). Bacterial enumeration data was converted to log10 cfu/g before analysis.  
The effect of other combinations of feeding treatments (SBM, SBM+TI, PPC) 
and litter treatment (reused and clean) on the data obtained were compared using 3x2 
factorial arrangement with a randomised block analysis of variance (ANOVA) (Genstat 
11 for Windows, IACR Rothamstead, England). Room was included as a block. The 
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partitioned sources of variation included treatment, litter and their interaction. An 
individual pen was treated as the experimental unit.  
Because of the skewed nature of the counts of C. perfringens, data was 
transformed according to log (n + 1) to normalize the data before statistical analysis. 
Duncan’s multiple range test was used to separately significantly different means. 
Effects were reported as significant at P<0.05.  
 Results  4.4
During the experiment no clinical signs of NE were observed following the 
litter challenge in any of the treatment groups. However, birds from the CM dietary 
treatment group were stunted, slightly dull, and depressed with ruffled feathers (Figure 
4.4). Only one bird during the experiment was found dead, from the CM-reused litter 
treatment group. This was on day 16 of the experiment and was diagnosed as death 
from an acute heart failure. Feed analysis showed that the trypsin inhibitor activity of 
the four diets (SBM, SBM+TI, PPC and CM) was the same, 0.8mg/g of feed. 
 
Figure 4.4: Bird showing signs of depression fed canola meal dietary treatment 
with litter challenge. 
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4.4.1 Gross lesions  
On day 21, none of the birds had full blown lesions of sub-clinical NE in the 
small intestine in the CM dietary treatment groups. Some lesions were seen in 14 out of 
36 CM chickens, which were all from the reused litter treatment, although lesions were 
mostly of coccidiosis (Figure 4.5). Lesions observed were distended jejunum and ileum 
as well as thin, friable intestinal walls. No necrotic lesions were identified in the small 
intestine of the birds fed a CM diet in clean litter pens. 
On days 30, 31 and 32, none of the SBM, SBM+TI and PPC chickens had 
definite sub-clinical NE gross lesions in their small intestines. However, some lesions of 
coccidiosis were seen in two SBM+TI birds and one PPC bird, which were all from the 
reused litter treatment.  
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Figure 4.5: Mucosal surface of intestines of broiler 
chickens fed canola meal dietary treatment group with 
challenged litter (a) Duodenum (b) Ileum, arrows showing 
white lesions of coccidiosis (c) caeca, circle showing 
haemorrhages. 
a 
b 
c 
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4.4.2 Histopathology  
Histological examination of formalin fixed intestinal tissue confirmed that the 
lesions were not NE specific. There was no necrosis or desquamation of epithelial cells 
in the villi. Lamina propria did not show infiltration of polymorphs nuclear cells in any 
section of intestine. There was also no evidence of gram-positive rod-shaped organisms 
attached to intestinal mucosa. However various sexual and asexual stages of coccidia 
were found in many intestinal sections from CM birds on the reused litter treatment. 
Endogenous stages of Eimeria acervulina were particularly predominant in their 
intestinal tissue sections (Figure 4.6). 
 
Figure 4.6: photomicrography of intestine of broiler chicken fed 
canola meal diet with litter challenge showing presence of 
shizonts of Eimeria acervulina (arrow) H and E (x40). 
4.4.3 Quantification of C. perfringens and α-toxin in ileal 
digesta 
Table 4.4 shows the effect of litter treatment on the number of C. perfringens 
(cfu/g) in ileal digesta of broilers fed CM diet. There was no significant effect of litter 
treatment on counts of C. perfringens in ileal digesta of these birds. Figure 4.7 shows 
the effect of feeding and litter treatment on C. perfringens concentrations in ileal digesta 
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of the SBM, SBM+TI and PPC birds. Neither feeding treatment nor litter treatment 
significantly affected concentrations of C. perfringens in ileal digesta (P>0.05). Alpha 
toxin was not detected in ileal samples of birds from any of the treatment groups on 
different dissection days 
.
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Figure 4.7: Concentrations of C. perfringens in ileal digesta of broiler chickens (on days 30-32 post hatch) subjected to different dietary 
treatments (SBM: soybean meal; SBM + TI: soybean meal with added synthetic trypsin inhibitor and PPC: potato protein) with and without 
litter challenge (clean and reused). 
The error bars are the standard error of the mean (SEM). 
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4.4.4  Analysis of litter 
The reused litter had C. perfringens and coccidial oocytes counts of 1.24 x 10
4 
cfu/g and 30,686/g respectively, on day 16. Table 4.4 shows the effect of litter treatment 
on numbers of C. perfringens (cfu/g) and pH in the litter of broilers fed CM on day 21. 
There were no significant differences in C. perfringens concentrations and pH between 
clean and reused litter by day 21. Table 4.3 shows the effect of feeding and litter 
treatment on pH and C. perfringens concentrations in litter of the SBM, SBM+TI and 
PPC birds at day 30. None of these parameters were affected by feeding treatment or its 
interaction with litter treatment (P>0.05). However, reused litter had significantly 
increased pH (P=0.02) and counts of C. perfringens (P=0.02) compared to clean litter at 
day 30 (Table 4.3). 
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Table 4.3: Litter analysis (day 30) of different dietary treatment groups 
 C. perfringens (cfu/g 
of litter) 
pH 
Diet 
SBM 3.44 6.70 
SBM + TI 2.77 6.60 
PPC 4.08 6.46 
SEM
1 
0.59 0.16 
   
Litter 
Clean  2.48
a 
6.34
a 
Reused 4.38
b 
6.83
b 
SEM
 
0.49 0.13 
   
 Diet x Litter  
SBM x clean 2.49 6.54 
SBM + TI 1.65 6.32 
PPC x clean  3.29 6.16 
SBM x reused 4.38 6.85 
SBM + TI x reused 3.88 6.87 
PPC x reused 4.87 6.75 
SEM 0.84 0.23 
   
Probability of differences  
Diet  0.34 0.59 
Litter 0.02 0.02 
Diet x litter 0.92 0.81 
1
SEM: Standard error of means 
ab 
Means with the different superscripts within a column differ significantly (P<0.05) 
Data are means of 3 pens with 6 broiler chickens per pen 
SBM: Soybean meal 
SBM+ TI: Soybean meal with added synthetic trypsin inhibitor 
PPC: Potato protein concentrate 
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4.4.5 Growth performance 
Table 4.4 shows the effects of litter treatment on broilers BW on days 16 and 
21 as well as on WG, FI and FCR during days 16-21 of birds fed the CM dietary 
treatment. On day 21, birds on reused litter had significantly lower BW than birds on 
clean litter (P=0.02). Birds on reused litter had significantly lower WG (P=0.042) and 
FI (P=0.03) during days 16-21 compared to birds on clean litter, which concurred with 
higher FCR (P=0.012;  Table 4.4).  
Figure 4.8 shows the effects of feeding treatments (SBM, SBM+TI, PPC) and 
litter treatment on BW on day 30. Final BW was not significantly affected by dietary 
protein treatments (P=0.11) or its interaction with litter treatment (P=0.17). However, 
litter treatment significantly reduced final BW (P= 0.01). 
Figure 4.9 shows the effect of feeding treatments (SBM, SBM+TI, PPC) and 
litter treatment on broiler WG between days 16-30. Weight gain was not affected by 
dietary protein treatments (P=0.14) or its interaction with litter treatment (P=0.11). 
However, litter treatment significantly reduced the WG (P=0.009).Figure 4.10 shows 
the effects of feeding treatments (SBM, SBM+TI, PPC) and litter treatment on broiler 
FI during days 16-30. Feed intake was not affected by feeding treatment (P=0.82), by 
litter treatment (P=0.39) or their interaction (P=0.27).  
Figure 4.11 shows the effects on broiler FCR during days 16-30. Feed 
conversion ratio was not affected by feeding treatment (P=0.84), by litter treatment 
(P=0.37) or their interactions (P=0.13). 
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Figure 4.8: Body weight of broiler chickens (on day 30 post hatch) subjected to different dietary treatments (SBM: soybean meal; SBM + TI: 
soybean meal with added synthetic trypsin inhibitor and PPC: potato protein) with and without litter challenge (clean and reused). 
 The error bars are the standard error of the mean (SEM). 
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Figure 4.9: Weight gain of broiler chickens (on days 16-30 post hatch) subjected to different dietary treatments (SBM: soybean meal; SBM 
+ TI: soybean meal with added synthetic trypsin inhibitor and PPC: potato protein) with and without litter challenge (clean and reused). 
The error bars are the standard error of the mean (SEM). 
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Figure 4.10: Feed intake of broiler chickens (on days 16-30 post hatch) subjected to different dietary treatments (SBM: soybean meal; SBM 
+ TI: soybean meal with added synthetic trypsin inhibitor and PPC: potato protein) with and without litter challenge (clean and reused). 
The error bars are the standard error of the mean (SEM). 
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Figure 4.11: FCR of broiler chickens (on days 16-30 post hatch) subjected to different dietary treatments (SBM: soybean meal; SBM + TI: 
soybean meal with added synthetic trypsin inhibitor and PPC: potato protein) with and without litter challenge (clean and reused). 
The error bars are the standard error of the mean (SEM). 
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Table 4.4: Growth performance, C. perfringens counts in ileal digesta and litter 
and litter pH (on day 21) of male broiler chickens fed canola meal with clean 
and reused litter. 
Variable Litter SEM
1 
Probability of 
treatment effect Clean Reused 
Body weight (day 
16) (g/bird) 
338 346 2.8 0.20 
Body weight (day 
21) (g/bird) 
473
a 
446
b 
3.1 0.02 
Weight gain (16-21) 
(g/bird) 
135
a 
100
b 
5.2 0.042 
Feed intake (16-21) 
(g/bird) 
407
a 
377
b 
3.7 0.03 
FCR
2
 (16-21) 3.08
a 
3.80
b 
0.05 0.012 
C. perfringens 
(log
10
) (cfu/g of 
digesta) 
3.15 3.91 0.4 0.32 
    
Litter analysis    
 pH 6.76 6.92 0.42 0.809 
C. perfringens 
(log
10
) (cfu/g of 
litter) 
2.49 3.65 0.63 0.32 
Data are means of 3 pens with 6 broiler chickens per pen 
1
 SEM: Standard error of means  
2 
Feed conversion ratio 
ab 
Means with the different superscripts within a column differ significantly (P<0.05) 
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 Discussion 4.5
Until 2006 the occurrence of litter related problems, such as wet or poor litter 
quality, was successfully controlled by the use of in-feed growth promoters (Clarke & 
Wiseman, 2010). The litter used for bedding in poultry houses may play a role as 
reservoir for possible intestinal colonization of pathogen microbes, as pathogens such as 
clostridia have been isolated from poultry litter (Alexander et al., 1968). It has long 
been suggested that a relationship exists between the type of litter and the incidence of 
NE under field conditions (Nairn & Bamford, 1967). C. perfringens is known to be 
transmitted to other birds within the same flock through litter ingestion as well as being 
transmitted to subsequent flocks placed on old litter (Craven et al., 2001b). Literature 
has documented that an important component in the development of sub-clinical NE is 
the build up and recycling of C. perfringens in the litter (Alexander et al., 1968; Nairn 
& Bamford, 1967; Craven et al., 2001a; Craven et al., 2001b). Therefore the present 
study aimed to challenge birds by exposure to reused litter from a commercial farm in 
order to stimulate the natural conditions for the development of sub-clinical NE.  
None of the birds had overt clinical signs of NE following litter challenge. 
However on day 21, all birds from the CM dietary treatment showed signs of depression 
and stunted growth and were therefore culled. Necropsy findings showed lesions of 
coccidiosis with litter challenge in 14 out of 36 birds (39%). No birds on the SBM, 
SBM+TI and PPC treatments with reused or clean litter had any lesions of coccidiosis 
or sub-clinical NE, even though these birds were killed 10 days later. Histopathological 
examination from CM birds showing lesions confirmed that the lesions were typical of 
coccidiosis. The distribution of lesions and oocytes morphology at microscopic 
examination showed Eimeria acervulina as the primary species involved. The rapid 
appearance of coccidial lesions in the CM dietary treatment about 1 week after 
placement of challenged litter suggests that the litter had been seeded with a large, 
infected dose of coccidial oocytes by the previous commercial flock. 
Although CM is increasingly replacing other sources of vegetable protein 
sources, its nutritional value is limited by the presence of a number of anti-nutritional 
factors such as a relatively high levels of phytate or phytic acid (3-6%), tannins (1.5-
3%), sinapine (0.6-1.8%) and non-starch polysaccharides (NSPs;  18%). Phytate can 
bind minerals, reduce the digestibility of amino acids and can damage the mucosal layer 
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of the intestine (Bell, 1984; Bell, 1993) resulting in birds with a higher susceptibility to 
many intestinal diseases. Recent research has concluded that dietary tannins may not 
only affect the performance of chickens, but also alter the proper development of 
immunity against coccidiosis (Mansoori & Modirsanei, 2012). Coccidiosis has been 
recognized as a crucial factor that predisposes birds to NE. It has also been identified as 
having synergistic association with C. perfringens during the development of 
experimentally induced NE (Alsheikhly & Alsaieg, 1980; Shane et al., 1985; Broussard 
et al., 1986; Park et al., 2008; Fernando et al., 2011). As a consequence, coccidiosis is 
usually found when NE is diagnosed (Nairn & Bamford, 1967; Helmbold & Bryant, 
1971; Williams, 2005). A number of studies have shown that chickens infected with C. 
perfringens and coccidial oocytes have higher rates of NE lesions than birds infected 
with the pathogen alone (Maxey & Page, 1977; Wicker et al., 1977). This suggests that 
the occurrence of NE has a high correlation with coccidiosis. The reproductive stages of 
coccidia in the intestinal epithelium initiate gut damage. Mucosal damage is necessary 
to initiate sub-clinical NE since it provides a base for C. perfringens to establish, 
colonize and cause necrosis of intestinal mucosa. In addition, coccidial infection can 
also cause immunosuppression that further predisposes birds to sub-clinical NE 
(McReynolds et al., 2004b). All these studies indicate the importance of coccidiosis in 
the occurrence of NE.  
The overall performance of the birds in the CM treatment in both control and 
challenged litter groups was relatively poor compared to all other dietary treatment 
groups. In the present study stunted growth or reduced WG in birds with CM dietary 
treatment were observed during days 16 to 21. Higher levels of dietary CM (more than 
20%) could result in increased liver metabolic activities so could lead to increased 
utilization of various nutrients for maintenance at the cost of tissue deposition, in turn 
leading to reduced WG (Woyengo et al., 2011). Higher levels of NSPs tend to increase 
the viscosity of digesta, resulting in a reduction in both nutrient digestion and 
absorption, (Annison, 1991; Bell, 1993). This may have contributed to the poor growth 
performance of CM birds in the current study. Shires et al. (1981) reported that 
inclusion of extracted dehulled canola up to 10% of the diet had no adverse effect on the 
performance of chicks, but at levels above 20% canola can cause a progressive decrease 
in FI and WG with an increase in feed/ gain ratio. This concurs with the current study, 
where CM was used at a level of 21.68% and similar negative results were observed by 
others (Newkirk & Classen, 2002; Mushtaq et al., 2007; Woyengo et al., 2011). A 
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further reduction in WG in CM birds on reused litter compared to their clean litter 
counterparts was expected as these birds developed lesions of coccidiosis. Coccidial 
infections are known to cause a reduction in growth of birds during acute infection or 
the first eight days post-infection due to decreased nutrient absorption (Sharma et al., 
1973), and indeed, lower WG in birds with coccidiosis has been observed by a number 
of researchers (Willis & Baker, 1981; Matthews & Southern, 2000; Watson et al., 2005; 
Woyengo et al., 2011). Similarly Golder et al. (2011) found decreased BW and 
increased FCR in birds infected with both coccidial and clostridial infection.  
More than 70% of CM phosphorus is in the form of phytic acid (Summers et al., 
1983). Hydrolysis of phytate is necessary to release phosphorus so it is available for 
absorption from GIT. However poultry lack effective endogenous phytases, so have a 
limited ability to dephosphorylate and utilize any phosphorus present in the form of 
phytate (Ravindran et al., 1999; Selle et al., 2000). The reduced growth performance of 
the birds on the CM dietary treatment in the present study may therefore be due to these 
higher levels of phytate content in CM. Studies indicate that phytate reduces or inhibits 
the activity of digestive enzymes such as pepsin, trypsin and α–amylase (Pallauf & 
Rimbach, 1997; Sebastian et al., 1998), so may help in stabilization of α-toxin, the 
primary cause of NE in poultry. However, this toxin was not found in this study. In the 
present study no lesions of sub-clinical NE were observed in any of the birds fed the 
CM diet. However, lack of development of NE lesions may be due to the restricted time 
period on the reused litter treatment (5 days). 
In the present study one of the dietary treatments was SBM+TI as TIA in the 
diet may also play a role in the induction of sub-clinical NE. However, post hoc dietary 
analysis showed that all four diets (SBM, SBM+TI, PPC and CM) had almost the same 
levels of TI activity (0.8mg/g of feed) so comparison of dietary treatments cannot be 
made solely on the basis of the TIA content of the diet. To the authors knowledge there 
has been no study to assess the effect of synthetic TI on the induction of sub-clinical NE 
in poultry. The absence of higher TI activity in post hoc dietary analysis could indicate 
the possibility of a degradation of synthetic TI after mixing it with the experimental 
diet. There is also the possibility that concentration of synthetic TI added was too small. 
It is also possible that the differences between natural and synthetic TI are sufficiently 
significant that they cannot be analysed in the same way. However the activity of 
synthetic trypsin inhibitor as supplied, (Sigma T9003)  was not itself tested. Such a test, 
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had it been applied before use of the trypsin inhibitor, would have determined if it was 
active when used in the experiment. A high amount of TIA (3.88mg/g) in PPC has been 
found in other studies (Palliyeguru et al., 2010). The amount of protease inhibitors in 
PPC can vary considerably depending upon both the quality and variety of potatoes 
used (Kadam, 1998) and the method of processing of the potatoes (Knorr, 1982).  
No effect from dietary treatment and litter challenge was observed on the counts 
of C. perfringens in ileal digesta on any day. Experimental evidence suggests that birds 
fed with a high content of dietary PPC had higher numbers of C. perfringens when 
compared with birds fed other plant proteins diets, (Wilkie et al., 2005; Palliyeguru et 
al., 2010), or fishmeal (Palliyeguru et al., 2010). Wilkie et al. (2005) found higher 
numbers of C. perfringens in the caecal content of birds fed on a PPC diet and orally 
gavaged in the crop with 0.5ml of an actively growing culture of C. perfringens (~1.0 x 
10
8
 cfu/ml of broth). However in the present study C. perfringens were not significantly 
increased in the ileal digesta of birds fed on a PPC diet. This may be due to different 
levels of PPC used in the diet formulation as previous experimenters used a PPC diet 
containing ~400g/kg of PPC compared to the 110g/kg used in the present experiment. 
Moreover very low concentrations of C. perfringens were present in the litter compared 
to 10
8 
concentrations in the gavage. Some of these studies also documented that diets 
containing PPC increased the incidence of sub-clinical NE in poultry (Wilkie et al., 
2005; Palliyeguru et al., 2008). However Palliyeguru et al. (2010) later found no 
differences in haemorrhagic lesions in the mid-intestines of birds fed a PPC diet, 
fishmeal or SBM. In agreement with the current study findings of Fernando et al. 
(2011) did not show any significant differences between the NE lesions of the birds on 
the PPC and SBM diets.  
Some of the studies that have successfully induced NE under experimental 
conditions Hamdy et al. (1983a) reared birds in a conventional dirt floor broiler house 
that  contained a build up of litter obtained from a flock that had experienced a severe 
outbreak of NE, so probably had a higher number of C. perfringens than the present 
study where the number of C. perfringens in litter was 1.24 x 10
4 
cfu/g. Palliyeguru et 
al. (2010) successfully induced sub-clinical NE with typically 70 birds per pen. The 
overall NE frequency in the positive control groups in these studies was between 53%-
77% based on duodenal haemorrhages. According to Lovland et al. (2003) spontaneous 
C. perfringens infection with some precipitating factors, is sufficient to induce sub-
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clinical NE in relatively large floor reared flocks. Mikkelsen et al. (2009) also 
successfully induced NE by raising birds in pens with reused litter from a previous NE 
challenged experiment, in addition to orally gavaging the birds with 2500 sporulated 
oocytes of different Eimeria species. Litter analysis showed that the numbers of C. 
perfringens in Mikkelsen et al.’s (2009) pens with reused litter had 6.65 log10 cfu/g of 
litter, compared to 3.65 and 4.38 log10 cfu/g of litter on days 21 and 30 in the present 
study. Moreover (Mikkelsen et al., 2009; Mikkelsen et al., 2009)’s diagnosis of NE was 
made with regard to mortality compared to the present study’s analysis using a score of 
NE typical lesions. Cowen et al. (1987) found a 2-10% incidence of NE when giving a 
C. perfringens culture (1.6x 10
8 
to 1x 10
9
) in feed along with the addition of reused 
(used) litter from a flock that had experienced NE. As in the present study, lesions of 
NE were not observed in bird trials where only NE infectious litter was used. Thus, it 
can not be excluded that the reused litter treatment used was ineffective in establishing 
sub-clinical NE due to the absence of sufficient C. perfringens challenge. 
Alsheikhly & Alsaieg (1980) confirmed that under field conditions, coccidiosis 
can play a significant role in the incidence of NE when sufficient numbers of toxigenic 
C. perfringens are present. The finding of this study may indicate that if considerable 
numbers of coccidial oocytes are present in the litter, including of CM in the diet may 
facilitate the development of coccidiosis-damage to the mucosal layer of the digestive 
tract as this is considered to be the crucial predisposing factor for the onset of sub-
clinical NE in broiler chickens.  
Necrotic enteritis was not induced in the present study as no characteristic 
necrotic lesions were found in any of the birds. Consistent induction of sub-clinical NE 
has been difficult with variable results even when replicating the same experimental 
conditions. Palliyeguru et al. (2010) were able to successfully induce the disease with 
the addition of reused litter from a flock without any history of NE whereas Cowen et 
al. (1987) in one experiment were unable to induce the disease with just the addition of 
NE-infectious litter. Absence of disease induction in the present study may be the result 
of either inadequate numbers of C. perfringens in the reused litter (10
4
), and/or the lack 
of some diet induced intestinal damage failing to replicate suitable conditions for C. 
perfringens to proliferate and release α-toxin. Different researchers have demonstrated 
the effectiveness of different C. perfringens strain on the induction of sub-clinical NE. 
Only specific strains of C. perfringens are capable of producing NE in poultry (Cooper 
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et al., 2010; Keyburn et al., 2006). It is possible that the litter used in the current study 
did not have the right strain of C. perfringens to induce sub-clinical NE. 
 Conclusion 4.6
Soybean meal, PPC and CM failed to predispose birds to sub-clinical NE. 
However, the canola based diet did predispose the birds to coccidiosis. It is postulated 
that this could have been the result of anti nutrients such as phytate damaging the 
mucosal layer (Cowienson et al., 2004) , making it more susceptible to coccidia. There 
is evidence that coccidia are a co-factor in NE and as such it would be expected that, 
although not shown in this study, under commercial conditions canola would also 
predispose birds to sub-clinical NE. 
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5 EXPERIMENT THREE: 
EFFECTS OF ADDING FISH MEAL TO GROWER BROILER 
DIETS ON PROLIFERATION OF CLOSTRIDIUM PERFRINGENS 
ON IN VITRO DIGESTED DIETS 
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 Introduction 5.1
Clostridium perfringens is an anaerobic, spore-forming, large, gram positive rod 
that has been identified as major cause of NE in chickens (Alsheikhly & Truscott, 
1977a; Flores-Diaz & alape-Giron, 2003; Nauerby et al., 2003). The organism is 
pathogenic to both humans and animals and is cosmopolitan in nature. The organism is 
normally present in the gut at levels as high as 10
4
 cfu/g of digesta without causing 
disease (Kondo, 1988; Drew et al., 2004; Dahiya et al., 2006). However, an overgrowth 
of C. perfringens in the gut has been implicated in outbreaks of NE. When the normal 
population of C. perfringens is disturbed, levels can increase rapidly reaching 10
8
 cfu/g 
of digesta with a concomitant production of toxins. The principal toxin produced by C. 
perfringens type A (α-toxin) is believed to be a major virulent factor of NE. Under field 
conditions outbreaks of NE can occur as early as 17-18 days of age (McDevitt et al., 
2006b). 
Several dietary factors have been suggested to precipitate outbreaks of NE, 
including high dietary levels of wheat (Branton et al., 1987; Riddell & Kong, 1992) 
and/or barley (Kaldhusdal & Skjerve, 1996). Diets rich in protein, particularly from 
animal sources and fish meal may also contribute to the growth of C. perfringens and 
therefore increase risk of NE (Truscott & Alsheikhly, 1977). It has specifically been 
suggested that there is a close relationship between fish meal and the incidence of NE in 
poultry (McDevitt et al., 2006b). Most experimental models of NE rely on the addition 
of fish meal to diets (Gholamiandehkordi et al., 2007; Pedersen et al., 2008; 
Timbermont et al., 2010). However, not all experimental models using fish meal were 
able to reproduce NE under controlled environmental conditions in poultry (Pedersen et 
al., 2003). 
The purpose of the present study was to determine the effect of fish meal addition 
on C. perfringens proliferation on in vitro digested grower diets. It was expected this 
would enable assessment of the role of fish meal as a possible predisposing factor in the 
development of NE. 
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 Materials and Methods 5.2
5.2.1  Experimental diets 
Wheat-soybean based broiler grower diet was formulated (Aviagen, 2007) 
containing approximately 50% wheat (Table 5.1). No antibiotic growth promoter or 
anti-coccidial drugs were used in the diets. Diets were produced and mixed at ASRC. 
Two diets were evaluated: one was a wheat-soybean diet (Table 5.1), the second was 
the same wheat-soybean diet but with an additional 30% fish meal on top of diet (i.e., 
30g of fish meal was added to 70g of basal diet).  
Table 5.1: Feed ingredients and calculated chemical composition (g/kg) of the 
basal grower diet 
Ingredient Grower (g/kg) 
Wheat 538 
Peas 50 
Canola meal 60 
Fish meal 30 
Animal lipids (tallow) 20 
Soya oil 30 
Soya bean meal (48) 235 
Dicalcium Phosphate
1 
14 
Limestone 11 
Sodium chloride 2 
Sodium bicarbonate 2 
Methionine  5 
V & M mixture
2
 3 
  
Calculated chemical composition  
Metabolisable energy (MJ/Kg) 13.9 
Crude Protein 226 
Available Phosphorus 1.3 
1
 Contained 21.3% Ca, 18.7% P 
2
V and M supplement provided (units kg
-1
 diets): Vit A 16,000 iu;  Vit D3 3,000 iu;  Vit 
E 75 iu (iu=mg);  Vit B1 3 mg;  Vit B2 10 mg;  Vit B6 3 mg;  Vit B12 15 µg;  Vit K3 5 mg;  
Nicotinic acid 60 mg;  Pantothenic acid 14.5 mg;  Folic acid 1.5 mg;  Biotin 275 µg;  
Choline chloride 250 mg;  Iron 20 mg;  Copper 10 mg;  Manganese 100 mg;  Cobalt 1 
mg;  Zinc 82 mg;  Iodine 1 mg;  Selenium 0.2 mg;  Molybdenum 0.5 mg (Target feed, 
Whitchurch,  Shropshire). 
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5.2.2 In-vitro Digestion of Diets 
Diets were in vitro digested according to previously published methods (Zyla et 
al., 1995; Annett et al., 2002) with minor modifications. All in vitro digestion steps 
were carried out using an orbital incubator (Gallenkamp) with a water bath (Type SB2, 
Grant instruments) at 40°C to mimic the naturally occurring avian body temperature.  
Diets were ground in a grinder (ZM 100, Retsch) using a 1mm screen to stimulate the 
normal grinding action of the gizzard. 10g of each diet was placed in 50 ml 
polypropylene centrifuge tubes and mixed vigorously with 20 ml of 0.03 M HCl. The 
pH was measured (range 5.19-5.2) by pH meter (240, Corning), by addition of 1.5M 
HCl. The tubes were incubated in a water bath at 40°C for 30 minutes. Passage through 
the proventiculus was simulated by adding 30,000 units of pepsin (P-6887; Sigma-
Aldrich Ltd, UK) and 5 ml of 1.5M HCl at pH 1.4-2.0, followed by incubation for a 
further 45 min. Then, a mixture of 68.3 mg of pancreatin (Sigma-Aldrich Ltd, UK) in 
6.5 ml of 1.0M NaHCO3 was added drop wise with constant stirring, at pH 6.3-6.7 
through 1.0M NaHCO3 addition. Volumes of mixture in the tubes were equalized by 
adding distilled water. The samples were incubated for a further 2 hrs. The samples 
were centrifuged for 30 minutes at 2000g and then filtered through gauze. The 
supernatant was immediately dispensed in sterile screw-capped tubes and frozen at –
20°C to be used the next day. 
5.2.3 Preparation of inoculum  
Vegetative cells of fresh overnight cultures were used for inoculation of in vitro 
digested diets. C. perfringens strain 56 was isolated from the intestines of broiler 
chickens with severe necrotic gut lesions producing moderate amounts of α-toxin in 
vitro. This was a type A strain (no enterotoxin or ß-2 gene), that is netB positive and has 
been previously used to induce NE in an in vivo model (Gholamiandehkordi et al., 
2007; Pedersen et al., 2008; Timbermont et al., 2010). The strain was kindly provided 
by Dr. Leen Timbermont (Ghent University, Belgium), stored in the form of frozen 
beads. From the frozen culture, bacteria were grown overnight on TSC agar plates under 
anaerobic conditions as described in section 3.2.2. Following incubation a colony from 
the TSC plate was streaked on fresh TSC agar, incubated overnight and inoculated into 
a sterile BHI broth (Oxoid, UK). BHI was dispensed into an already autoclaved sterile 
flask with a cotton plug for 15 minutes. 1ml of BHI was taken into a small bijou bottle 
and 3 colonies of C. perfringens from the TSC plate was mixed with the BHI. From this 
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inoculated BHI, 0.2ml was added to the flask with 100ml of BHI and further incubated 
overnight in a shaking incubator at 60rpm. Before inoculation into the in vitro digested 
diets the concentration of C. perfringens in the BHI was determined by 
spectrophotometer (Spectronic 301, Milton Roy) before serial dilution and plating onto 
TSC agar according to the procedure described in section 3.2.2. 
5.2.4 Proliferation of C. perfringens on in vitro digested diets 
The fluid thioglycollate (CM0173) was obtained as dehydrated media (Oxoid 
Ltd, UK) and reconstituted according to the manufacturer’s instructions. 29.75gms of 
powdered agar compound was weighed into a 1litre Schott Duran bottle, and diluted 
with distilled water to a volume of 1000ml. Fully mixed bottles of liquid media were 
boiled to completely dissolve the powder. On completion the liquid media was 
distributed into final containers that were sterilized in an autoclave at 121°C for 15 
minutes. Finally the fully mixed TG fluid was cooled at room temperature for later use. 
The frozen diets were rapidly defrosted under cold running water. For growth 
assessment of C. perfringens 1ml of BHI (CM 1135, Oxoid, UK) (7.2 x10
6
 colony-
forming units) were inoculated into four treatment (1-4) (see below). Four replication 
tubes were used per sample: 
1.  Containing 9 ml thioglycollate medium served as control. 
2.  Containing 9 ml TG plus enzymes (0.22 mg/ml pancreatin and 0.63 
mg/ml pepsin) that have been added during in vitro digestion of diets, 
served as enzyme added control . 
3.  Containing 6 ml TG with 3 ml supernatant from digested grower 
diet. 
4. Containing 6 ml TG with 3 ml supernatant from digested grower diet 
with 30% fish meal.  
The samples were incubated anaerobically at 40°C for 3hours, 6 hours, 12 hours 
and 24 hours at 200 rpm. At the end of incubation, the tubes were vigorously agitated to 
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ensure even distribution of bacteria throughout the media, and 1ml of sample was 
withdrawn to make serial dilution (10
-1 
to 10
-7
) in maximum recovery diluents (MRD). 
The presumptive identification and enumeration of C. perfringens was done on TSC 
agar as described in section 3.2.2. 100µl of each dilution was transferred aseptically into 
three replicates. Tryptose Sulphate Ccylcoserine agar plates with the help of a sterile 
spreader, with gentle rotation of the petri plates. An additional layer of 15ml TSC agar 
without egg yolk was then poured onto the plates. When the agar was solidified, the 
plates were placed in an upright position in an anaerobic box with anaerobic packs 
(AN0025 and AN0035). The jar was kept at 37°C for 24 hours. Plates with 20-200 
black colonies were counted and cfu/ml for each sample was determined. 
 Statistical Analysis 5.3
The treatment means were compared using 4x4 factorial arrangements with 
analysis of variance (ANOVA). The partitioned sources of variation included treatment, 
time and their interactions. Because of the skewed nature of the counts of C. perfringens 
data was transformed according to log (n + 1) to normalize the data before statistical 
analysis. Differences were reported as significant at P<0.05. All statistical procedures 
were performed using Genstat 11 for Windows (VSN International Ltd, Hemel 
Hempstead, UK). 
 Results: 5.4
Plate counts on BHI were used to confirm the levels of C. perfringens in 
inoculum following overnight incubation and were 7.2 x10
6
 cfu/ml of BHI. Initially all 
the supernatants (in vitro digested diets) were assessed for the presence of C. 
perfringens and were found to be negative. 
Figure 5.1 shows the effect of controls (TG medium, enzymes) and in vitro 
digested diet supernatants on the growth of C. perfringens over different time periods. 
The C. perfringens counts averaged 8.51, 8.68, 7.84, and 7.30 log10 cfu/ml after 3, 6, 12 
and 24 hours of incubation, respectively (S.E.D. 0.10 log10 cfu/ml;  P<0.001). C. 
perfringens levels increased in TG medium during the 6 hour incubation period and 
then start declining until 24 hrs of incubation being averaged 8.49, 8.81, 7.53, and 6.95 
log10 cfu/ml after 3, 6, 12 and 24 hours of incubation, respectively (S.E.D. 0.10 log10 
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cfu/ml;  P<0.084). However C. perfringens growth in TG with added enzymes did not 
show much dramatic change, it remained steady throughout the incubation time being 
averaged 8.28, 8.33, 8.08, and 7.99 log10 cfu/ml after 3, 6, 12 and 24 hours of 
incubation, respectively (S.E.D. 0.10 log10 cfu/ml;  P<0.084). 
Levels of C. perfringens increased in the supernatants with fish meal during 
the 6 hour incubation period. In particular, C. perfringens proliferation tended to be 
greatest in the medium containing supernatant from the digested grower diet with 30% 
added fish meal, compared with the digested grower diet alone (Figure 5.1; 8.26 vs 7.93 
log10 cfu/ml;  S.E.D 0.18 log10; P= 0.084) Whilst the interaction between diet and time 
was not formally significant (P=0.13), fish meal effects were most pronounced after 24 
hours of incubation (7.60 vs. 6.65 log10 cfu/ml; S.E.D 0.36 log10 cfu/ml;  P<0.05). At 3, 
6 and 12 hours of incubation (S.E.D 0.26 log10) concentrations of C. perfringens were 
8.52, 8.82, and 8.11 log10 cfu/ml  in the diet with added fish meal compared to 
concentrations of 8.75, 8.78 and 7.56 log10 cfu/ml in the digested grower diet (Figure 
5.1)  
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Figure 5.1: Proliferation of C. perfringens in controls, supernatants from grower diet with and without 30% fish meal. TG: Thioglycollate; 
+30% Fish meal: supernatant from grower diet with added 30% fish meal; Grower: supernatant from simple grower diet. 
The standard bars are the standard error of means (SEM). 
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 Discussion 5.5
Previously published evidence on the role of fish meal on NE incidence is 
conflicting. Some authors concluded that diets rich in fish meal predispose birds to NE 
(Kocher, 2003). Others used elevated levels of fish meal in diets to aid experimental 
induction of NE (Alsheikhly and Truscott, 1977). However, some concluded that high 
dietary fish meal neither increased the risk of NE nor the number of C. perfringens in 
the ileum or caeca of broiler chickens (Olkowski et al., 2006). Indeed, high levels of 
dietary fish meal have been used during experimental production of NE in poultry 
(Truscott & Alsheikhly, 1977; Pedersen et al., 2008; Wu et al., 2010).  
Annet et al. (2002) found that supernatant obtained from digested wheat and 
barley based diets resulted in higher proliferation of C. perfringens A compared to corn-
based diets. In the present study the growth of C. perfringens type A was similarly 
investigated although grower diets with and without 30% added fish meal were used. 
Prior to inoculation, all the supernatants were analysed for C. perfringens, however 
none were recovered at the 10
1
 level indicating that diets used unlikely had detectable 
numbers of C. perfringens. The present study found that C. perfringens proliferation 
tended to be higher in in vitro digested grower diet with added fish meal, especially 
towards the end of the study. Enzymatic exposure to pancreatin and pepsin in the 
grower diet with added fish meal may have yielded more nutrients (e.g. amino acids) 
that would have been available for C. perfringens utilization, resulting in increased 
proliferation. Drew et al. (2004) examined the effect of fish meal and soy protein on 
intestinal populations of C. perfringens and found that fish meal (400g/kg) significantly 
increased the counts of C. perfringens in the ileum and cecum of broiler chickens. Drew 
et al. (2004) attributed this increase to a better amino acid profile in terms of higher 
amounts of methionine, histidine, glycine and alanine in the fish meal diet. 
In the present study, the presence of fish meal appeared to aid the survival of C. 
perfringens as at 12 hrs there was 0.55 log difference between grower and added fish 
meal diets. By 24 hrs this difference was almost full log (0.95) indicating that additional 
growth nutrients were released and/or made available for the growth of C. perfringens. 
Increased clostridial proliferation in the fish meal diet compared with the simple grower 
diet is in agreement with the previously reported in vivo studies. Wu et al. (2010) 
assessed the effect of high levels of fish meal on the incidence of NE in broiler chickens 
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and found higher C. perfringens in birds with fish meal compared with the non-fish 
meal control group. However, Olkowski et al. (2006a) were unable to find any effect of 
fish meal on the occurrence of NE, although higher levels of dietary fish meal 
significantly increased the number of C. perfringens in the caecum and ileum of the 
birds. This strongly suggest that higher levels of C. perfringens alone are unlikely 
responsible for inducing (sub-clinical) NE. The levels of C. perfringens observed 
decreased throughout the incubation period in all cases for both simple grower and 
grower with added fish meal, likely due to nutrient exhaustion of the medium used. 
The possible reason for the higher growth of C. perfringens, after 24 hrs in TG 
media with added enzymes compared to treatments with in vitro digested grower diets 
and simple grower diet with added fish meal, may be the higher amount of TG used for 
this treatment (9ml vs 6ml), thus providing more media for C. perfringens growth. 
Although both enzymes (pepsin and pancreatin) were added during the in vitro 
digestion of the diets, it is assumed that some of the enzymes would have been used 
during the process. Further since it was impossible to run and analyse all tests 
simultaneously, all supernatants were kept frozen overnight which is likely to have 
resulted in diminished enzyme activity in those diets due to their proteinous nature. 
Xuan Wang (2008) found that proliferation of different strains of C. perfringens was 
inconsistent and he attributed this inconsistency to variables in strain metabolism and 
growth requirements by different strains. 
In vitro assays do not fully recreate the same conditions as in vivo due to 
absence of factors such as feed passage in the gut. Other factors like food passage time, 
gut flora, that also influence the extent of digestion are difficult to reproduce in vitro. 
Despite these differences, in vitro techniques have been utilized for prediction of broiler 
intestinal viscosity when fed rye based diets in the presence of exogenous enzymes, and 
these studies found a good relationship between in vitro and in vivo assays (Bedford & 
Classen, 1993). Zyla et al. (1995) described in vitro methods for feed digestion as 
accurate, rationally fast, cost-effective, simple and robust when compared with in vivo. 
Welfare concerns relating to animal experiments mean that generally in vitro methods 
are preferred (Weurding et al., 2001). However the various draw backs of in vitro 
approaches may impact results i.e. failure to take account of competition from other gut 
flora that may affect the growth of C. perfringens in vivo. Despite these obvious 
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limitations, in vitro assays have been shown to be useful when budgetary limitations 
make in vivo studies too expensive.  
 Conclusion  5.6
The overall findings of the present study support the view that high levels of 
dietary fish meal may assist survival of C. perfringens, suggesting that the role of fish 
meal as a predisposing factor for (subclinical) NE cannot be excluded. 
. 
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6 EXPERIMENT FOUR:  
INDUCTION OF SUB-CLINICAL NECROTIC ENTERITIS 
THROUGH IN-FEED CHALLENGE WITH LOW AND HIGH DOSES 
OF CLOSTRIDIUM PERFRINGENS
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6.1 Introduction 
Sub-clinical NE is an economically important disease of poultry with global 
significance since it is usually undetected so often remains untreated (Skinner et al., 
2010). Although C. perfringens is the primary etiological agent of sub-clinical NE, 
other contributory factors are also required to predispose birds to this disease. These 
precipitating factors are both numerous and mostly ill-defined, but a number of previous 
researchers have shown these to include diet composition, other intestinal diseases and 
management related stress (Shane et al., 1985; Kaldhusdal & Lovland, 2000; McDevitt 
et al., 2006b). In order to investigate, strategies for controlling sub-clinical NE, it is 
crucial to create a model that enables repeatable experimental induction of sub-clinical 
NE under controlled environmental conditions. However it has proved difficult to 
reproduce the disease and to date there is no standardized model. The published models 
vary in C. perfringens strains, challenge procedures, challenge dose, challenge days, 
and incorporation of predisposing factors (Truscott & Alsheikhly, 1976; McReynolds et 
al., 2004b; Palliyeguru et al., 2010). 
As a result, despite much research in many countries, the exact conditions that 
precipitate out-breaks of NE under field conditions continue to be ambiguous. 
Numerous factors have been identified that promote the development of sub-clinical 
NE. These predisposing factors are mainly dietary in nature, although another risk 
factor for the onset of sub-clinical NE is concurrent intestinal diseases like coccidial 
infection. Under field conditions, particularly when there sufficient numbers of C. 
perfringens are present, coccidial infection can play a crucial role in the occurrence of 
NE. In particular the Eimeria species that colonize the small intestine such as Eimeria 
maxima and Eimeria acervulina may predispose birds to NE (Alsheikhly & Alsaieg, 
1980). Bradley and Radhkrishnan (1972) observed an increased growth of C. 
perfringens in the caecum during infection with E. tenella. However Baba et al. (1997) 
suggested that concurrent infection with E. nacatrix and C. perfringens has a synergistic 
effect and increases clostridial population in the intestine of the chickens.  
From experiment three (Chapter 5; Saleem et al., 2011) it was concluded that 
fish meal (30% added on top of grower diet) may enhance C. perfringens proliferation It 
was therefore decided to use fish meal as a predisposing factor in subsequent 
experiments. The current experiments were to develop experimental model of sub-
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clinical NE with low in-feed doses of C. perfringens, together with higher doses of 
coccidial vaccine in broiler chickens fed wheat-based diets incorporating high amounts 
of fish meal (Experiment 4a) and with higher and repeated in-feed doses of C. 
perfringens, together with higher doses of coccidial vaccine (Experiment 4b). 
The targeted in-feed C. perfringens level was 10
2
 cfu per g of feed in Experiment 
4a. As sub-clinical disease was not observed, this target increased to 10
9
 cfu in 
Experiment 4b. Experiment 4b was also set out to compare two breeds (Ross 308 & 
Hubbard) in their resistance to induction of sub-clinical NE under the same 
experimental conditions, as different broiler strains can differ in susceptibility to 
infectious diseases (Lamont, 1998; Zekarias et al., 2002). 
6.2 Materials and Methods  
6.1.1 Treatment groups and Experimental Design 
6.1.1.1 Experiment 4a 
A total of 48 day-old male Ross 308 broiler chickens were obtained from a 
commercial hatchery, reared in solid-floored pens in an environmentally controlled 
house from day one to up to day 21. Two treatments (see below) were compared using 
three replicate pens with 8 birds per pen. Six floor pens, in three positional blocks, were 
used in an environmentally controlled room. 
6.1.1.2 Experiment 4b 
A total of 45 day-old male (30 Ross 308 and 15 Hubbard) were obtained from a 
commercial hatchery, reared in solid-floored pens in an environmentally controlled 
house. Three groups of birds (2 Ross and 1 Hubbard) were subjected to one of three 
different treatments (see below). All three treatments were randomly allocated to pens 
in three positional blocks. A total of nine floor pens, with 5 birds per pen were used in 
an environmentally controlled room. At this time only one Hubbard treatment was 
included due to limitations, imposed by the Animal Ethics committee, to use low 
number of animals whereever possible - particularly in studies putting the birds under 
challenge. This effectively limited the researcher to a small scale pilot study. If this 
experiment had achieved greater success, more birds would have been used.  
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Table 6.1 : Experimental design for experiment 4a and 4b showing the days of age at which the challenges and vaccines were given and 
the days for lesion scored 
Experiment Treatment No of replicates  
(pens) 
No of birds  
per pen 
C. perfringens 
Challenge   
Coccidial 
Vaccination 
(days) 
Lesion 
scoring 
(days) 
 C. perfringens 
Challenge dose
a 
Number of 
birds sampled 
per pen
b 
         
4a Control (Ross) 3 8 - 18 21 - 8 
4a Challenge 
(Ross) 
3 8 17,18,19 18 21 1.00 x 10
2 8 
         
4b Control (Ross) 3 5 - 18 21 
- 5 
4b Challenge 
(Ross) 
3 5 17,18,19 18 21 1.54 x 10
9 
5 
4b Challenge 
(Hubbard) 
3 5 17,18,19 18 21 1.45 x 10
9 
5 
a 
Calculated number of C. perfringens in average inoculum in feed  
b 
Birds were randomly sampled at day 21 
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In both experiments the birds were reared as a single flock from day 0 to day 7. 
On day 7, the birds were weighed and randomly allocated to each pen with similarly 
averaged day 7 BW. The designs of experiments 4a and 4b are shown in Table 6.1. 
Adequate feeders and drinkers were provided for the age and the number of the birds 
with commercial wood shavings provided as bedding. 
6.1.2 Diet and feed mixing: 
The same starter and grower diets were used for both of these experiments. Two 
nutritionally complete diets, wheat-soybean based broiler starter and grower were 
formulated (Aviagen, 2007). Both feeds contained approximately 50% wheat. No 
antibiotic growth promoter or anti-coccidial drugs were used in the diets. Diets were 
produced and mixed at the ASRC, SAC, Ayr and fed as mash. Both starter and the 
grower diets had the same formulation for all the birds involved in both study 4a and 4b 
(Table 6.2). 
All the groups were fed the starter diet from day 0 to day 7, followed by the 
grower diet from day 8 until day 15. Thereafter all birds were fed the grower diet, 
mixed 3:1 with fish meal until day 21. Challenged groups were given a C. perfringens 
culture in their diet on days 17, 18 and 19. In contrast, the birds of the control group 
were given feed mixed with sterile brain heart infusion broth (BHI) only. The 
challenge-feed was mixed in the Microbiology Laboratory, SAC, Ayr each day during 
the challenge period. Feed and water were given ad libitum throughout the study period. 
Pen dimensions in both experiments were 1.74 x 1.28 m. A solid 45cm high plywood 
barrier at bird level separated adjacent pens. A wire fence was located on the top of all 
barriers up to the ceiling. Fresh wood shavings to the depth of 10cm were provided as 
bedding at the start of each study. Each pen was provided with a single food hopper and 
bell drinker.  
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Table 6.2: Ingredients and calculated composition (g/kg) of starter and grower 
diets used in experiments 4a and 4b 
Ingredient Starter (g/kg) Grower (g/kg) 
Wheat 523 538 
Peas 50 50 
Canola meal 60 60 
Fish meal 30 30 
Animal lipids (tallow) 23 20 
Soya oil 30 30 
Soya bean meal (48%) 245 235 
Dicalcium phosphate
1 
14 14 
Limestone 12 11 
Sodium chloride 2 2 
Sodium bicarbonate 2 2 
Methionine  5 5 
Vitamin & mineral mixture
2
 4 3 
Calculated chemical composition  
Metabolisable energy (MJ/Kg) 13.8 13.9 
Crude Protein 217 226 
Available Phosphorus 1.5 1.3 
1
Contained 21.3% Ca, 18.7% P 
2 
V and M supplement provided (units kg
-1
 diets): Vit A 16,000 iu;  Vit D3 3,000 iu;  Vit 
E 75 iu (iu=mg);  Vit B1 3 mg;  Vit B2 10 mg; Vit B6 3 mg;  Vit B12 15 µg; Vit K3 5 mg;  
Nicotinic acid 60 mg; Pantothenic acid 14.5 mg; Folic acid 1.5 mg; Biotin 275 µg;  
Choline chloride 250 mg;  Iron 20 mg; Copper 10 mg;  Manganese 100 mg; Cobalt 1 
mg; Zinc 82 mg; Iodine 1 mg; Selenium 0.2 mg; Molybdenum 0.5 mg (Target feed, 
Whitchurch, Shropshire. 
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The birds in the experimental pens were reared following a standard commercial 
environmental control programme from day 0 to day 21. All treatment groups were 
housed in the same room. To avoid contamination with C. perfringens, the birds were 
reared in alternate pens, thereby creating an empty pen between each pen of birds. The 
empty pen was disinfected every second day during the study. There were foot dips in 
front of each challenge pen. Additional precautions, such as changing gloves and foot 
dipping tanks between treatment pens, were taken to avoid accidental contamination of 
unchallenged pens with C. perfringens. Light was provided for 23hrs with controlled 
temperature and humidity. Birds were individually tagged. All birds that died or were 
culled were recorded, weighed and post-mortemed. All experimental procedures were 
approved by the SAC Animal Ethics committee (AU AE 22/2009 (Exp 4a) and AU AE 
1/2010 (Exp 4b)) and carried out under Home Office authorization (PPL 60/3383 (Exp 
4a) and 60/3398 (Exp 4b)). 
6.1.3 Preparation of inoculum and challenge procedure 
Vegetative cells of fresh overnight cultures were used for inoculation of 
chickens. C. perfringens strain 56 was isolated from the intestines of broiler chickens 
with severe necrotic gut lesions producing moderate amounts of α-toxin in vitro. It is a 
type A strain (no enterotoxin or beta-2 gene), strain is netB positive and has been used 
previously to induce NE in an in-vivo model (Gholamiandehkordi et al., 2007; Pedersen 
et al., 2008; Timbermont et al., 2010). The strain was kindly provided by Dr. Leen 
Timbermont (Ghent University, Belgium), stored in the form of frozen beads. From the 
frozen culture, bacteria were grown overnight on Tryptose Sulphite Cycloserine (TSC) 
agar plates. Before inoculation in the feed, the bacteria were cultured for 24hrs at 37°C 
in BHI broth (Oxoid, UK) as describe in section 3.2.2. After overnight incubation on 
TSC agar plates, colonies of C. perfringens were taken, mixed with BHI, incubated at 
37ºC shaken at 60rmp anaerobically overnight. After incubation, 0.2ml of BHI was 
mixed with BHI broth in flasks for final mixing with the feed. Before preparation of 
each batch of challenge-feed the concentration of C. perfringens in the BHI was 
determined by spectrophotometer and then serially diluted and plated onto TSC agar 
according to the procedure described in section 3.2.2. On days 17, 18 and 19 birds on 
the challenge treatments were offered inoculated feed only. Feed and BHI broth 
containing C. perfringens were in a ratio of 1:1. Fresh cultures and mixtures of culture 
and feed were prepared daily. The mixture, which had a paste-like consistency, was 
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placed in feed trays. Birds were fed with challenge feed once daily and had continual 
access to the challenge feed. Uneaten feed was removed and the feeders thoroughly 
cleaned before the next feeding. The birds of the non-challenged control group were 
given grower diet mixed 1:1 w/v with sterile BHI broth once a day, also on days 17, 18, 
and 19. 
6.1.4 Coccidial Vaccination 
On day 18, all birds received anticoccidial vaccine “Paracox-8™” (Schering-
Plough Animal Health, Welwyn Garden City, UK). This vaccine contains live 
attenuated oocytes of Eimeria acervulina Eimeria brunetti, Eimeria maxima (two lines), 
Eimeria mitis, Eimeria necatrix Eimeria praecox, and Eimeria tenella and was given by 
oral gavage at 10 times the dosage prescribed by the manufacturer. This level of 
coccidial vaccine was chosen because at this dose slight reddening of intestinal mucosa 
was observed (Pedersen et al., 2008).  
6.1.5 Sampling and data recording 
6.1.5.1 Enumeration of C. perfringens in BHI and feed  
A sample of BHI mixed with C. perfringens culture was used for enumeration of 
C. perfringens by the spread plate method on TSC agar plates. After mixing with BHI, 
representative feed samples were collected and immediately examined for enumeration 
of C. perfringens. Feed sample aliquots of approximately 10g of feed were weighed out 
and suspended in 90ml of Maximum Recovery Diluent (MRD). From this dilution 
further 10 fold dilutions were made. From each dilution 100µl of mixture was 
inoculated onto TSC plates. After incubation the number of colonies was counted on the 
most appropriate dilution (Plates with 30-300 colonies). This figure was then used to 
calculate the number of colony forming units per gram of original sample. 
6.1.5.2 Clinical signs and lesion scoring 
Birds were assessed daily for clinical signs and symptoms of NE, from the day 
feed was inoculated with C. perfringens until termination of the experiment. On day 21 
all the birds were humanely killed by intravenous administration of an overdose of 
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barbiturate. The entire gastro-intestinal tract (GIT) was inspected for the presence of 
lesions/pathological changes associated with sub-clinical NE or evidence of lesions of 
coccidiosis. The disease frequency was measured per treatment, as the fraction of 
randomly selected birds with gross lesions consistent with sub-clinical NE. Three 
different segments of GIT (duodenum, jejunum and ileum) were identified, immediately 
incised, and washed in Phosphate Buffer Saline (PBS). Then the mucosal surfaces were 
inspected and scored for any lesions of clostridia, necrotic and haemorrhagic lesions. A 
modification of the scoring system used by Shane et al. (1985) was planned to be used 
to score intestinal lesions. However, in experiment 4b, only a small proportion of birds 
were found with lesions. All these were observed as focal necrosis with 5-10mm 
diameter. Therefore only two scores were used, i.e. lesions present (1) or absent (0). 
6.1.5.3 Histopathology 
Samples from the small intestine, particularly those showing lesions, were taken 
for histopathology. A 1.5-2cm of tissue sample was taken, washed with phosphate 
buffer saline (PBS) and stored in 10% neutral phosphate-buffered formalin for 
histopathology as described in section 3.2.5.3. Specimens for histopathology were 
embedded in paraffin, processed routinely, cut at 5-6µm and stained with haematoxylin 
and eosin (Appendix A). Gram’s staining was also done to confirm the presence of 
Gram positive bacilli (Appendix B). The prepared tissue sections were later examined 
using a binocular stereo-microscope (Olympus BX 41, U-LH100HG, Olympus optical, 
Co. Ltd) connected by camera (spot idea™ 28.2-5MP) to computer software (Spot idea, 
Version 4.7) using different magnifications. 
6.1.5.4 Quantification of C. perfringens and α-toxin in digesta 
Ileal content (digesta content from the Meckel’s diverticulum to ileo-caecal-
colon junction) of all the birds from each replicate pen were taken into sterile screw- 
capped bottles and immediately transferred immediately to the Microbiology laboratory, 
for analysis of C. perfringens. The presumptive identification and enumeration of C. 
perfringens was done on TSC agar as described in section 3.2.5.4. Each of the digesta 
samples was vortexed for 15 seconds in order to ensure adequate mixing. One g of 
digesta was weighed and serially diluted in MRD. From each dilution to be plated, 
100µl was applied to the centre of each agar plate, allowed to be absorbed and then 
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15ml of TSC overlay was spread before the plate was incubated invertedly in an jar 
provided with anaerobic conditions as described in section 3.2.2. The jar was placed in 
an incubator at 37°C for 24hrs. After incubation the number of colonies was counted to 
calculate the number of colony forming units per gram of original sample. 
Quantification of α-toxin in the intestinal digesta was done by Enzyme linked 
immunosorbent Assay (ELISA) using α-toxin C. perfringens kit (Cypress diagnostics, 
Ref. Vb040) following the manufacturer’s recommendations as described in section 
3.2.5.5. 
6.1.5.5 Growth performance 
At days 0, 7, 16 and 21 all birds were weighed individually, to calculate bird 
weight gain (WG) during the experimental periods. Starter feed was weighed at day 0 
and weighed back at day 7. The grower feed was weighed back at days 16 and 21. Feed 
intakes (FI) were calculated by weighing the initial feed inputs against the uneaten feed 
over the experimental period. Feed conversion ratio (FCR) was calculated by dividing 
average feed consumed per pen over average weight gain of birds per pen. 
6.1.5.6 Feed analysis 
Amino acid contents of grower feed with added fish meal were determined as 
described in section 4.2.5.6. Analysis of feed samples was done in duplicate.  
  Statistical Analysis 6.2
The effect of challenge on digesta counts of C. perfringens, FI, BW, WG and 
FCR were compared using randomized complete block analysis of variance (ANOVA). 
The pens were treated as an experimental unit, and pen position used as a block. Data 
are presented as means. 
Because of the skewed nature of the counts of C. perfringens, data was 
transformed according to log (n + 1) to normalize the data before statistical analysis. 
Differences were reported as significant at P<0.05. Day 16 BW was initially used as a 
covariate, but omitted from the final model used when it did not contribute significantly. 
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The data obtained for the incidence of intestinal lesions were compared using a non-
parameteric Fisher’s exact test. In experiment 4b, comparison contrast was used to 
separate treatment means. Significance of the test was determined at P< 0.05. All 
statistical procedures were performed using Genstat 11 for Windows (VSN 
International Ltd, Hemel Hempstead, UK). 
 Results  6.3
In both experiments, none of the control or challenged birds showed clinical 
abnormalities of NE. Moreover no mortality was observed in any of the treatment 
groups during both studies. 
6.3.1 Enumeration of C. perfringens in feed 
During the days when the birds were challenged with C. perfringens in their 
feed, a fresh feed and C. perfringens broth culture mixture were prepared daily. 
Analysis of feed mixed with BHI containing the culture of C. perfringens showed that 
average inoculums for the birds on days 17, 18 and 19 for the challenged group were 
1.00 x 10
2
 cfu/g feed (SEM 5.7 cfu/g) offered in experiment 4a and ~1.5 x 10
9
 cfu/g 
feed (SEM 4.29 x 10
8 
cfu/g) offered in experiment 4b (Table 6.1). C. perfringens was 
not detected in the feed of the control groups. 
6.3.2 Lesions score 
Table 6.3 shows the occurrence of sub-clinical NE lesions in the small intestine 
on day 21 in experiments 4a and 4b. In experiment 4a, no lesions of sub-clinical NE 
were observed in birds who had received the C. perfringens challenge (P=1.00). In 
experiment 4b, slight reddening of the intestinal mucosa was observed in most of the 
birds receiving C. perfringens challenge. In addition, lesions typical of sub-clinical NE 
were observed in two challenged Ross birds and one challenged Hubbard bird (P= 1.00; 
Table 6.3). Thus, overall, sub-clinical NE lesions were observed in three out of 30 
challenged birds (10%) but there were no treatment differences (P=1.00) All lesions 
were focal necrosis, 5-10 mm in diameter. In one Ross bird focal necrotic areas were 
almost confluent. No bird in the control group developed lesions in either of the 
experiments. 
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Table 6.3: Occurrence of lesions of sub-clinical NE in the small intestine of 
broiler chickens on day 21 in experiments 4a and 4b  
Experiment Treatment Bird No of 
pens 
No. of 
birds 
per pen 
Sub-clinical 
NE lesions  
Total % 
       
4a Control  Ross 3 8 0/24 0 
4a Challenge  Ross 3 8 0/24 0 
       
4b Control   Ross 3 5 0/15 0 
4b Challenge  Ross 3 5 2/15 13.3 
4b Challenge  Hubbard 3 5 1/15 6.66 
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Figure 6.1: Focal necrosis (black circles)in the mucosa of intestine of broiler 
chickens receiving higher concentration of C. perfringens (approximately 109) 
and higher dose of coccidial vaccine with high fishmeal diets (experiment 4b). 
 
  
a 
b 
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6.3.3 Histopathology 
Histopathological examination of formalin fixed intestinal tissue from 
experiment 4a revealed no lesions of sub-clinical NE.  However in experiment 4b, 
histopathological sections from the three birds that had visible gross lesions exhibited 
microscopic changes typical of sub-clinical NE. There was severe necrosis of the 
intestinal mucosa, with an abundance of fibrin admixed with cellular debris adherent to 
necrotic mucosa. Marked infiltration of heterophilic granulocytes was also observed. 
The tissue sections with Gram stains from these birds demonstrated the presence of 
Gram positive bacilli with characteristic C. perfringens morphology in the form of large 
clumps primarily around necrotic areas (Figure 6.2). Some colonies of C. perfringens 
were also seen in the vicinity of non-necrotic areas. Many haemorrhagic cells were also 
visible in intestinal villi in some tissue sections from these birds. The lesions like villous 
atrophy, as well as blunting and necrosis of villi tips were also seen in some 
microscopic sections. There was no evidence of coccidial oocytes or schizonts in any of 
the intestinal tissue sections examined either with or without gross lesions. 
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Figure 6.2: Photomicrography of the intestine of broilers exhibited gross lesions 
of sub-clinical NE in experiment 4b (a) necrotic villi and presence of  fibrin like 
material  in the lumen, Gram stain (x10)  Figure 2 (b) same section showing 
aggregation of Gram positive bacilli (arrow) thickly clustered around necrotic 
villi, Gram stain (x40). 
 
a 
b 
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6.3.4 Quantification of C. perfringens and α-toxin in the ileal 
digesta 
The average log transformed counts of C. perfringens in experiment 4a and 4b 
are shown in Table 6.4 and Table 6.5 respectively. In experiment 4a, counts of C. 
perfringens in ileal digesta from control and challenged birds did not differ. In 
experiment 4b, unchallenged control birds had a significantly lower numbers of C. 
perfringens on day 21 compared to C. perfringens challenged Ross and Hubbard 
(P<0.001; Table 6.5). However, counts of C. perfringens did not differ between 
challenged Ross and Hubbard birds (2.87 vs 3.35 log10 cfu/g of digesta). Alpha toxin 
was not detected in the ileal samples of birds from any of the treatment group, with or 
without lesions. 
6.3.5 Growth performance 
Table 6.4 and 5 shows the effect of challenge on BW on days 16 and 21, and 
WG, FI and FCR during day 16 to 21 in experiment 4a and 4b respectively. Challenge 
did not significantly affect final BW, WG, FI and FCR in both experiments 4a and 4b 
(P>0.05). 
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Table 6.4: The growth performance and C. perfringens counts (day 21) in ileal digesta of broilers chickens in 
challenge and control treatment groups in experiment 4a 
Variable Control Challenge SEM
1 
Probability of treatment 
effect 
Body weight (day 16)  
 (g/bird) 
445 436 17.2 0.721 
Body weight (day 21) 
(g/bird) 
747 731 17.1 0.569 
Weight gain (days 16-21) 
(g/bird) 
302 295 6.70 0.539 
Feed Intake (days 16-21) 
(g/bird/day) 
68 68 0.96 0.922 
Feed conversion ratio
2
 1.13 1.15 0.02 0.470 
C. perfringens 
(Log10 cfu/g of digesta) 
1.76 1.33 0.44 0.499 
Data represent the mean of 3 pens with eight broiler chickens per pen. 
1 
SEM: Standard error of means. 
2 
Feed conversion ratio = feed intake: weight gain (g/g). 
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Table 6.5: The growth performance and counts of C. perfringens (day 21) in ileal digesta of broiler chickens in control and 
challenge treatment groups in experiment-4b. 
Variable  Control 
(Ross) 
Challenge 
(Ross) 
Challenge 
(Hubbard) 
SEM
1 
Probability of treatment 
effect 
Body weight (day 16)   
(g/bird) 
461 492 478 31.8 0.804 
Body weight (day 21)  
(g/bird) 
806 797 794 8.8 0.662 
Weight gain (days16-21)  
(g/bird) 
327 322 317 8.75 0.761 
Feed intake (days 16-21) 
(g/bird/day) 
75 77 75 1.69 0.623 
Feed conversion ratio
3
 
(days16-21) 
1.14 1.19 1.18 0.02 0.456 
C. perfringens                 
(Log10 cfu/g of digesta) 
0.30
b
 2.87
a
 3.35
a
 0.48 <0.001 
 Means within a row without a common superscript differ significantly (P < 0.05). 
1 
SEM: Standard error of means. 
2 
Data represent the mean of 3 pens with five broiler chickens per pen. 
3 
Feed conversion ratio = feed intake: weight gain (g/g). 
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 Discussion 6.4
Necrotic enteritis and its sub-clinical form under field conditions are very 
complex with outbreaks dependant upon innumerable factors such as the nature of the 
diet, gut environment, overall poultry management and co-infection with other enteric 
diseases (McDevitt et al., 2006b). When faced with such a multi-factorial disease, a 
working reproducible experimental model is an essential tool if the industry is to be able 
to determine a variety of control strategies such as effective, long lasting vaccination, 
novel feed additives or other nutritional strategies. However, successful and consistent 
reproduction of NE has proved to be difficult. Limited data is available from attempts to 
reproduce NE under controlled experimental conditions, with even less data relating to 
reproduction of sub-clinical NE (Truscott & Alsheikhly, 1977; Alsheikhly & Truscott, 
1977b; Kaldhusdal et al., 1999; Pedersen et al., 2003; Wu et al., 2010).   
Experiments 4a and 4b included various suggested predisposing factors to 
induce sub-clinical NE in a model of challenged broiler chickens, in the presence of 
both low and high concentrations of C. perfringens through oral gavage. All birds were 
administered with coccidial vaccine (Paracox-8
®
) at a dose 10 times higher than that 
prescribed by manufacturer as Eimeria co-infection is known to be the important 
predisposing factor provoking NE lesions (Van Immerseel et al., 2004). Our work 
(Experiment 2) together with studies conducted by Prescott et al. (1978a) has shown 
that fish meal supports the growth of C. perfringens. Therefore a high level of fish meal 
(30% on top of basic diet) was used during days 16 to 21 to further facilitate sub-
clinical NE. In addition to these two factors, diets contained approximately 50% of 
wheat, as higher levels of wheat have also been shown to excerbrate the incidence of 
NE (Truscott & Alsheikhly, 1977; Branton et al., 1987; Riddell & Kong, 1992).  
In both experiment 4a and 4b, birds were closely monitored for clinical signs of 
NE. However, neither clinical signs of the disease were observed nor was any mortality 
recorded. For examination of gross lesions day 21 of age was chosen because this is the 
age at which outbreaks of NE often occurs (Long, 1973; Wilson et al., 2005). In 
experiment 4a no disease lesions were seen whereas in experiment 4b lesions were seen 
in some challenged birds only. As none of the birds showed clinical signs specific to NE 
the lesions observed in experiment 4b must be classified as sub-clinical NE. However, 
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the proportion of inoculated birds that developed such lesions was low (3 out of 30, or 
10%). 
In experiment 4b, histopathological examination of birds with lesions confirmed 
that these were typical of sub-clinical NE, revealing damaged intestinal villi with 
multifocal necrosis along with the presence of necrotic debris. The apical parts of the 
villi were most affected. There was also marked infiltration of heterophilic 
granulocytes. Colonies of bacterial rods were frequently noted within the necrotic areas. 
Similar histopathological findings have been observed in birds with sub-clinical NE by 
other researchers (Branton et al., 1987; Kaldhusdal & Hofshagen, 1992; Palliyeguru et 
al., 2010). 
In experiment 4b, on day 21, concentrations of C. perfringens in ileal digesta of 
the control group were significantly lower compared to the challenged Ross and 
Hubbard group, clearly demonstrating an association between in feed C. perfringens 
and NE (Figure 6.3). Alpha toxin is believed to be the major virulent factor of NE (Van 
Immerseel et al., 2004). However in the present studies α-toxin was not detected in ileal 
digesta of any of the broiler chickens, with or without lesions. Quantification of α-toxin 
may not be a reliable parameter since a clear relationship between α-toxin production by 
different strains of C. perfringens and induction of NE has yet to be established. 
Moreover α-toxin production by C. perfringens isolates from diseased and healthy 
broiler flocks has been shown to be similar (Gholamiandekhordi et al., 2006), although 
this would not explain the absence of α-toxin from our studies.  
In addition to gross lesions, the sub-clinical form of NE is often associated with 
damage to intestinal mucosa leading to a retarded growth rate and increased FCR 
(Kaldhusdal & Hofshagen, 1992; Liu et al., 2010; Elwinger et al., 1992). However, in 
the present studies C. perfringens challenge did not affect weight gain or the FCR of 
groups of broiler chickens from days 16-21. Similar results were found by Pedersen et 
al. (2008) who did not find any difference in the weight gain between challenged and 
unchallenged birds. In experiment 4a no intestinal lesions of sub-clinical NE were 
observed whereas in experiment 4b the proportion of birds with lesions was too low so 
judged unlikely to have had an impact on growth parameters. 
Chapter 6  147 
 
 
 
Figure 6.3: Counts of C. perfringens (cfu/g) in feed and ileal digesta of different 
treatment groups. 
It was not possible from Experiment 4a to establish an infection challenge model 
for C. perfringens. Although some of the predisposing factors were applied, such as 
incorporation of more than 50% of wheat in the diet (Branton et al., 1987; Riddell & 
Kong, 1992), high levels of fish meal (30% on top of basic diet) in grower diet from 
days 7 to 16 (Prescott et al., 1978a). Diet was offered in the form of mash rather than 
pellets as Engberg et al. (2002) found higher numbers of C. perfringens in the  caecum 
of birds fed a mash compared to pelleted diet. Lack of successful induction of the 
disease in experiment 4a indicates that some factors other than diet are also critical for 
disease induction. 
There could be many reasons for the failure of the challenge model in 
experiment 4a to reproduce NE, thought the most likely explanation is that the number 
of C. perfringens cfu in inoculum was very low (10
2
), as this was even lower than that 
found in GIT of healthy chickens (10
4
 (Kondo, 1988; Drew et al., 2004)) These results 
suggest that the oral dosage of C. perfringens was insufficient to produce lesions even 
in presence of higher doses of coccidial vaccine and a diet high in fish meal. Challenge 
inoculum was prepared once, and stored for use on the three inoculation days. It can not 
be excluded that by day 3, some bacterial cells may have died in this older broth before 
it was administered to the birds. Alsheikhly & Truscott (1977b) inoculated fresh 
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cultures of C. perfringens directly into the duodenum of the chickens and were able to 
detect changes in intestine within 1hr. There is also a possibility that when broth was 
mixed with feed some of the vegetative cells converted into spores that could not find 
suitable conditions for growth in the lower gut. It was therefore decided to make 
significant changes in the subsequent model i.e. experiment 4b, when in-feed challenge 
was repeated giving higher numbers of C perfringens (10
9
). An additional change was 
instead of preparing inoculum once for adding to the feed on each subsequent day, the 
inoculum was freshly prepared every day prior to being added to that day’s feed only.  
The literature records many attempts to reproduce NE in poultry, all using 
different methods but most using recognised predisposing factors to induce NE. The 
most well known factors are coccidial infection and the inclusion of high protein levels 
in diets. Various approaches for challenge have been applied such as use of a bacterial 
culture (Alsheikhly & Truscott, 1977b; Branton et al., 1997; Cowen et al., 1987; Long 
& Truscott, 1976) and contaminated litter (Cowen et al., 1987; Hamdy et al., 1983b). 
However, these published reports indicate only limited success to experimentally 
reproduce NE, let alone sub-clinical NE (Nairn & Bamford, 1967; Bernier & Filion, 
1971; Davis et al., 1971). Interestingly, although presence of Eimeria spp. and high 
levels of fish meal in the diet proved essential in inducing of NE in some studies (Miller 
et al., 2010), other studies very high levels of C. perfringens inoculation (10
10
 cfu) 
along with higher doses of coccidial vaccine and fish meal (grower diet 3:1 fish meal) 
failed to induce NE in broiler chickens (Pedersen et al., 2003; Timbermont et al., 2010). 
In the present studies wet mount preparations at the time of necropsy from intestinal 
scrapings showed no evidence of any Eimeria spp. Previous studies with higher doses 
of coccidia (up to 50,000 sporulated oocytes orally along with feed containing C. 
perfringens (approximately 10
7
 cfu/g of feed) also failed to produce NE lesions (Baba et 
al., 1992). A later series of experiments (Baba et al., 1997) only showed oedema of the 
intestine, in spite of giving higher coccidial infection and higher dose of C. perfringens 
(10
8
-10
9
) for 5 consecutive days. 
In experiment 4b, some birds developed NE lesions. Although the number of 
sub-clinical NE positive birds in experiment 4b was small (3 out of 30, or 10%), birds 
from the challenge groups had developed gross NE lesions without clinical signs and 
mortality, which is typical of sub-clinical NE. According to Olkowski et al. (2006a) 
gross lesions are not always observed in experimental trials. The incidence noticed in 
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experiment 4b was considerably lower than the 79% incidence reported elsewhere in 
commercial flocks (Cooper et al., 2009). However, several challenged studies with high 
doses of C. perfringens have failed to reproduce (sub-clinical) NE under controlled 
conditions, though intestinal lesions like hyperaemia and haemorrhages with high 
colonization of C. perfringens have been documented (Craven, 2000; Pedersen et al., 
2003; Dahiya et al., 2007a; Liu et al., 2010). The 10% incidence observed in 
experiment 4b is roughly consistent with many other studies. Cowen et al. (1987) found 
1.3-10% incidence of NE in three out of five trials. Long & Truscott (1976) found 12% 
and 26% incidence, based on mortality, after feeding C. perfringens infected feed for 24 
hrs or 5 days, respectively. The amount of C. perfringens in culture was 1.6 x 10
8
 to 1x 
10
9
 cfu per ml of broth and a incidence of NE (10%) was found in trials where, in 
addition to C. perfringens culture, birds were reared on litter from a flock with NE. 
Incidence of sub-clinical NE has been shown by Kaldhusdal & Hofshagen (1992) at 
only 3.64%, with only seven out of 192 birds exhibiting sub-clinical NE lesions. In 
contrast, later trials by the same group found 10% of birds with NE lesions found that 
response to C. perfringens challenge differs significantly from one experiment to 
another (Kaldhusdal et al., 1999). According to Long & Truscott (1976) lesions typical 
of NE could be produced in 11-24% of broiler chickens consuming feed containing 
approximately 10
7
 per gram of C. perfringens. Thus, in conclusion, though the 
incidence of sub-clinical NE in experiment 4b could be considered low, its level is 
within the wide range reported in the literature. 
 Conclusion  6.5
In conclusion, lower concentrations of C. perfringens in feed (10
2
), predisposing 
factors like higher doses of coccidial vaccine and high levels of fish meal in the diet 
were unable to produce sub-clinical NE. The results also show that on high levels of 
fishmeal diets, even excessively high challenges of C. perfringens may not result in 
consistent production of gross lesions of sub-clinical NE. Whether the lower number of 
Hubbard birds with gross lesions (1 out of 15) compared to Ross birds (2 out of 15) 
indicates a higher level of resistance that requires further study. Further study is also 
needed to determine whether continued feeding of challenged feed beyond day 3 and 
other predisposing factors are also critical for disease production. 
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7 EXPERIMENT FIVE:  
INDUCTION OF SUB-CLINICAL NECROTIC ENTERITIS WITH 
HIGH DOSES OF CLOSTRIDIUM PERFRINGENS THROUGH 
GAVAGE CHALLENGE IN THE PRESENCE OF A COMBINATION 
OF PREDISPOSING FACTORS
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7.1 Introduction 
Some dietary factors, such as high protein content, or high levels of animal 
protein sources (e.g. fish meal, meat and bone meal) can all significantly increase 
intestinal C. perfringens concentrations (Hafez, 2003; Kocher, 2003) so have been 
identified as risk factors for NE. However, previous experiments (detailed in Chapters 
3, 4 and 6) have shown that the provision of each of the following predisposing factors, 
when applied alone, does not always result in the induction of sub-clinical NE. 
Litter condition is an important factor as it not only creates suitable conditions for 
sporulation and growth of C. perfringens but also indirectly facilitates another 
predisposing factor, the sporulation of coccidial oocytes (Williams, 2005). However 
Experiment 2 (Chapter 4) was unable to induce NE by manipulating the diet together 
with using reused litter. Although sub-clinical NE  was not induced, there were lesions 
of coccidiosis together with a failure to gain sufficient weight in birds that were given 
canola meal as the major protein source. A possible reason for this may have been 
insufficient viable and/or vegetative C. perfringens present in the reused litter.   
Experiments 4a and 4b, detailed in Chapter 6 demonstrated that, despite having 
high levels of fish meal included in the experimental diets along with higher doses of 
coccidial vaccine, sub-clinical NE was not induced in the presence of low numbers of 
C. perfringens (experiment 4a) or high numbers of C. perfringens (experiment 4b). This 
shows that higher levels of fish meal in diet even when combined with high doses of 
coccidial vaccine may not be sufficient to induce sub-clinical NE. 
Analysis of the results of all the previous experiments, when viewed together 
appear to suggest that challenging birds with C. perfringens in the individual presence 
of previously known, predisposing factors (i.e. extra fish meal, coccidial vaccination 
and IBD vaccination) is not sufficient to reliably induce sub-clinical NE. The 
experiment described here seeks to draw on the lessons learnt from these previous 
experiments by combining all the predisposing factors that have, in isolation not 
induced sub- clinical NE. 
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The objective of the present experiment was to induce sub-clinical NE in broiler 
chickens by combining all the predisposing factors that have previously been used in 
isolation (i.e. diet; fishmeal, canola meal, feed withdrawal, coccidial and IBD 
vaccinations detailed in Chapters 3, 4 and 6) following oral gavage with high doses of 
C. perfringens to determine if, together, this can induce sub-clinical NE. 
7.2 Materials and Methods  
7.2.1 Treatment groups and Experimental Design 
A total of 112, one-day-old mixed sex Ross 308 birds were obtained from a 
commercial hatchery and reared in a single solid-floored pen from 0 to 7 days of age in 
an environmentally controlled house. Two treatments (challenge and sham challenged) 
were compared using 8 replicate pens. For the first 7 days the birds were given a 
commercial starter diet. On day 7 the birds were randomly allocated to one of 16 pens, 
resulting in 7 birds per pen with similarly averaged day 7 body weights. The study was 
conducted using a randomized complete-block design. 
7.2.2 Diets and feed mixing. 
Two nutritionally complete feeds were formulated, a wheat-soybean based 
broiler starter and a grower (Aviagen, 2009). Both feeds contained approximately 46-
50% wheat (Table 7.1). None of the experimental diets contained antibiotic growth 
promoter or anti-coccidial drugs. Diets were produced and mixed at SAC and fed as 
mash. All the birds were fed the starter diet from day 0 to day 7, followed by the grower 
diet from day 8 until day 15. Thereafter all birds were fed the grower diet containing 
canola meal (155 g/kg; Table 7.1), mixed 3:1 with fish meal until the end of the study. 
Throughout the experimental period birds were fed and watered ad libitum except for a 
20 hour feed withdrawal on day 16, prior to commencing experimental challenge 
through gavage (see below). 
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Table 7.1: Feed ingredients and calculated chemical composition (g/kg) of the 
experimental diets 
Ingredients Starter Grower 
Wheat, White 515 464 
Gluten Meal 50 - 
Soybean oil 26 - 
Rye  40 80 
Soybean Meal -48% 284 200 
Tallow 43 63 
Canola - 155 
Di-Calcium Phosphate
1 
20 20 
Common Salt 4.5 3.5 
Vitamin/Mineral Premix
2 
3 3 
DL-Methionine 1.4 2 
L-Lysine HCl 0.5 2 
Limestone - 7.5 
Calcium carbonate  12.5 - 
   
Calculated Chemical Composition 
Dry Matter 868 868 
Metabolisable energy (MJ/Kg) 13.2 13.5 
Crude protein 227 211 
Calcium 10 10 
Total Phosphorus  7.5 8.0 
Potassium 8 8 
1
Contained 21.3% Ca, 18.7% P. 
2
Vitamin and Mineral supplement provided (units kg
-1
 diets): Vit A 16,000 iu;  Vit D3 
3,000 iu; Vit E 75 iu (iu=mg); Vit B1 3 mg; Vit B2 10 mg; Vit B6 3 mg; Vit B12 15 µg; Vit 
K3 5 mg; Nicotinic acid 60 mg; Pantothenic acid 14.5 mg; Folic acid 1.5 mg; Biotin 
275 µg; Choline chloride 250 mg; Iron 20 mg; Copper 10 mg; Manganese 100 mg; 
Cobalt 1 mg; Zinc 82 mg; Iodine 1 mg; Selenium 0.2 mg; Molybdenum 0.5 mg (Target 
feed, Whitchurch, Shropshire).  
The birds were reared following a standard commercial environmental control 
programme from day 0 to day 25 in the experimental pens. The research facility was 
thoroughly cleaned and disinfected prior to bird placement. Adequate feeders and 
drinkers were provided for the age and number of the birds with commercial wood 
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shaving provided as bedding. Pen dimensions were 0.87 x 0.64 m. A solid 45cm high 
plywood barrier at bird level separated adjacent pens with a wire fence located topping 
all barriers to the ceiling. Fresh wood shavings to the depth of 10cm were provided as 
bedding at the start of the study. Each pen was provided with a single food hopper and 
bell drinker. To avoid accidental cross-pen contamination with C. perfringens, the birds 
were reared in every second pen, creating an empty pen between each pen with birds. 
The empty pen was disinfected every second day of the study. Precautions such as 
changing of gloves and use of foot dipping tanks were also taken. Light was provided 
for 23hrs with controlled temperature and humidity. Birds were individually tagged. All 
experimental procedures were approved by Scottish Agricultural College Animal Ethics 
Committee (AU AE 19/2011) and carried out under Home Office authorization (PPL 
60/3898). 
7.2.3 Preparation of inoculum and challenge procedure 
Vegetative cells of fresh overnight cultures were used for inoculation of the 
chickens. C. perfringens strain 56 was isolated from the intestines of broiler chickens 
with severe necrotic gut lesions producing moderate amounts of α-toxin in vitro. It is a 
type A netB positive strain (no enterotoxin or beta-2 gene), and has been used 
previously to induce NE in an in vivo model (Gholamiandehkordi et al., 2007; Pedersen 
et al., 2008; Timbermont et al., 2010). The strain was kindly provided by Dr. Leen 
Timbermont (Ghent University, Belgium), stored in the form of frozen beads. From the 
frozen culture, bacteria were grown overnight on TSC agar plates. The bacteria were 
cultured for 24hrs at 37°C in BHI broth (Oxoid, UK) as described in section 3.2.2 of 
this thesis. After overnight incubation on TSC agar plates, colonies of C. perfringens 
were taken, mixed with BHI, incubated at 37ºC and shaken at 60rmp anaerobically for 
8-12hrs (Appendix C). The concentration of C. perfringens in the inoculum was 
estimated spectrophoto-metrically at 600nm (Spectronic 301, Milton Roy) with the aid 
of a standard curve. Actual C. perfringens concentration in the inoculum was confirmed 
by plating on TSC agar plates, incubating the plates at 37°C overnight, and counting the 
number of black presumptive C. perfringens colonies as described in section 3.3.3. of 
this thesis. 
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All the birds in the challenge group were orally gavaged daily (on days 17, 18, 
19 and 20) with 1.5ml of inoculum (BHI broth containing actively growing culture of C. 
perfringens) using a 10ml bottle equipped with vinyl tubing about 3-4cm long. The C. 
perfringens inoculum was gavaged twice a day and freshly prepared each time as 
described in Appendix- C. The chickens in the control treatment were orally gavaged on 
the same days with 1.5ml of freshly prepared sterile BHI twice a day. Bacterial counts 
were performed on the culture every time prior to gavaging (see below).  
7.2.4 Infectious Bursal disease vaccination  
On day 16, all birds were vaccinated with infectious bursal disease (IBD) 
vaccine (Poulvac® Bursine2, Pfizer Animal Health) in the drinking water following 
normal vaccination procedure i.e. one hour prior to vaccination the birds’ water supply 
was stopped to ensure every bird was vaccinated. 
7.2.5 Coccidial vaccination 
On day 18, all the birds received anticoccidial vaccine “Paracox- VIII (Schering-
Plough Animal Health, Brussels, Belgium). The vaccine contains live attenuated 
oocytes of Eimeria acervulina (two lines), Eimeria maximum (two lines), Eimeria mitis, 
Eimeria necatrix, Eimeria praecox and Eimeria tenella. Vaccine was by oral gavage at 
10 times the dosage prescribed by the manufacturer as described in section 3.2.4. 
7.3 Sampling and data recording 
7.3.1 Enumeration of C. perfringens in BHI and feed 
A sample of BHI mixed with C. perfringens culture was used for enumeration of 
C. perfringens by the spread plate method on TSC agar plates. Samples of BHI were 
approximately 1ml suspended in 9ml of Maximum Recovery Diluent (MRD). From this 
dilution further 10 fold dilutions were made. From each dilution 100µl of mixture was 
inoculated onto TSC plates as described in section 3.2.2. After incubation the number of 
colonies was counted on the most appropriate dilution (Plates with 30-300 colonies). 
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This figure was then used to calculate the number of colony forming units per gram of 
original sample. 
7.3.2 Clinical signs and lesion scoring 
Birds were assessed daily for clinical signs and symptoms of NE from the day of 
oral inoculation of C. perfringens through gavage till termination of the experiment. On 
days 21 (one day post-challenge), 25 (four days post-challenge), and 26 (five day post-
challenge) of the experiment, two birds from each replicate pen were selected at 
random, weighed and killed by electric stun followed by exsanguinations. The entire 
GIT was inspected for the presence of lesions/pathological changes associated with sub-
clinical NE or evidence of lesions of coccidiosis. Three different segments of GIT 
(duodenum, jejunum and ileum) were identified, immediately incised, and washed in 
PBS. Then the mucosal surfaces were inspected and scored for any lesions of clostridia, 
necrotic and haemorrhagic lesions. A modification of the scoring system used by Shane 
et al. (1985) was used to score intestinal lesions: 
 score 0: absence of gross lesions or no lesions; 
 score 1: focal necrosis or focal ulceration; 
 score 2: focal ulceration coalesced to form discrete patches; 
 score 3: extensive diffuse mucosal necrosis; 
On all dissection days the livers of killed birds were also examined for the 
presence or absence of hepatitis or cholangiohepatitis, both of which are recognized as 
consistent with the pathological changes of NE. 
7.3.3 Histopathology 
Following post-mortem examinations on days 21, 25 and 26, samples from the 
small intestine, particularly those showing lesions, were taken for histopathology. A 
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1.5-2cm tissue sample was taken, washed with phosphate buffer saline (PBS) and stored 
in 10% neutral phosphate-buffered formalin for histopathology as described in section 
3.2.5.3. Specimens for histopathology were embedded in paraffin, processed routinely, 
cut at 5-6µm and stained with Haematoxylin and Eosin (Appendix A). Gram’s staining 
was also done to confirm the presence of Gram positive bacilli (Appendix B). The 
prepared tissue sections were later examined using a binocular stereo-microscope 
(Olympus BX 41, U-LH100HG, Olympus optical, Co. Ltd) connected by camera (spot 
idea™ 28.2-5MP) to computer software (Spot idea, Version 4.7) using different 
magnifications. 
7.3.4 Quantification of C. perfringens and α-toxin in digesta 
One bird on day 16 (pre-challenge) and two birds on days 21, 25, and 26 (post-
challenge) were selected at random from each pen and euthanized. Ileal content (digesta 
content from the Meckel’s diverticulum to ileo-caecal-colon junction) of all killed birds 
from each replicate pen were taken into sterile screw-capped bottles and immediately 
transferred to the Microbiology laboratory, for analysis of C. perfringens. The 
presumptive identification and enumeration of C. perfringens was done on TSC agar as 
described in section 3.3.3. Each of the digesta samples was vortexed for 15 seconds in 
order to ensure adequate mixing. One gm of digesta was weighed and serially diluted in 
MRD. From each dilution to be plated, 100µl was applied to the centre of each agar 
plate, allowed to be absorbed and then 15ml of TSC overlay was spread before the plate 
was incubated invertedly in a jar providing anaerobic conditions. The jar was placed in 
an incubator at 37°C for 24hrs. After incubation the number of colonies was counted to 
calculate the number of colony forming units per gram of original sample. 
On days 21, 25 and 26, four birds from each treatment were selected at random 
and ileal digesta were collected for determination of α-toxin. Quantification of α-toxin 
in the intestinal digesta was done by Enzyme linked immunosorbent Assay (ELISA) 
using α-toxin C. perfringens kit (Cypress diagnostics, Ref. Vb040) following the 
manufacturer’s recommendations as described in section 3.2.5.5. 
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7.3.5 Growth performance 
At days 0, 7, 16, 21 and 25 all birds were weighed individually, to calculate 
weight gain (WG) during the experimental periods. Starter feed was weighed at day 0 
and weighed back at day 7. The grower feed was weighed back at days 16, 21 and 25. 
Feed intakes (FI) were calculated by weighing the initial feed inputs against the uneaten 
feed over the experimental period. Feed conversion ratio was calculated by dividing 
average feed consumed per pen over average weight gain of birds per pen. Feed intake, 
WG and FCR were calculated for the period days 7-16, 16-21 and 21-25. The birds 
were inspected daily within the experimental period.  
7.3.6 Feed analysis 
Amino acid contents of grower feed with added fish meal were determined as 
described in section 4.2.5.6 of this thesis. Analysis of feed samples was done in 
duplicate.  
7.4  Statistical Analysis 
The effect of challenge on sub-clinical NE lesion score, growth performance and α-
toxin antibodies in ileal digesta were compared using a randomized block analysis 
variance (ANOVA). The interactive effects of challenge (infected vs sham-infected), 
gender (male and female) and post-challenge days (21, 25 and 26) on the enumeration 
of C. perfringens in ileal digesta were compared using split plot design under 
generalized analysis of variance (ANOVA). The data obtained for the incidence of 
intestinal lesions were compared using a non-parameteric Fisher’s exact test. 
Due to the skewed nature of the numbers of C. perfringens and α-toxin antibodies 
in ileal digesta, the data was log transformed (n+1) to normalize the data before 
statistical analysis. Effects were reported as significant at P<0.05 and trends were noted 
when the P-value was near to 0.1. All procedures were performed using Genstat 11 for 
windows (VSN International Ltd, Hemel Hemstead, UK).  
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7.5 Results  
Following gavage, birds were examined at least twice daily for any clinical 
abnormalities. During the experiment there were no clinical signs of disease requiring 
medical treatment in any of the groups (challenged or control). No mortality was 
observed in any of the treatment pens. 
7.5.1 Enumeration of C. perfringens in BHI 
A fresh C. perfringens broth culture mixture was prepared each time the birds 
were challenged through gavage. Analysis of BHI containing the culture of C. 
perfringens showed that on average inoculums contained 6.5 x 10
9
 cfu/ml (SEM 9.5 x 
10
8
) of BHI on day 17, 7.9 x 10
9 
cfu/ml (SEM 6.55 x 10
8
) of BHI on day 18, 3.2 x 10
9 
(SEM 1.45 x 10
8
) of BHI
 
on day 19 and 1.3 x 10
9
 cfu/ml
 
(SEM 4.5 x 10
7
) of BHI on day 
20 respectively. C. perfringens was not detected in the BHI broth of the control groups. 
7.5.2 Lesions score 
Figure 7.1 shows the effect of challenge and post-challenge days (21, 25 and 26) on 
intestinal lesion scores of sub-clinical NE. Lesions occurred in several birds receiving 
C. perfringens challenge and were similar to those of sub-clinical NE as described 
previously (Shane et al., 1985). Chickens with C. perfringens challenge had 
significantly higher sub-clinical NE lesion scores compared to the unchallenged control 
group (P<0.001). Sub-clinical NE lesions scores were significantly higher in challenged 
groups on days 21 (P<0.001) and 25 (0.023), but not on day 26 (P=1.00). 
In chickens with sub-clinical NE lesions the small intestine was not only distended 
with gas but also was thin walled. Most lesions were focal necrosis (Figure 7.2). In 
some of the birds, despite random distribution of lesions, these were so extensive as to 
appear almost confluent in certain areas. In most cases, there were more than 5 small 
necrotic foci. Most of the lesions were located in the jejunum mainly proximal to 
Meckel’s diverticlulm. However, in birds having severe cases (Figure 7.4), lesions 
extended to both the duodenum and ileum. Unexpectedly, although lesions were seen on 
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days 21 and 25 (31.2% and 35.9% respectively), on day 26, no birds in the C. 
perfringens challenged treatment had lesions.  
 
Figure 7.1: Evaluation of sub-clinical NE lesion score (percentage) in broilers 
subjected to different treatments (control and challenge) on different days of 
age (21, 25, and 26).  
The error bars are standard error of the means (SEM). 
Although none of the birds had clinical coccidiosis, lesions of coccidiosis were 
seen in most of both the challenged and unchallenged control birds (Table 7.3). Birds 
with coccidial lesions showed transverse white foci. No lesions were detected in the 
livers of any of the birds with or without lesions in their small intestine. During 
necropsy it was particularly noticeable that birds with NE lesions also had more watery 
digesta compared to birds without any lesions. None of the birds had liver lesions on 
any dissection days in any treatment group. 
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Table 7.2: Occurrence of lesions (sub-clinical NE and coccidiosis) in small 
intestine of broiler chickens on different days (pre-challenge and post-
challenge). 
Sampling days  Sub-clinical NE Probability of difference 
 control Challenge  
16 0/8 0/8  
21 0/16 10/16 <0.001 
25 2/16 9/16 0.023 
26 1/16 0/16 1.00 
    
 
 
 
Table 7.3: Occurrence of coccidial lesions in small intestine of broiler chickens 
on different days (pre-challenge and post-challenge with C. perfringens 
gavage). 
Sampling days  Coccidial lesions 
 Control challenge 
16 0/8 0/8 
21 15/16 16/16 
25 15/16 16/16 
26 15/16 13/16 
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Figure 7.2: Focal necrosis in the mucosa of jejunum of broiler chickens 
receiving a challenge with C. perfringens through gavage 
 (a-b, lesions score 1+). 
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Figure 7.3: Focal ulceration on mucosal surface of small intestine of broiler 
chickens coalesced to form discrete patches 
 (a-b, lesions score 2+). 
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Figure 7.4: Extensive diffuse mucosal necrosis on mucosal surface of small 
intestine of broiler chicken. Note the appearance of pseudo membrane  
(lesion score 3+). 
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7.5.3 Histopathology 
Microscopically, most of the challenged birds showed diffuse coagulative necrosis 
of the mucosal layer of the intestine typical of sub-clinical NE. Lamina propria were 
hyperaemic and infiltrated with numerous inflammatory cells. There were intense 
nuclear basophilia, pyknosis, karyorrhexis and karyolysis, showing a complete break 
down of nuclear material. Mild to moderate haemorrhages or congestion was present 
throughout the mucosal layer. Some of the tissue sections showed distended, irregular 
crypts sometimes filled with necrotic debris. Necrotic debris contained degenerated 
epithelial cells, remnants of lamina propria and fibrin. There was a marked congestion 
of blood vessels in both the lamina propria and sub- mucosa.  
Histopathological slides with Gram stain showed the presence of numerous rod-
shaped bacteria with C. perfringens morphology forming large clumps and sloughed 
epithelium. These were primarily around necrotic areas, but also on the epithelial 
surface of the villi (Figure 7.4). Gram positive bacilli can also sometimes be found in 
the vicinity of non-necrotic tissue (Figure 7.6). Although lamina muscularis and serosa 
were not affected the diphtheric membrane was composed of erythrocytes, desquamated 
epithelial cells, heterophils, fibrin and Gram positive bacilli. In addition rod shaped 
bacteria could be seen in the sub-mucosa of the small intestine. Various sexual and 
asexual stages of coccidia were found in most of the intestinal segments; large coccidial 
schizonts were particularly seen in regions of the lamina propria and in the crypt region. 
Occasionally tissue sections from challenged birds showed food particles in this debris. 
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Figure 7.5: Intestine of broiler chickens showing (a) epithelial detachment (b) 
separation of epithelial cell layer from underlying lamina propria (c) note base of 
normal intact cells at base separated from necrotic tissue by clusters of bacteria 
(H & E; 40x). 
 
 
Figure 7.6: Gram stained C. perfringens on tip of villi (black arrow). 
a 
c 
b 
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Figure 7.7: Formation of pseudo-membrane on villous surface. Note the 
presence of C. perfringens (black arrows) on desquamated villi (x 10). 
7.5.4 Quantification of C. perfringens and α-toxin in the ileal 
digesta 
Baseline values of C. perfringens in the ileal content were assessed prior to 
challenge on day 16 of the experiment. No significant difference was observed in the 
number of C. perfringens between control and challenged birds on day 16 (3.70 vs 3.50 
log10 cfu/g; P= 0.425). Table 7.4 shows the effect of challenge (infected and sham 
infected), gender (male and female) and post-challenge days (21, 25, 26 days) on C. 
perfringens concentrations in ileal digesta of the birds. Counts of C. perfringens were 
significantly affected by challenge treatment and post-challenge days and their 
interaction (Table 7.4). The C. perfringens counts (cfu/g of digesta) were found to be 
highest on day 25 and the lowest on day 26. Concentrations of C. perfringens were 
affected by a gender x treatment interaction (Table 7.4), female broiler chickens had a 
greater increase in concentrations of C. perfringens compared to male broiler chickens 
(57% vs 38%). 
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Table 7.4 : Counts of C. perfringens in ileal digesta of control and challenged 
broiler chickens on different post-challenge days 
Treatment Gender days C. perfringens count  
(log cfu/g of digesta) 
 
 
Control 
 
Male 21 2.32 
25 5.41 
26 4.42 
Female 21 1.61 
25 4.41 
26 3.67 
 
 
Challenge 
Male 21 8.27 
25 7.19 
26 4.39 
Female 21 7.85 
25 7.87 
26 6.65 
                               S.E.D
1 
0.584 
P-value 
Treatment  <0.001 
Day 0.001 
Gender  0.973 
Treatment x day  <0.001 
Treatment x gender  0.013 
Day x gender 0.246 
Treatment x day x gender 0.242 
Means within a row with different letter superscripts indicate a significant (P<0.05) difference 
1
SED: Standard error of differences of means 
Data are means of eight pens, and one male and one female per pen per time point. 
Figure 7.8 shows the effect of challenge on C. perfringens specific α-toxin in the 
ileal digesta of control and challenged birds. C. perfringens specific α-toxin was 
detected in the ileal digesta of birds in both the control and challenged treatment groups. 
A significantly higher level of C. perfringens α-toxin (P=0.022) was found in the ileal 
digesta of birds with C. perfringens challenge treatment compared to the control group 
(Figure 7.8).  
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Figure 7.8: Alpha toxin level (optical density unit, OD450) in the ileal digesta of broilers 
chickens in control and C. perfringens challenged treatment groups. a-b values within treatment 
groups with different superscripts are significantly different (P<0.001). 
The error bars are standard error of the means (SEM). 
7.5.5 Growth performance 
Table 7.5 shows the effect of challenge on weight gain, feed intakes and FCR 
during days 7-16, 16-21 and 21-25. Weight gain was not affected by challenge 
treatment during days 7-16 and 21-25 (P>0.05). However during days 16-21, there was 
a trend for the control birds to be heavier than challenged birds. Challenge did not 
significantly affect feed intake on any of the days. During days 7-16 and 21-25, FCR 
was not affected by C. perfringens challenge but during days 16-21, challenged birds 
had significantly higher FCR than control birds.  
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Table 7.5: The growth performance of broiler chickens in challenge and control 
treatment group 
 Days Control  Challenge  SEM
1 
Probability of 
difference  
 
Weight gain 
(g/bird) 
7-16 245 256 6.71 0.272 
16-21 271 237 12.58 0.080 
21-25 257 239 7.60 0.114 
      
 
 Feed 
intake(g/bird) 
7-16 376 387 6.35 0.236 
16-21 266 263 7.02 0.706 
21-25 361 370 16.68 0.715 
      
 
Feed 
conversion 
ratio (FCR) 
7-16 1.54 1.51 0.03 0.572 
16-21 0.99
a 
1.11
b 
0.03 0.020 
21-25 1.41 1.56 0.08 0.247 
Means within a row with different letter superscripts indicate a significant (P<0.05) difference. 
1
SEM: Standard error of the means. 
Data are means of eight pens. 
Chapter 7  171 
7.6 Discussion 
With an absence of clinical signs to indicate NE, the presence of gross lesions in 
the intestine with related histopathological changes, suggests that the type of disease 
induced in the present study met the recognised criteria to warrant its classification as 
sub-clinical NE (Lovland & Kaldhusdal, 2001; Skinner et al., 2010).  
The birds in the challenged treatment group that had been repeatedly gavaged 
with C. perfringens showed an increase in their intestinal lesion score, compared with 
the non-challenged control group birds (Table 7.2). Typical gross lesions consisted of 
necrotic areas surrounded by hyperaemic zones on the mucosal surface of the small 
intestine. Some cases also showed the formation of a yellow to brown, diphtheric 
pseudo-membrane covering the intestinal mucosa (Kaldhusdal & Hofshagen, 1992). In 
most field cases of NE gross lesions are most commonly found in the jejunum, followed 
by the ileum and duodenum (Long et al., 1974; Kwatra & Chaudhury, 1976; Alsheikhly 
& Alsaieg, 1980). It is difficult to predict the time when gut lesions peak (Lovland et 
al., 2003). In the present study similar gross lesions were observed in experimentally-
infected birds. Birds were sampled on 3 days (21, 25 and 26) and most of lesions were 
observed on days 21 and 25 (31.2% and 35.9% respectively). However, on day 26 no 
lesions were detected in any of the birds. This experiment therefore appears to suggest 
the optimal time point for lesion detection is between 21 and 25 days of age. These 
findings agree with those of (Gholamiandekhordi et al., 2006) who also detected lesions 
only for 4 days after the final C. perfringens inoculation although further lesions were 
not detected after an additional 2 days. Riddell & Kong (1992) found that mortality 
began in the birds just one day after commencement of experimental challenge with 
most mortality occurring during the following 3 days. The exact reason(s) for a higher 
number of birds with lesions on day 25, yet not a single bird with lesions on day 26 in 
the C. perfringens challenged treatment group remains unclear, although it can not be 
excluded that this is may be to some extent the result of random sampling of the 
remaining birds. 
The finding that three chickens (two on day 25 and one on day 26) in the control 
group, which had not been challenged with C. perfringens also developed NE lesions is 
not unexpected. Since the broiler chickens in the control group had been subjected to 
the same predisposing factors underlying our NE model, it is likely that their intestines 
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were primed for the development of NE arising from proliferation of the low level of C. 
perfringens present in their microflora. In addition, and despite the precautions 
described in section 3.2.1. it is impossible to totally exclude the possibility that C. 
perfringens may have spread from the challenged pens to one of the unchallenged pens, 
since the available pen space dictated that both challenged and unchallenged pens were 
in the same experimental building. Floor litter has been recognised as being a 
continuous source of C. perfringens due to the coprophagic activity of the birds (Line et 
al., 1998). Another possibility is the ubiquitous nature of C. perfringens: the bacteria is 
widely present throughout the environment, having been isolated from wall swabs, 
litter, feeders, drinking water, transport coops and even from hatcheries in egg shell 
material and paper pads (Craven et al., 2001a; Craven et al., 2001b). Experimental 
conditions in the present experiment were optimum for the growth of C. perfringens 
leading to a subsequent release of α-toxin and sub-clinical disease induction. It is 
therefore possible that C. perfringens from either an endogenous or environmental 
source was responsible for causing the sub-clinical NE that arose in a small number of 
unchallenged birds. Kaldhusdal et al. (1999) found the frequency of NE lesions in 
control birds was actually higher than in challenged birds on 19 days post-challenge. 
C. perfringens proliferation and sub-clinical NE are also associated with 
cholangohepatitis together with multifocal to massive necrotic hepatitis, collectively 
referred to as C. perfringens associated hepatitis (CPH). Affected livers are usually 
enlarged, firm, pale and mottled in appearance with small focal lesions (Kaldhusdal et 
al., 1999; Lovland & Kaldhusdal, 2001). In the present study none of the birds had any 
form of liver lesions. Liver lesions are usually found in broiler carcasses at processing, 
both with and without clinical NE being recognized in the flocks. Results from Lovland 
& Kaldhusdal (1999) showed that 24 out of 45 (55%) livers showing lesions were 
positive for C. perfringens, which suggests that liver lesions may not always be seen in 
birds with sub-clinical NE. 
The histopathological changes typical of sub-clinical NE were observed in the 
intestine of all the birds with lesions. There was a marked inflammatory response to the 
C. perfringens with focal areas of diffuse necrosis. These changes were consistent with 
those described in the literature (Parish, 1961; Alsheikhly & Truscott, 1977b; 
Kaldhusdal & Hofshagen, 1992; Kaldhusdal et al., 1995). Kaldhusdal & Hofshagen 
(1992) explained that microscopic changes of sub-clinical NE start with slight oedema 
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in the lamina propria, together with dilation of vessels and a desquamation of epithelial 
cells, later resulting in oedema followed by detachment of the epithelial cells from the 
underlying lamina propria. Tips of the villi have coagulated necrosis and sloughed 
epithelium. The affected area has large amounts of fibrinous exudates with mononuclear 
cell infiltration but limited heterophil infiltration. As time passes the necrotic lesions 
involve more than half the length of the villi (Alsheikhly & Truscott, 1977b). Gram 
positive bacilli colonizing the necrotic areas in birds with sub-clinical NE, as in the 
present study, have also been observed by many researchers (Parish, 1961; Arbuckle, 
1972; Helmbold & Bryant, 1971; Long, 1973). On day 26, C. perfringens appeared to 
have been trapped within the necrotic area and remained away from regenerated villi. 
Similar changes have been seen by Alsheikhly & Truscott (1977b) who reported them 
as a regeneration process; they observed that lesions of NE developed after 3hrs of 
infusion of crude toxin subsided (regeneration of villi) after 12-20hr (Alsheikhly & 
Truscott, 1977b).  
Baseline C. perfringens concentrations determined on day 16 (pre-challenge), 
showed no difference between the counts of C. perfringens in the ileal digesta of 
subsequently challenged birds and the unchallenged birds in the control group. This 
suggested that all chicks in the experiment probably had a similar concentration of 
intestinal C. perfringens, prior to commencing the C. perfringens challenge. On day 21 
(post challenge), the C. perfringens challenged birds had a significant increase in 
concentrations of C. perfringens compared to the unchallenged/uninfected control group 
(Table 7.4). This demonstrates a successful challenge. The highest C. perfringens 
counts were found on day 25, followed by 21 whilst the lowest counts were found on 
day 26, which agrees with an absence of lesions on that day. In further agreement, 
Pedersen et al. (2003) found that C. perfringens was not able to persist in the intestine 
of broilers for more than 6 days after cessation of experimental inoculation. 
The main virulent factor of sub-clinical NE is believed to be α-toxin produced 
by C. perfringens type A (Alsheikhly & Truscott, 1977a). There was a significant 
increase in the antibodies to α-toxin in the ileal digesta of birds challenged with C. 
perfringens. However, there is on going debate regarding the involvement of α-toxin in 
producing NE. Recent studies have shown that an α-toxin mutant strain can induce 
severe necrotic lesions (Keyburn et al., 2006), whilst involvement of α-toxin in disease 
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production has been confirmed by successfully producing NE using bacteria free crude 
toxin (Alsheikhly & Truscott, 1977b). 
Intestinal coccidial lesions, consistent with typical coccidial infection, were 
observed in most of the birds in both treatments (Table 7.2). These findings are in line 
with data from the literature which reports finding coccidial lesions whilst developing a 
disease model for NE (McReynolds et al., 2004b; Pedersen et al., 2008). Overdose of 
live coccidial vaccine (10 times above that prescribed by the manufacturer) induces gut 
damage. So it can reasonably be hypothesized that mucosal damage caused by a live 
overdose of coccidial vaccine will allow a portal of entry for C. perfringens, releasing 
toxin(s) that may further affect many cells including enterocytes. Both C. perfringens 
and coccidia act synergistically in inducing gross, visible lesions. Intestinal coccidiosis 
may slow intestinal motility resulting in transient stasis of digesta and subsequent 
anoxia since C. perfringens is a facultative anaerobic that will lead to a proliferation of 
C. perfringens and sub-clinical NE (Helmbold & Bryant, 1971; Hong et al., 2012) 
Another possible explanation of the association between coccidiosis and NE is 
intestinal damage by coccidian sporozoites causing release of proteins into the gut 
lumen. Proteolytic enzymes may degrade these proteins into amino acids that increase 
the acidity of digesta. Lower pH (5.6 or below) affects the permeability of the smooth 
muscles of the intestine, causing stasis. Some species of coccidia not only cause a 
decrease in the pH of the small intestine but also cause an increase in caecal pH, where 
C. perfringens normally exists. A decrease in the pH of the small intestine, together 
with increase in pH of the caeca and intestinal stasis all are factors that promote the 
growth of C. perfringens (Shane et al., 1985; Ruff & Reid, 1975). Since C. perfringens 
lacks the ability to form amino acids it requires a medium containing amino acids. This 
means that a diet rich in fish meal provides an excellent nutritional medium, further 
enhancing the growth of C. perfringens so may help in the induction of sub-clinical NE 
(McDevitt et al., 2006b). Collier et al. (2008) proposed that coccidial infection induces 
mucogenesis as a result of the host’s inflammatory response, leading to an increase in 
mucin that subsequently enhances C. perfringens growth, due to its ability to utilize the 
mucus as a substrate (Deplancke et al., 2002). Lesions of NE have been found 
associated with the sexual forms of coccidia in field studies (Long et al., 1974). The 
same results also confirmed that co-infection with Eimeria species is an important 
predisposing factor in the development of sub-clinical NE.  
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It was particularly noted during examination of the gross coccidial lesions that 
most were superficial and did not pierce deeply into the intestinal wall. This was later 
confirmed to be consistent with earlier findings (Alsheikhly & Alsaieg, 1980), showing 
that superficially developing coccidial species were more significant in providing 
optimum conditions for C. perfringens to establish and multiply in the gut, so causing 
NE. 
Several researchers have reported that coccidiosis does not always result in NE 
(Long, 1973; Broussard et al., 1986; Dhillon et al., 2004; Hermans & Morgan, 2007). 
However Long (1973) reported that coccidiosis is a factor associated with the 
occurrence of NE under practical field conditions. Coccidiosis has been described as a 
contributory factor for NE by many researchers as it has usually been observed in 
conjunction with NE (Alsheikhly & Alsaieg, 1980; Shane et al., 1985; Wu et al., 2010). 
In the present study, no relation was found between the number of C. perfringens in the 
ileal digesta and coccidia lesions (data not shown). This appears to confirm that 
coccidia only provide a gateway for the entry of C. perfringens into the intestinal wall, 
but do not have any direct effect on the growth of C. perfringens. 
No mortality was observed in any of the treatment pens, and birds showed no 
clear symptoms. There was also no anorexic response to challenge; C. perfringens 
challenged birds had similar intake to their unchallenged counterparts. However there 
was a trend in the challenged group to show a lower weight gain compared to the 
control birds during days 16-21. This was reflected in a significantly increased FCR in 
the C. perfringens challenged birds compared to the unchallenged controls. The results 
are in accordance to the findings of other researchers, showing that inoculation with C. 
perfringens and the subsequent production of α-toxin results in reduced growth and 
increased FCR (Kaldhusdal & Lovland, 2000; Lovland & Kaldhusdal, 2001; 2010 Liu 
et al., 2010; Miller et al.,). Damage to the mucosal layer of the intestine of birds, as 
indicated by necrotic lesions, may result in decreased digestion as well as reduced 
absorption of nutrients, which together lead to both reduced weight gain and an 
increased FCR. The overall performance of birds in the challenged treatment group was 
consistently poor on all days (Table 7.5). This might have been due to the fact that the 
birds were under stress of C. perfringens challenge with higher levels of C. perfringens 
in their intestinal tract. Broilers having higher number of C. perfringens in their gut 
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have decreased weight gain and poor feed conversion efficiencies (Kaldhusdal et al., 
1999; Dahiya et al., 2005b). 
7.7 Conclusion 
It was concluded that multiple C. perfringens inoculations through gavage, in 
the presence of high levels of live coccidial vaccine, together with other predisposing 
factors such as feed withdrawal, and higher levels of fish meal (30%) in the grower diet 
with CM do provide a suitable model for induction of sub-clinical NE. In the present 
experiment a statistically significant proportion (>40%) of the challenged birds 
developed necrosis of their intestinal mucosa without inducing mortality. Therefore 
what is successfully developed here is a sub-clinical NE model, though subsequent 
studies are required to confirm its repeatability. Molecular studies conducted by various 
researchers indicated that NE usually occurs following multiplication of one or two 
specific strains of C. perfringens in the gut (Engstrom et al., 2003; Nauerby et al., 
2003). Therefore it may be reasonable to assume that the presence of numerous 
predisposing factors that help to create optimum growth for multiplication of a specific 
strain of C. perfringens is necessary for induction of sub-clinical NE. 
Gholamiandehkordi et al. (2007) did not find any visible NE lesions when using a 
single C. perfringens infection along with an high dose of coccidial vaccine. However 
the same researcher found that multiple oral doses of C. perfringens in combination 
with an high dose of live coccidial vaccine did give a suitable model for subclinical NE 
(Gholamiandehkordi et al., 2007). According to Wu et al. (2010) diets containing high 
levels of fish meal (250- 500g/kg) and Eimeria infection is the most effective 
combination to produce effective NE lesions. Sub-clinical NE is a complex multi-
factorial disease so successful reproduction needs careful incorporation of all these 
factors that, acting synergistically, induce gross, visible gut damage. 
The ideal model to study the pathogenesis of sub-clinical NE is one in which a 
statistically significant proportion of challenged birds develop grossly visible lesions, 
but without clinical signs or associated mortality. The disease model used in the present 
study incorporates the different predisposing factors that commercial poultry operations 
are likely to face on a day to day basis. Most of the challenged models used a mixture of 
C. perfringens strains to induce NE (McReynolds et al., 2005; McReynolds et al., 
2008), although only one strain was used in the present study. Ficken & Wages, (1997) 
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suggested that factors such as coccidiosis, IBD and dietary stress along with high doses 
of C. perfringens would favour experimental induction of NE in chickens. The present 
study confirms this finding. Above all, this model will be more acceptable to animal 
welfare activists since it presents minimal ethical issues for consideration due to the 
lack of mortality associated with this C. perfringens challenge.  
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8 SIX:  
IDENTIFICATION OF BIOCHEMICAL MARKERS FOR SUB-
CLINICAL NECROTIC ENTERITIS IN BROILER CHICKENS
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8.1 Introduction  
Sub-clinical NE is a commonly prevalent condition that causes a serious threat 
to the global broiler poultry industry, as under field conditions the sub-clinical form of 
disease is difficult to detect, making it one of the major causes of economics losses to 
today’s world wide broiler industry (Kaldhusdal & Lovland, 2000; Shane et al., 1984). 
Although the presence of intestinal necrotic lesions is considered as a characteristic 
feature of the sub-clinical disease, the timing of the peak in numbers of gut lesions is 
largely unpredictable, so using measurement of gut lesions alone to quantify the sub-
clinical NE severity would need repeated examinations of the flock (Lovland et al., 
2003).  
Currently the only way to assess the degree of host response is by scoring gross 
pathological lesions within the intestine and most of the cases of sub-clinical NE are 
only identified at the time of carcass rejection (Kaldhusdal & Lovland, 2000). To date 
there is no validated lesion scoring system that characterizes the disease condition in 
poultry. The different lesion scoring systems that have been used makes identification 
even more complex (Shane et al., 1985; Prescott, 1979; Lovland et al., 2004). Olkowski 
et al. (2006a) also emphasised that diagnosis of sub-clinical NE can not be made merely 
on gross observations. It is recognized that there is an urgent need to develop another 
test that can be reliably used to identify sub-clinical NE presence, and possibly to 
quantify its severity. An alternative, objective approach could be to measure the levels 
of acute phase proteins (APP) and the expression of different genes in response to C. 
perfringens challenge in the intestinal tract of broiler chickens. 
The acute phase proteins are a group of blood proteins released as a result of an 
acute phase response, a natural systemic reaction to neutralize the effect of pathogens, 
trauma and immune disorders. In response to inflammation, inflammatory cells 
(macrophages) secrete a number of cytokines into the blood stream, most noticeably 
IL1, IL6, IL8 and TNF-α. At the same time, the liver responds by producing a large 
number of acute phase proteins/reactants (Murata et al., 2004). Similarly, during 
infection, inflammation of the gut mucosa can cause a significant change in the 
expression pattern that has a harmful effect on the underlying epithelium which can also 
trigger the release of different APPs. Acute phase response appears earlier than specific 
antibodies, and decreases as the inflammatory response subsides. In cases of chronic 
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infection, levels of APPs may remain elevated if stimulatory cytokines are still active 
(Chamanza et al., 1999;Gruys et al., 1994). APPs can be considered as positive or 
negative, depending on whether their level increase or decrease in response to 
challenge. The positive APPs include haptoglobin, C- reactive protein, ceruloplasmin, 
fibrinogen and alpha 1 acid glycoprotein, although there are differences between 
species. Negative APPs include albumin and transferrin (Yoshioka et al., 2002; Murata 
et al., 2004). Mammalian acute phase protein responses are well studied for many 
infections, however information regarding avian APPs are much less available. Much of 
the research on APP in fowls has been published in recent years (Chamanza et al., 
1999), though little is still known of the dynamics of APP in chickens.  
Measurement of levels of various APPs has been used for detecting various 
pathological conditions. Ceruloplasmin, an important APP with well known beneficial 
functions, is an extracellular ferroxidase, which plays a role in regulating iron 
homeostasis by oxidizing toxic ferrous iron to its non-toxic ferric form, so protecting 
tissues from oxidative action (Chamanza et al., 1999; Patel et al., 2002; Olivieri et al., 
2011). Various studies have confirmed that ceruloplasmin, can be used as an indicator 
of infection in cattle (Conner et al., 1986), dogs (Conner et al., 1988) and chickens 
(Piercy, 1979). The application of another important APP, haptoglobin has been 
investigated in various species of infected animals i.e: cattle with acute mastitis and 
dogs with polyarthritis. However in avian species it is present in the form of an 
analogue, known as PIT 54 (Eckersall et al., 1999; Georgieva, 2010).  
Functional haptoglobin has two chains (alpha and beta), PIT 54 is a single chain 
polypeptide belonging to blood plasma α 2-glycoprotein and form a complex after 
binding with the globin portion of free blood haemoglobin. This large complex can not 
pass through the renal glomeruli. Therefore the binding of haptoglobin with 
haemoglobin prevents the systemic loss of iron following systemic haemolysis. 
Production of haptoglobin is enhanced by growth hormone, insulin, bacterial 
endotoxins, prostaglandins and different cytokines (IL-1, IL-6, and TNF) (Raynes et al., 
1991; Georgieva, 2010). 
Ovotransferrin (OTF) or conalbumin is an iron binding protein in chickens, the 
concentration of which is significantly increased in response to chemical, bacterial and 
viral inflammation. The exact function of OTF in avian species is not known, however 
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in laying hens OTF is synthesized under the control of oestrogen (Xie et al., 2002). 
Studies have shown that OTF may be used as a marker of inflammation associated with 
various infectious and non-infectious conditions (Xie et al., 2002). 
Ceruloplasmin, PIT 54 and OTF have been reported to increase in response to 
certain bacterial, viral and parasitic infections (Rath et al., 2009). Various APPs have 
been used as diagnostic and prognostic markers of inflammation in both humans and 
animals (Chamanza et al., 1999; Olivieri et al., 2011). Economically important diseases, 
especially sub-clinical forms which are not detectable by clinical signs or even by post-
mortem examination, may be diagnosed by levels of APPs, since APR in chickens is 
linked to growth depression and decreased production (Klasing & Korver, 1997). Its is 
known that changes in APP concentrations remain detectable until the inflammation or 
infection subsides in response to treatment or self recovery (Xie et al., 2002). The 
potential use of APPs for examining the existence of infectious diseases during ante-
mortem and post-mortem meat inspection has also been suggested (Saini & Webert, 
1991). Thus, whilst APP response in chickens is different to that of mammals and 
humans (Georgieva, 2010), changes in levels of APPs have in addition mostly been 
assessed for aseptic inflammation, induced by intramuscular injection of turpentine 
(Chamanza et al., 1999) or by lipopolysaccharide administration (Hallquist & Klasing, 
1994). 
There has been no previous attempt to characterise the APP changes that occur 
as a result of sub-clinical NE in broilers. Therefore the objective here was to assess the 
response of three main APPs, i.e. ceruloplasmin, PIT 54 and OTF in response to sub-
clinical NE so to investigate whether (some of) these APPs could be used as 
biochemical diagnostic markers for sub-clinical NE in poultry. 
During infection, inflammation of the gut mucosa can cause a significant change 
in the gene expression patterns having a harmful effect on the underlying epithelium. 
Earlier our laboratory (Athanasiadou et al., 2011) utilised a novel in situ broiler model 
for genomic wide transcriptomic analysis to characterise the consequences of α-toxin 
infusion in the duodenum of broilers and early host responses through microarray. More 
than 30 genes were differentially expressed between toxin-infused and control birds. 
The expression level of 9 out of 11 genes expressed in microarray was validated by 
qPCR analysis.  
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Here, 6 gene transcripts that were differentially expressed in the aforementioned 
study were studied in challenged and sham-challenged birds. Different species of 
broilers can differ in their susceptibility to different infectious diseases. Resistance to 
diseases could be due to genetic differences between the species (Zekarias et al., 2002;  
Lamont, 1998). Therefore an additional objective was to observe the pattern of up / 
down regulation of the same genes between two different broiler species (Ross 308 vs 
Hubbard yield). It is hoped that host responses in terms of APPs and gene expression 
will provide greater insight into the pathogenesis of NE. 
8a: Acute Phase Protein  
 Materials and Methods 8.2
The chickens used in the APP studies were the same as used in the experiment of 
Chapter 7. Briefly a total of 112, one-day-old mixed sex Ross 308 birds were obtained 
from a commercial hatchery and reared in a single solid-floored pen from 0 to 7 days of 
age in an environmentally controlled house. All the birds were fed the starter diet from 
day 0 to day 7, followed by a canola-rich grower diet from day 8 until day 15. 
Thereafter all birds were fed the grower diet, mixed 3:1 with fish meal until the end of 
the study. Throughout the experimental period birds were fed and watered ad libitum 
except for a 20 hour feed withdrawal on day 16 prior to first gavage. 
All the birds on the challenge treatment were orally gavaged with  1.5ml of 
inoculum (BHI broth containing an actively growing culture of C. perfringens) using a 
10ml bottle equipped with vinyl tubing about 3-4cm long on days 17,18, 19 and 20. C. 
perfringens inoculum was gavaged twice a day, using freshly prepared inoculum each 
time as detailed in (Appendix- C). The chickens in the control treatment were orally 
gavaged at the same time with 1.5ml of freshly prepared sterile BHI only. Bacterial 
counts were performed on the culture every time prior to gavaging. On day 16, all birds 
were vaccinated with infectious bursal disease (IBD) vaccine (Poulvac® Bursine2, 
Pfizer Animal Health) in the drinking water. On day 18, all the birds received 
anticoccidial vaccine “Paracox- VIII (Schering-Plough Animal Health, Brussels, 
Belgium). 
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All the birds on the challenge treatment were orally gavaged with  1.5ml of 
inoculum (BHI broth containing an actively growing culture of C. perfringens) using a 
10ml bottle equipped with vinyl tubing about 3-4cm long on days 17,18, 19 and 20. C. 
perfringens inoculum was gavaged twice a day, using freshly prepared inoculum each 
time as detailed in (Appendix- C). The chickens in the control treatment were orally 
gavaged at the same time with 1.5ml of freshly prepared sterile BHI only. Bacterial 
counts were performed on the culture every time prior to gavaging. On day 16, all birds 
were vaccinated with infectious bursal disease (IBD) vaccine (Poulvac® Bursine2, 
Pfizer Animal Health) in the drinking water. On day 18, all the birds received 
anticoccidial vaccine “Paracox- VIII (Schering-Plough Animal Health, Brussels, 
Belgium). 
8.2.1 Determination of ceruloplasmin in blood serum  
Serum ceruloplasmin (Cp) was measured indirectly using p-phenylenediamine 
(PPD) oxidase activity. Ceruloplasmin catalyses the oxidation of PPD to yield a purple 
coloured product whose rate of formation can be determined by spectrophotometry. The 
rate of formation of the coloured oxidation product is proportional to the concentration 
of serum Cp (Sunderman and Nomoto, 1970). Before applying the PPD assay to 
chicken serum the optimum pH was established according to Martinez et al. (2007) and 
found to be pH 6.2. The PPD reagent was made by adding 61.5mg of p-phenylene di 
amine dihydrochloride (Sigma P1519) to 25ml of 0.598M sodium acetate buffer pH 6.2. 
Porcine serum of a known cerloplasmin concentration was used as standard and double 
diluted 4 times to achieve a standard curve. 50µl of PPD and 15µl of either serum 
sample or standard solution was added to each well of a 96 well plate. This was left in 
the dark for 20 minutes and then read on a Flurostar optical density reader at 550nm. 
The same method was subsequently used with a biochemical auto analyser (Figure 8.1; 
ABX Pentra 400, Horiba medical) to measure the experimental samples all in one batch. 
8.2.2 Determination of PIT54 in blood serum 
Commercial methods for measuring haptoglobin, which is the haemoglobin 
binding protein in mammals, has found to be effective with its chicken equivalent 
PIT54 (Eckersall et al., 1999). The peroxidise activity of a haemoglobin haptoglobin 
complex at low pH (or PIT54 when measured in chickens) is directly proportional to the 
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concentration of the haptoglobin in a sample. A biochemical auto analyser (Figure 8.1; 
ABX Pentra 400, Horiba medical) was used to measure this activity and calculate the 
concentration of PIT54. 
 
Figure 8.1: Biochemical auto analyser used to determine ceruloplasmin and PIT 
54 concentrations in the serum of broiler chickens. 
8.2.3 Determination of ovotransferrin in blood serum  
An ovotransferrin (OVT) assay detailed by Rath et al., (2009) was modified and 
used in the investigation. A 96 well plate was coated with chicken OVT (Conalbumin 
Sigma C0755) at a concentration of 1µg/ml in 0.2M Sodium hydrogen carbonate and 
stored at 4°C overnight. Wells were washed with TBS and blocked with 0.5% fish 
gelatin (Sigma G7765) for 1 – 2hours, although this was removed before the addition of 
the test solutions. Ovotransferrin standards were made by serially diluting 32µg of OVT 
in 1 ml TBS to 0.125µg/ml. Rabbit anti-chicken transferrin (OVT) antibody (Accurate 
Chemical AI-AG 8240) was diluted to a concentration of 0.2µg/ml in TBS. Serum was 
diluted 1:20 (5 µl in 1ml) in TBS. 50 µl of diluted standards or samples were added in 
duplicate to each well before the addition and mixing of 50 µl anti-chicken transferrin 
antibody with this final mixture being incubated by rocking for a further 2 hours. The 
wells were washed successively 4-5 times using TBS containing 0.05% tween-20 (TBS-
T). 100µl of 0.02% goat anti-rabbit IgG-HRP was added to each well. After 1 hour 
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incubation with constant shaking, each well was aspirated and further washed 3-4 times 
with TBS-T. 100µl of IMB peroxidase substrate (KPL 50-76-00) was then added to 
each well followed by incubation for 4 – 5 minutes at room temperature as the wells 
turned blue. The reaction was halted with the addition of 100µl 1M NaOH. Absorbance 
was measured at 450nm on a Flurostar optical density reader. 
8.3 APP: Statistical analysis 
The effect of challenge on serum concentration of ceruloplasmin, PIT54 and 
OTF were compared using a split plot design (Genstat 14 for Windows, IACR 
Rothamstead, England). The partitioned sources of variation included challenge, gender, 
post-challenge days and their interactions. 
 Because of the skewed nature of the concentrations of ceruloplasmin, data was 
transformed according to log (n + 1) to normalize the data before statistical analysis. 
Means were compared by Duncan’s multiple range test. Effects were reported as 
significant at P<0.05.  
 APP: Results 8.3
8.3.1 Serum Ceruloplasmin concentration  
Figure 8.2 shows serum ceruloplasmin concentrations on day 16, and the effect 
of challenge (infected and sham infected), gender (male and female) and post challenge 
days (21, 25, 26 days). Serum ceruloplasmin concentrations were significantly affected 
by challenge treatment (P= 0.023) but not by its interactions with gender (P= 0.739) and 
post challenge days (P= 0.346). Challenged birds showed a significantly larger increase 
in concentrations of serum ceruloplasmin compared to the unchallenged control birds. 
There was a significant difference in ceruloplasmin concentrations on different 
experimental days (P< 0.001). Concentrations of serum ceruloplasmin increased from 
day 21 (one day post-challenge), to a maximum at day 25 followed by a sharp decline 
on day 26 (5 days post-challenge). Serum ceruloplasmin concentrations were not 
affected by gender (P= 0.881) or the interaction between post challenge days and gender 
(P= 0.092). 
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8.3.2 Serum PIT54 concentration  
Figure 8.3 shows serum PIT 54 concentrations on day 16, and the effect of 
challenge (infected and sham infected), gender (male and female) and post challenge 
days (21, 25, 26 days). Serum PIT 54 concentrations were not affected by treatment (P= 
0.872) post challenge days (P= 0.118) but it was affected by the interaction between 
challenge treatment and post challenged days; challenged birds had higher 
concentrations of serum PIT 54 on day 25 whereas on day 26 control birds had higher 
concentrations of serum PIT 54  (P= 0.008). Serum PIT 54 concentrations were not 
affected by gender (P= 0.959) or its interaction with treatment (P= 0.884) or post 
challenge days (P= 0.172). 
8.3.3 Serum ovotransferrin concentration  
Figure 8.4 shows serum OTF concentrations on day 16 and the effect of 
challenge (infected and sham infected), gender (male and female) and post challenge 
days (21, 25, 26 days). Concentrations of serum OTF was not affected by challenge 
treatment (P= 0.303), post challenge days, (P= 0.795) or their interaction (P= 0.972). 
Serum OTF concentrations was significantly affected by gender (P= 0.001) but not by 
its interactions with challenge (P= 0.256) and post challenge days (P= 0.539). 
Concentrations of serum OVT was significantly higher in females compared to male 
birds (P < 001). 
Chapter 8 187 
 
Figure 8.2: Serum ceruloplasmin concentration of male and female in challenged and unchallenged control 
treatment groups on days 16 (pre-challenge), 21,25, and 26 (post challenge).  
The error bars are standard error of means (SEM). 
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Figure 8.3 : Serum PIT54 concentration of male and female in challenged and unchallenged control 
treatment groups on days 16 (pre-challenge), 21,25, and 26 (post challenge).  
The error bars are standard error of means (SEM). 
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Figure 8.4: Serum Ovotransferrin concentration of male and female in challenged and unchallenged 
control treatment groups on days 16 (pre-challenge), 21,25, and 26 (post challenge). 
The error bars are standard error of means (SEM). 
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8.5 APP: Discussion  
Experimental models of sub-clinical NE are increasingly required for studies of 
disease progress and the effect of novel interventions products. However reliable, easily 
quantifiable indicators of sub-clinical NE are not readily available. Even scoring system 
for the disease characterization varies greatly (Prescott, 1979; George et al., 1982; 
Lovland et al., 2004) Acute phase proteins as a result of early inflammation can 
represent a potential useful marker of bacterial infection (Chamanza et al., 1999). 
Economically important diseases especially sub-clinical forms which are difficult to 
detect by clinical signs or even by post-mortem examination may be diagnosed by 
levels of APPs, as the acute phase response in chickens is linked to growth depression 
and decreased production (Klasing & Korver, 1997). The effect of sub-clinical NE on 
the concentration of various APPs has not been assessed in broiler chickens. The 
present study analysed the effect of experimental challenge on three important APPs 
and their relation to attempted induction of sub-clinical NE. 
The disease was successfully produced in the present study. The appearance of 
typical lesions of sub-clinical NE following C. perfringens challenge confirmed the 
presence of infection in the gut. During the initial phase of inflammatory process 
induced by infection involves the release of acute phase proteins (Gruys et al., 1994). 
The present study indicates that serum levels of the positive acute phase protein 
ceruloplasmin increased in challenged birds compared to unchallenged controls 
probably due to gut lesions mediated through gut microbiota. These findings are in 
agreement with previous studies which reported significant elevations of ceruloplasmin 
concentrations during experimental infection with E. coli and E. tenella (Georgieva, 
2010). Mazur-Gonkowska et al. (2004) found a significant increase in concentrations of 
ceruloplasmin in turkeys infected with E. coli, and levels remained elevated until day 10 
post infection. This indicates that ceruloplasmin is an important APP in chickens 
responding to bacterial infection. 
The present study showed that serum ceruloplasmin levels increased during the 
course of infection, reaching a peak at day 25 (4 days post challenge) when the 
maximum number of birds were found to be positive for sub-clinical NE lesions 
(Chapter 7). This was followed by sharp a decline on day 26, although levels remained 
elevated compared to pre-challenge (day 16). This pattern of response is similar to the 
Chapter 8 191 
 
 
previous study in chickens experimentally infected with collibacillosis (Piercy, 1979). 
Piercy (1979) found peak ceruloplamin concentrations on day 4 post-challenge after 
which the concentration decreased. Piercy (1979) suggested that an increase in 
concentration of serum ceruloplasmin may be a change mediated by pathogenic bacteria 
to overcome the host hypoferraemic response. Similarly serum levels of ceruloplasmin 
found to be increased following experimental infection with salmonella in commercial 
layers (Garcia et al., 2009). 
Ceruloplasmin was the only APP to be affected by sub-clinical NE challenge. 
Increased levels of pro-inflammatory cytokines such as IL-1 and IL-6 and TNF-α 
following infection stimulate liver production of APPs resulting in an increased 
concentration in the blood (Tosi, 2005). A similar mechanism may apply to the 
elevation of ceruloplasmin in birds challenged with C. perfringens.  
In the present study no significant effect of challenge was observed on PIT 54 in 
the serum of male and female broilers. Literature regarding haptoglobin in poultry is 
very scarce. In cattle haptoglobin has been reported as useful indicator of bovine 
bacterial infection (Eckersall & Conner, 1988). Deignan et al. (2000) after experimental 
infection with salmonella in calves found a significant increase in serum haptoglobin 
with in 3 days of post-challenge, although after 5 further days the levels of haptogobin 
returned to normal. Conversely Georgieva (2010) found no difference in PIT 54 
concentrations after experimental infection with Eimeria tenella. This may be the case 
in the present experiment as some birds did develop sub-clinical lesions which may 
offset the response from birds in the challenge groups. However increase in levels of 
haptoglobin has not been studied with common chicken diseases as has been done with 
ruminants (Chamanza et al., 1999). 
Transferrin is a negative APP in cattle as its levels are known to decrease with 
acute infection (Moser et al., 1994). Conversely in chicken transferrin act is a positive 
APP, as the levels of OTF increase with inflammatory and infectious diseases (Xie et 
al., 2002). In mammals OTF is down-regulated during inflammation (Murata et al., 
2004). Conversely OTF is up-regulated in fibroblasts and chondrocytes in response to 
viral infection (Morgan et al., 2001) and inflammation (Xie et al., 2002). In the current 
study levels of OTF neither increased nor decreased in the serum of challenged and 
unchallenged treatment groups. Xie et al. (2002) reported that ovotransferrin increased 
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in SPF chickens upon challenge with different viral diseases, like fowl pox virus, 
infectious bronchitis virus or infectious laryngotracheitis virus. However, there are 
studies where levels of transferrin remained unchanged after administration of 
endotoxin (Moser et al., 1994). In agreement with the present study, Rath et al. (2009) 
did not find any significant change in chickens infected with pulmonary hypertension 
syndrome and tibial dyschondroplasia compared to their controls. However, 
phenomenon of changes in concentration of serum OTF remains unexplained. Murata et 
al., (2004) suggested an increase in concentration in many microbial challenges may 
help the host’s non-specific defence. In the current study female broiler chicks had 
significantly higher concentrations of OTF compared to male birds possibly due to the 
fact that OTF synthesis is under the control of oestrogen (Palmiter et al., 1981). 
The expression of these APPs has yet to be fully determined through further 
investigation in experimental models. It is noteworthy that a proportion of birds in the 
control unchallenged groups developed lesions of sub-clinical NE. That could explain 
the difference in the levels of PIT 54 and OTF compared to ceruloplasmin (O’Reilly, 
Personnel communication). However this is the first study to measure/analyse the 
response of APPs in broiler chickens challenged with C. perfringens. 
8.6 APP: Conclusion  
 In conclusion, our results showed that ceruloplasmin may be considered a 
moderate APP in sub-clinical NE in chickens as it increased around 3 fold, suggesting 
that monitoring serum ceruloplasmin concentration could indicate the presence of C. 
perfringens infection in poultry. However further research confirming its role and 
concentrations in sub-clinical NE are needed to provide a diagnostic and prognostic 
marker for flock health and welfare to ultimately help in better understanding of the 
pathophysiology of sub-clinical NE. The potential for PIT54 and OTF as APP has not 
been confirmed in this study, perhaps the subclinical infection of the experimental 
model was not sufficient to cause substantial increases in the APP of chicken. 
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8b: Gene expression  
 Materials and Methods 8.7
The chickens used in the gene expression studies were the same birds referred to 
in chapter 6 (b) (previously published paper Saleem et al., 2012). Briefly a total of 45 
day-old male (30 Ross 308 and 15 Hubbard) were obtained from a commercial 
hatchery, reared in solid-floored pens in an environmentally controlled house. Three 
groups of birds (2 Ross and 1 Hubbard) were subjected to one of three different 
treatments (Table 6.1). All three treatments were randomly allocated to pens in three 
positional blocks. A total of nine floor pens, with 5 birds per pen were used in an 
environmentally controlled room with the birds reared as a single flock from day 0 to 
day 7. 
All the groups were fed the starter diet from day 0 to day 7, followed by the 
grower diet from day 8 until day 15. Thereafter all birds were fed the grower diet, 
mixed 3:1 with fish meal until day 21. Challenged groups were given a C. perfringens 
culture in their diet on days 17, 18 and 19. In contrast, the birds of the control group 
were given feed mixed with sterile brain heart infusion broth (BHI) only, as described in 
Chapter 3.2.2. On day 18, all birds received anticoccidial vaccine “Paracox-8™” 
(Schering-Plough Animal Health, Welwyn Garden City, UK) by oral gavage at 10 times 
the dosage prescribed by the manufacturer. 
8.7.1 Tissue collection  
On day 21 all the birds were humanely killed by intravenous administration of 
an overdose of barbiturate. Gut samples was taken (from lesions and jejunum) from all 
the birds (n= 48), briefly washed with PBS and stored in RNA Later for possible further 
gene expression analysis. All samples were kept and analysed on a per bird basis. RNA 
in animal tissue is not protected that is why each sample was treated with RNA later, 
after which samples were immediately stored at -80°C until further use. 
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8.7.2 Tissue disruption and RNA Isolation 
Efficient disruption and homogenization of the tissue is an absolute requirement 
for all total RNA purification procedures. Tissue disruption is required to break cell 
membrane and organelles to release all RNA contained in the sample. A maximum 
amount of 30µg of duodenal sample was taken using a sterilized forceps with the tissue 
sample being cleaned and placed in ceramic beaded tube (CK28 tubes; Stretton 
Scientific, Stretton, UK) with 600µl of RLT buffer (Appendix -D). The beaded tube was 
placed in the cell disrupter machine (FastPrep®, model FP100, Qbiogene, Inc, Cedex, 
France) at 6.5 for 40 seconds. The mixture was then centrifuged for 3 minutes at 
13,000rpm, and 500ml of the supernatant was pipetted and transferred to new 2ml 
centrifuge tube. 
RNA isolation was done using RNeasy Mini Kit (Qiagen, according to 
instructions of the manufacturer with an additional step. One volume of the 70% ethanol 
(Appendix -D) was added to the cleared lysate mixed immediately by pipetting. Up to 
700µl of the sample with any precipitate that may have formed was transferred to an 
RNeasy spin column placed in a 2ml collection tube. This mixture was centrifuged for 
15 seconds at 10,000 rpm and flow throw was discarded. 700µl of buffer RW1 was 
added to the RNeasy spin column, before gentle lid closure and 15 seconds of 
centrifuging at 10,000rpm followed by discarding of the flow throw. 500µl of buffer 
RPE was added to the RNeasy spin column, centrifuged for 2minutes at 10,000rpm 
before discarding both flow throw and collection tube. The RNeasy spin column was 
placed in a new 2ml of collection tube, centrifuged at full speed for 1minute. The 
RNeasy spin column was placed in a new 1.5ml collection tube 30-50µl of RNase-free 
water was added directly into the spin column membrane and centrifuged at full speed 
for 1minute to elute RNA.  
After extraction of RNA, the quantity of RNA in each sample was determined 
spectro-phometrically at 260/280nm (Nano Drop®, ND-1000, Nanodrop Technologies 
Inc). 
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8.7.3 Conversion of RNA into cDNA 
As the extracted RNA was unstable, RNA was converted into complementary DNA 
(cDNA) using Verso
TM
 cDNA synthesis kit (Thermo Scientific, UK). Different 
quantities of samples were used for conversion of RNA to cDNA: 
 Samples having more than 2000ng/µl of RNA used 0.5µl of sample 
 Samples having less than 800ng/µl of RNA used 2 µl of sample  
 Samples having RNA from 800 to 2000ng/µl used 1μl of sample. 
Following the manufacturer’s protocol for reverse transcription in RNA samples 
the following were added: 4µl 4x cDNA synthesis buffer, 2 µl  2 µM dNTP mix, 1 µl 
RNA primer, 1 µl of RT enhancer, 1 µl of vero enzyme mix, water (PCR grade) to a 
final volume of 20µl. The reaction was incubated for 30 minutes at 42°C. The reaction 
was inactivated by heating at 95 C for 2 minutes. Generated cDNA was stored at -20 C 
until further use. 
8.7.4 Quantitative reverse transcriptase polymerase chain 
reaction (qPCR) 
PCR amplification and analysis were achieved using a MX 3000P™ 
thermocylcer (Startegene) using SYBR green (Sigma, UK). cDNA was diluted 10 fold 
in RNase free PCR grade water and 1µl added to a 20µl reaction. The reaction mixture 
consisted of 1µl of cDNA (1:10 diluted). 0.5 µl of each primer, 10 µl of Brilliant III 
ultra fast SYBR® qPCR Master Mix and 7.75µl of RNase free water. The primers for 
each gene analysed are shown in the Table 8.1. Since the PCR products were 
sequenced, this confirmed that analysed genes were correct. All templates were 
amplified using the following protocol: a pre-incubation for 2 minutes at 50°C, 10 
minutes at 95°C, amplification for 40 cycles, 30sec at 95°C, primer specific annealing 
temperature for 1 min (Table 8.1) and 30sec at 72°C. Fluorescent data was acquired 
during each extension phase. After 40 cycles a melting curve was generated by heating 
the samples to 95°C for 1 min followed by cooling down to 55°C for 30sec and heating 
the sample to 95°C for 30sec. with continuous measurement of the fluorescence. All 
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RT-PCRs were amplified as a single product as determined by melting curve analysis. 
In each run 6 standards of the gene of interest in duplicate were included with 
appropriate dilutions to determine the cDNA concentration in the sample. Relative 
mRNA levels were calculated for genes using an included standard curve for each 
individual gene and values were normalised to the housekeeping gene β-actin that was 
used as an internal control, the expression of which was measured in the same way. 
Expression of β-actin did not significantly affected by different treatment groups (P= 
0.896). 
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Table 8.1: Sequence of oligonucleotide primers used in quantitative real-time PCR 
Gene name  Primer sequence (5ʹ- 3ʹ) Size for PCR 
product (bp) 
Annealing 
temperature 
Forward  Reverse  
ßAct GAGAAATTGTGCGTGACATCA CCTGAACCTCTCATTGCCA 180 61 
NBL1 CGGCTGCGAGTCCAAGTCCATC TCCACCAGCTTGTCAACCCTGG 200 60 
BL-A ACGTCCTCATCTGCTACGCCGA TTCCGGCTCCCACATCCTCTGG 236 59 
FAS CCTGACCCACCACGTCCCTGA GGTTTCGTAGGCTCCTCCCATTCCA 196 61 
GIMAP8 TCGTGGGCAAGACGGGGAGT CCGCAGAAGCGGCCTTTAGC 130 60 
 Primer sequences are proprietary; assays were designed and provided by Qiagen (Quantitect Primer Assay) and conditions 
used were as described in the Qiagen Quantitect Primer Assay handbook. 
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 Gene expression: Statistical analysis 8.8
cDNA levels of genes of interest and the housekeeping gene were then subjected 
to a comparative quantitation analysis, using the MxPro software (Stratagene). 
Statistical differences between groups were compared using generalized analysis of 
variance (ANOVA). Effects were reported significant at P< 0.05. All procedures were 
performed using Genstat 14 for Windows (IACR Rothamstead, UK).  
 Gene expression: Results 8.9
8.9.1 Expression of fas 
Figure 8.5 shows the effect of C. perfringens challenge (infected and sham 
infected), on the expression of the fas gene in intestinal tract of broilers. Challenge did 
not significantly affect the expression of fas in different treatment groups (P= 0.249). 
Moreover the expression of fas did not differ between the challenged Ross and Hubbard 
birds (5.36 x 10
4
 vs. 7.69 x 10
4
). 
 
Figure 8.5: Effect of experimental challenge with C. perfringens on relative 
expression of fas in intestine of broiler chickens.  
The Error bars are the standard error of means (SEM). 
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8.9.2 Expression of BL-A 
Figure 8.6 shows the effect of C. perfringens challenge (infected and sham 
infected), on the expression of the BL-A gene in the intestinal tract of broilers. 
Challenge did not significantly affect the expression of BL-A in different treatment 
groups (P= 0.592). Moreover the expression of BL-A did not differ between the 
challenged Ross and Hubbard birds (3.52 x 10
2
 vs. 2.98 x 10
2
). 
 
Figure 8.6: Effect of experimental challenge with C. perfringens on relative 
expression of BL-A in intestine of broiler chickens. 
The Error bars are the standard error of means (SEM). 
8.9.3 Expression of NBL1 
Figure 8.7 shows the effect of C. perfringens challenge (infected and sham 
infected), on the expression of the NBL1 gene in the intestinal tract of broilers. 
Infection tended to reduce expression of NBL1 in Ross birds (P= 0.072). Moreover the 
expression of NBL1 did not differ between the challenged Ross and Hubbard birds 
(3.13 x 10
3
 vs. 6.07 x 10
3
). 
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Figure 8.7: Effect of experimental challenge with C. perfringens on relative 
expression of NBL1 in intestine of broiler chickens.  
The Error bars are the standard error of means (SEM). 
8.9.4 Expression of GIMAP8 
Figure 8.8 shows the effect of C. perfringens challenge (infected and sham 
infected), on the expression of the GIMAP8 gene in the intestinal tract of broilers. 
Challenge did not significantly affect the expression of GIMAP8 in different treatment 
groups (P= 0.377). Moreover expression of GIMAP8 did not differ between the 
challenged Ross and Hubbard birds (1.92 x 10
3
 vs. 5 x 10
7
). 
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Figure 8.8: Effect of experimental challenge with C. perfringens on relative 
expression of GIMAP8 in intestine of broiler chickens.  
The Error bars are the standard error of means (SEM). 
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 Gene expression: Discussion  8.10
At both cellular and molecular level a pathogen can modulate and interfere with 
different programmes within an organism. In terms of primary host response, it is 
necessary to recognise that a pathogen can cause a number of changes in gene 
expression levels in particular host cells. Gene changes that occur can vary between 
susceptible and resistant chickens as well as between infectious and control birds 
(Hemert, 2007). The literature reports differences in gene expression levels between 
control and challenged birds following experimental induction of diseases (Liu et al., 
2001; Hong et al. 2012; Sumners et al., 2012). Following experimental induction of 
malabsorption syndrome (MAS), chickens susceptible to MAS had much lower 
expressions of IL-2, IL-6, IL-18 and IFN-gamma in their small intestine when 
compared with birds with a high resistance to MAS with higher expressions of the same 
genes. Following induction of Marek’s disease, similar differences in gene expression 
were found between the lymphocytes of birds resistant or susceptible to the disease (Liu 
et al., 2001). 
By using a genome-wide transcriptomic analysis and an in situ broiler gut loop 
model from earlier work, Athanasiadou et al.(2011) identified the pathways that 
regulate early host responses to C. perfringens toxin in the duodenum of broilers. 
Genome-wide transcriptomic analysis of duodenum in broiler chickens infused with 
crude C. perfringens α-toxin showed a wide range of genes associated with an innate 
immune response, which were up and down-regulated in toxin-infused birds compared 
to controls. 11 genes were confirmed by qPCR (Athanasiadou et al., 2011). Out of 11 
genes that were confirmed by qPCR, six genes were selected to be analysed. The 
expressions of 6 gene transcripts were analysed in broilers experimentally challenged 
with C. perfringens (1.54 x 10
9
 cfu/g of feed) in two genetically different commercial 
broiler chicken lines (Ross, Hubbard) with the objective of obtaining a better 
understanding of the immune competence possessed by these two commercial lines.  
Fas is a cell surface protein, belonging to the tumour necrosis factor family that 
plays a key role in cell death. It acts as a receptor for Fas ligand, a cell surface molecule. 
When Fas ligand binds to Fas it induces apoptosis of Fas bearing cells (Nagata & 
Golstein, 1995). In the present study C. perfringens challenge did not have a significant 
effect on expression of the Fas gene. The mechanism of cell death in C. perfringens 
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infection is attributed to both necrosis and apoptosis. One hour post infusion with C. 
perfringens crude toxin, cell death is attributed to necrosis as Pro-apoptotic genes, such 
as Fas, CASP8 and TNFRSF1B, that have been shown to be down-regulated in toxin-
infused birds compared to controls (Athanasiadou et al., 2011) Whereas, 24 hrs post C. 
perfringens inoculation, cell death in the spleen of infected broilers is said to be 
controlled via apoptosis (Zhou et al., 2009). 
GTPase of the immunity-associated protein family member 8, GIIMAP8, belongs to 
an immunity associated protein family also called immune-associated nucleotide 
binding proteins (IANs). They are functionally uncharacterized GTP-binding proteins 
expressed in vertebrate immune cells as well as in plant cells during antibacterial 
responses and during T-cell differentiation so are associated with immunological 
function (Filen & Lahesmaa, 2010; Nitta et al., 2006). GIMAP8 was one of the top gene 
that was down-regulated gene in toxin infused birds. In the present study C. perfringens 
challenge did not have a significant effect on expression of the GIMAP gene. 
Major histocompatibility complex (MHC) is known to encode class I and class II 
molecules. MHC class II molecules are highly polymorphic, consisting of two 
structurally related trans-membrane glycoproteins, α and ß chains that play  a central 
role in immune response by binding peptides for presentation as an antigen to T-
lymphocytes of the immune system. BL-A is one of the MHC class II alpha chain 
paralogues and lacks polymorphism (Salomonsen et al., 2003; Kaiser, 2010). There 
were no significant differences detected for expression of the BL-A gene in this study. 
BL-A has been found to be down-regulated in spleen lymphocytes of broilers 
experimentally infected with Salmonella gallinarum (Lim et al., 2009). 
Another gene NBL1, neuroblastoma, suppression of tumourigenicity 1: also known 
as DAN, DANDI. This, was selected as it was one of the top up-regulated genes in the 
gut loop model (Olakowski et al., 2009). NBL1 has been identified as a tumour 
supressing gene and also has roles in the inflammatory response. In the present study C. 
perfringens challenge did not have a significant effect on expression of the NBL1gene. 
In addition to these gene transcripts two more gene transcripts (IRAK-4 and VTN) were 
also analysed but unfortunately problems with these genes, failed to generate a qPCR 
standard curve so were excluded from the analysis. 
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The difference in results of the expression level of genes between the gut loop 
model and the present study could be due to several reasons (Athanasiadou et al., 2011). 
It may be due to the fact that toxin infused birds were investigated 1hr after toxin 
infusion, compared with the present experiment which investigated gene expression 
after 2 days C. perfringens challenge per se (so enough time is given to C. perfringens 
to grow and release its α-toxin into the gut). This time difference may account for the 
difference in gene expression patterns. Sumners et al. (2012) found higher expression of 
IL-13 gene after 2hrs of exposure to C. perfringens toxin but not after 4hrs. The 
expression pattern of one gene can be varied between different diseases (Hong et al., 
2012). Different genes respond differentially to various infections: production of several 
pro-inflammatory cytokines (IL-1ß, TNF-α, IL-6) are increased following infection with 
C. perfringens (Hong et al., 2006a; Hong et al., 2006b; Park et al., 2008). However 
Hong et al. (2012) could not find any differences in the expression levels of IL-1ß and 
IL-6 between NE infected and control birds. Similarly Park et al. (2008) did not find 
any altered response of some pro-inflammatory cytokines genes (IL-6, IL-16) in birds 
experimentally infected with C. perfringens. 
Moreover one cannot exclude the possibility of differential expression in genes 
response to crude toxin directly infused into the duodenum and C. perfringens per se. 
Challenging birds through in feed C. perfringens may not be able to produce 
sufficiently high amounts of α-toxin to produce a significant effect on gene expression, 
or vice versa, infusion studies may result in higher local toxin concentrations than 
occurring in (natural) infections. However the low numbers of birds exhibiting lesions 
in the present experiment is not enough to warrant ignoring the inability to find a 
difference between the different treatments groups. 
The two different commercial lines did not show any differential gene expression 
pattern for the different genes analysed in the present experiment. Hong et al. (2012) 
analysed the expression levels of different avian ß-defensins in two lines of commercial 
broiler chickens: Ross and Cobb following E. maxima and C. perfringens co-infection 
and found differential gene expression patterns. However not all of the genes 
investigated were expressed differentially as out of 14 ß-defensins only 8 showed 
differential gene expression in the jejunum across two species of chickens. Sumners et 
al. (2012) documented that resistance to C. perfringens infection is one instance where 
genetically divergent species do not follow their established trend of pathogen 
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susceptibility. High antibody response chickens have also been observed to be more 
resistant to C. perfringens infection compared to those with a low antibody response. 
Highly up-regulated expression of various cytokines, IFN-γ, IL-8, IL-15 has been 
observed in chicken species with a high antibody response during exposure to C. 
perfringens α-toxin compared to a species with a low antibody response (Sumners et al., 
2012). 
The comparatively low NE lesion score in the present study, together with 
insignificantly different counts of C. perfringens and α-toxin between the different 
treatment groups might have caused such subtle changes in mRNA transcripts of the 
genes analysed that detection of significant changes was not possible in qRT-PCR 
analysis. Si et al., (2007) found higher numbers of differentially expressed genes 
following C. perfringens challenge on the day when NE lesions were most serious. 
 Gene expression: Conclusion 8.11
In conclusion, our results showed that challenging birds with higher in-feed doses 
of C. perfringens did not alter the expression level of the gene transcripts (fas, BL-A, 
GIMAP8 and NBL) that were up and down regulated following infusion of crude toxin. 
Results of present study also indicate the difference of host response in term of gene 
expression, to toxin and C. perfringens per se, and/ or different stages in pathogenesis of 
C. perfringens infection. However, this preliminary study has paved the way for more 
extensive studies into changes in gene expression analysis, as in agreement with lack of 
gene expression variation, very few birds were observed to have sub-clinical NE. 
Further studies on gene expression in an experimental disease model will be necessary 
for better understanding of host pathogen interactions. 
.
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The objective of this section is to discuss the overall findings of the project rather 
than provide a comprehensive discussion of individual experiments’ results. 
 Introduction  9.1
Although NE is not a new disease it has, until now, been controlled by in-feed 
microbials, and ionophore anti-coccidials (Collier et al., 2003). Following an EU wide 
ban on in-feed growth promoters, it has re-emerged as a significant problem that 
ultimately results in reduced growth performance as well as increasing feed costs. 
Epidemiological data suggests that sub-clinical NE results in a 20% reduction in bird 
weight and a 10.9% increase in FCR compared to healthy birds – thus having the 
potential to cause a significant effect on both the growth and feed efficiency of broiler 
flocks. (Kaldhusdal et al., 2001; Hofacre et al., 2003; Skinner et al., 2010; Skinner et 
al., 2010; Timbermont et al., 2009a). However, the nature of sub-clinical NE makes it 
difficult to determine accurately the total impact of fully developed NE on chicken 
production. The primary etiological agent of sub-clinical NE is a gram positive, 
anaerobic, spore forming bacterium, Clostridium perfringens (C. perfringens), a 
commensal in the GIT of poultry (Ficken & Wages, 1997) that has been isolated from 
feed, litter, dust, and faeces (Wages & Opengart, 2003). 
The economic impact of sub-clinical NE has not been formally investigated 
although it is becoming progressively more apparent (Skinner et al., 2010). The sub-
clinical form of the disease causes damage to intestinal mucosa leading to decreased 
digestion and absorption, reduced weight gain and increased feed conversion ratio 
(Kaldhusdal et al., 2001). Although NE currently is a sporadic disease in developing 
countries it is still causing large scale outbreaks in chicken production units, so poultry 
farms cannot afford to ignore the economic losses caused by this disease. The exact 
conditions that precipitate the out breaks of NE under field conditions are still 
ambiguous, despite identification of numerous factors that promote the development of 
sub-clinical NE. These predisposing factors are mainly dietary in nature together with a 
degree of co infection with Eimeria. Despite the present understanding of the disease’s 
progression and identification of C. perfringens as the disease’s primary etiological 
agent, it is still unclear as to the predisposing factor(s) that lead to the overgrowth of C. 
perfringens in the GIT and the subsequent induction of NE. It has proved difficult to 
reproduce sub-clinical NE under experimental conditions. There are numerous 
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predisposing factors, but they are ill defined with contradictory results from 
experiments (Kaldhusdal et al., 1999). In order to control strategies and explore new 
methods for controlling sub-clinical NE it is essential to develop a reproducible 
experimental model for induction of sub-clinical NE that allows testing of a variety of 
factors, such as feed additives, vaccines and a range of new approaches, in order to 
achieve more effective control of this billion-dollar-costly disease.  
The focus of this thesis was:  
1. To develop a working infection model that enables experimental induction of 
sub-clinical NE in broiler chickens with special reference to prioritize nutrition 
related risk factors that purportedly predispose birds to sub-clinical NE. 
2. To test breed sensitivity to disease induction, two chicken breeds, Ross and 
Hubbard, with varying degrees of susceptibility to the induced infection. 
3. To identify the novel biochemical markers for sub-clinical NE.  
The major focus of the work described in this thesis is to gain a better 
understanding of the involvement and relevance of various anecdotal and potential risk 
factors for NE in isolation and/or in combination in order to develop a model of sub-
clinical NE, that is able to contribute to advancing new preventative strategies enabling 
control of this billion dollar disease in a post antibiotic era. 
 Responses of broiler chickens to various 9.2
predisposing factors used in various experiments 
of this PhD project 
9.2.1 Feed withdrawal /Fasting 
The first study, detailed in Chapter 3, was done to determine whether feed 
withdrawal assists the induction of sub-clinical NE in broiler chickens inoculated with 
C. perfringens. To our knowledge, this experiment is the first to have assessed the 
effect, in isolation, of feed withdrawal on sub-clinical NE in young broiler chickens. No 
specific lesions with low digesta counts of C. perfringens demonstrated that feed 
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withdrawal at the durations used, did not predispose the birds to NE. It can therefore be 
concluded that feed withdrawal alone does not predispose the birds to sub-clinical NE. 
This lack of expected results suggests that, if fasting is indeed predisposing to sub-
clinical NE, there must be other critical variables involved. 
Many earlier experiments applied feed withdrawal together with very high levels 
of C. perfringens, yet failed to induce NE (Jia et al., 2009; Pedersen et al., 2003). 
Digestive enzymes such as Trypsin, recognised as an effective in-activator of the α-
toxin of C. perfringens, increase in quantity during short hours of starvation (Baba et 
al., 1992). Although mucin quantity was not measured in this study it is possible that 
paracox-5®, used in the present experiment, was also unable to produce sufficient 
mucin to encourage proliferation of C. perfringens.  
9.2.2 Vegetable protein source  
A wide number of scientific publications have identified, dietary ingredients, 
such as wheat, barley and fishmeal, which affect the proliferation of C. perfringens, so 
also affect the incidence of NE (Kaldhusdal & Hofshagen, 1992; Kaldhusdal & Skjerve, 
1996; Drew et al., 2004). However, the experimental induction of sub-clinical NE is 
hampered due to poor definition of the relationship between these factors.  
The second study, detailed in chapter-4, was done to determine the effect, on the 
incidence of NE, of three alternative sources of vegetable protein, (SBM, PPC and CM), 
in nutritionally complete diets with similar crude protein content (212 g/kg). It has long 
been suggested that a relationship exists between the type of litter and the incidence of 
NE under field conditions since C. perfringens has been isolated from poultry litter 
(Nairn & Bamford, 1967). An important component in the development of NE is the 
recycling of C. perfringens through both litter ingestion between birds and transmission 
to subsequent flocks placed on old litter (Nairn & Bamford, 1967; Craven et al., 2001a; 
Craven et al., 2001b; Alexander et al., 1968; Craven et al., 2001b). Therefore this 
experiment challenged the birds by exposing them to reused litter material providing an 
innate infection, without the need to dose them with actively pathogenic C. perfringens 
to reproduce the disease. Reused litter material was obtained from a commercial farm in 
order to simulate the natural conditions for the development of sub-clinical NE.  
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9.2.3 Trypsin inhibitor  
Trypsin inhibitor is a recent addition to the list of predisposing factors for NE 
(Palliyeguru et al., 2010). It was therefore decided to include a fourth treatment, in a 
wheat-soya diet with added synthetic TI (6µg/ml) to study its impact on the onset of 
sub-clinical NE. To our knowledge this experiment is, again, the first to assess the effect 
of synthetic TI on the induction of sub-clinical NE in poultry. However, post hoc 
dietary analysis in this study showed that all four diets (SBM, SBM+TI, PPC and CM) 
had almost the same levels of TI activity (0.8mg/g of feed) so no comparison of dietary 
treatments can be made solely on the basis of the TIA content of the diet. This could 
indicate the degradation of synthetic TI after mixing with the experimental diet. It might 
also be due to too small a concentration of the synthetic TI or sufficiently significant 
differences between natural and synthetic TI that may have required different analytical 
techniques. 
Sub-clinical NE was not induced by the use of SBM, PPC or CM. However, a 
CM diet did predispose the birds to coccidiosis to such an extent that it was necessary to 
cull them all on day 21, although the other dietary treatment groups were continued to 
the planned completion of the experiment at day 30. It is postulated that this increased 
susceptibility to coccidiosis could have been the result of damage to the intestinal 
mucosal layer by anti nutrients present in CM such as phytate. Although not shown in 
this study, coccidia are recognised as a co-factor in NE so it is reasonable to assume 
that, under commercial conditions, CM would also predispose birds to sub-clinical NE.  
9.2.4 Fish meal  
The third study, detailed in Chapter 5, was done to determine the effect of 
fishmeal addition on C. perfringens proliferation on in vitro digested grower diets. 
There is a close relationship between fish meal and the incidence of NE in poultry as 
dietary levels of animal protein like fish meal are known to contribute to the growth of 
C. perfringens  (Truscott & Alsheikhly, 1977; McDevitt et al., 2006b). This is reflected 
in the number of experimental models relying on fish meal addition to diets (Pedersen et 
al., 2008; Timbermont et al., 2010; Gholamiandehkordi et al., 2007). However, it is 
worth noting that not all experimental models using fish meal were able to reproduce 
NE under controlled environmental conditions (Pedersen et al., 2003). The overall 
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findings of the present study support the view that high levels of dietary fish meal may 
assist survival of C. perfringens, suggesting that the role of fish meal cannot be 
excluded as a predisposing factor for (subclinical) NE. Therefore it was decided to use 
fish meal (30% added on top of a grower diet) in all subsequent experiments attempting 
to induce sub-clinical NE. 
9.2.5 Effect of combination of predisposing factors on 
experimental induction of sub-clinical NE  
The fifth experiment, detailed in Chapter 7, was done to induce sub-clinical NE in 
broiler chickens by combining all the predisposing factors previously considered 
individually (i.e. diet, coccidial vaccination, IBD vaccine and added fishmeal) following 
challenge through oral gavage with high numbers of C. perfringens (10
8
 cfu/ml). This 
experiment successfully produced the disease with a statistically significant percentage 
(40.6%) of birds developing NE lesions, but with no mortality. Ante-mortem 
examination of the birds had shown no clear symptoms. Post-mortem examination 
revealed gross lesions consisting of necrotic areas, surrounded by hyperaemic zones. 
Some cases also showed the intestinal mucosa covered by a yellow to brown, diphtheric 
pseudo-membrane. The overall performance of birds in the challenged treatment group 
was consistently poor on all days confirming the economic importance of the sub-
clinical form of the disease.  
The results of this experiment provides a suitable model for induction of sub-
clinical NE under controlled environmental conditions: multiple C. perfringens 
inoculations through gavage; together with a combination of different predisposing 
factors such as in the presence of high doses of live coccidial vaccine, feed withdrawal, 
and higher levels of fish meal (30%) in the grower diet with CM.  
It was possible to produce the disease by an appropriate combination of different 
predisposing factors. Various factors such as environment, diet and co infection with 
other pathogens can provide endogenous strains of C. perfringens with optimal 
conditions for proliferation of C. perfringens and subsequent production of α-toxin. 
Minor intestinal damage and sufficient numbers of C. perfringens in the intestine are 
pre-requisites to producing the disease as this research failed to induce NE lesions even 
after infusion of large number of C. perfringens alone (Alsheikhly & Truscott, 1977a). 
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Therefore it may be reasonable to assume that the presence of numerous predisposing 
factors applied in the experiment helped to create optimum conditions for multiplication 
of C. perfringens leading to induction of sub-clinical NE, confirming the findings that 
multiple oral doses of C. perfringens in combination with an high dose of live coccidial 
vaccine did give a suitable model for subclinical NE (Gholamiandehkordi et al., 2007). 
Much of the literature on induction of NE has shown that the most successful models, in 
addition to high and repeated doses of C. perfringens, also included a combination of 
different predisposing factors such as higher doses of coccidial vaccine, diets containing 
high levels of fish meal and IBD vaccination (Wu et al., 2010).  
Under controlled environmental conditions, earlier experiments appeared to 
show that it was easy to successfully produce NE (Alsheikhly & Truscott, 1977b; 
Cowen et al., 1987; Alsheikhly & Truscott, 1977a; Hamdy et al., 1983b; Prescott et al., 
1978a). However more recent attempts have failed to replicate their results with many 
researchers unable to induce the disease even in the presence of recognised predisposing 
factors (Pedersen et al., 2003; Olkowski et al., 2006b). Pedersen et al, (2003) failed to 
induce NE in broiler chickens in three of their experiments even after inoculation of 
very high numbers of C. perfringens. Challenge trials conducted by Olkowski et al. 
(2006a) also failed to produce clinical and/or pathological features characteristics of 
typical NE. 
The results of experiments 4b and 5 show that the response of challenge may 
differ from experiment to experiment depending upon the route of challenge, challenge 
dose and the number of days of challenge. The response in experiment 4b was weaker 
than that in experiment 5, although there were a number of differences between the 
other experimental conditions. A combination of all these factors may responsible for 
the onset of sub-clinical NE in experiment 5 (Chapter 7). 
The experiments detailed in this thesis measured the disease frequency per 
treatment on the basis of lesions of sub-clinical NE found in randomly euthanized birds, 
subsequently confirmed by histopathology. The use of lesion-like thin walled, friable 
intestines for diagnosis creates problems due to the difficulty of achieving objectivity. 
However, restriction of diagnostic criteria to just necrotic lesions can appear to reduce 
the incidence of the disease by not including the evidence of lesion-like thin walled, 
friable intestines. 
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9.2.6 Coccidiosis  
The most frequently described risk factor for the onset of NE is concurrent 
intestinal disease, such as coccidial infection. The Eimeria species particularly that 
colonize the small intestine, such as Eimeria maxima and Eimeria acervulina, are 
known to predispose to NE (Alsheikhly & Alsaieg, 1980). Bradley and Radhkrishnan, 
(1972) observed that growth of C. perfringens in the caecum increased during infection 
with E. tenella this increased growth also resulted in reduction in the number of 
Lactobacilli. Whereas Baba et al. (1997) suggested that concurrent infection with E. 
nacatrix and C. perfringens has a synergistic effect and increases clostridial population 
in the intestine of the chickens. 
Coccidiosis and NE are usually linked as they both have similar symptoms 
(Williams, 2005). Alsheikhly & Alsaieg, (1980) and Shane et al. (1985) suggested that 
supplementation with anti-coccidial preparations may reduce the incidence of NE. The 
precise mechanism of coccidial infection in the pathogenesis of NE is not clear but 
Alsheikhly & Truscott, (1977b) hypothesized that intestinal damage due to coccidiosis 
along with sufficient numbers of C. perfringens are prerequisites for NE to occur, 
although some of the experimental evidence lacks reliable results to support this 
hypothesis (Pedersen et al., 2003). The present project has demonstrated (Chapters 3, 4, 
6) that coccidial vaccination alone seemed insufficient to induce sub-clinical NE. 
9.2.7 Dietary amino acids  
Unfortunately there is scarce information in the literature on the affect of dietary 
amino acids on lesions of sub-clinical NE, although these have been recognized as a 
factor that affects the C. perfringens population in the gut so have been suggested as a 
risk factor for sub-clinical NE (Wilkie et al., 2005; Dahiya et al., 2007b; Dahiya et al., 
2007a; Drew et al., 2004). Drew et al. (2004) found significant increases in the ileal and 
caecal population of C. perfringens in chickens fed a fish meal diet (400g/kg) compared 
to a soy protein concentrated diet. This increase was attributed to the higher glycine 
content of fish meal in the diet. In addition to glycine, the dietary methionine level was 
also reported to stimulate the growth of C. perfringens (Muhammed et al., 1975; Drew 
et al., 2004).  
Chapter 9  214 
 
 
Analysis of different grower diets (SBM, PPC, and CM), used in experiment two 
(Chapter 4) showed no major differences between the amino acids levels. Glycine levels 
in the SBM (7.5%), PPC (8.2%) and CM (8.0%:Figure 9.1; Figure 9.2). Similarly there 
were no major differences in levels of methionine between CM (4.4%), SBM (4.7%) 
and PPC (3.8%) diets. Whereas C. perfringens counts in digesta of broilers fed SBM, 
PPC, and CM grower diets were 2.53 2.91 and 3.15 log10 cfu/g respectively. Moreover 
no lesions of sub-clinical NE were observed in any of the treatment groups.  
Analysis of different grower diets, used in experiments 4a 4b and 5 (Chapters 6 
and 7) showed no major differences between the amino acids levels. There were no 
major differences between glycine levels in the grower diets used in experiment 4 and 5 
(15 vs. 14 % respectively Figure 9.3: Figure 9.4). Similarly no major differences were 
found in methionine levels in the grower diet fed to birds in experiments 4a and 4b (7 % 
vs 6 % respectively). Counts of C. perfringens ranged from 1.3 -3.35 log10 cfu/g of 
digesta in experiments 4a and 4b whereas in experiment 5 counts ranged between 3.67 – 
8.27 log10 cfu/g of digesta over different dissection days. The total percentage of birds 
with lesions of sub-clinical NE in the Ross and Hubbard birds of experiments 4b 
(Chapter 7) was 13.3% and 6.66% respectively whereas in experiment 5 lesions of sub-
clinical NE were seen in 31.2% and 35.9% birds on days 21 and 25 respectively.  
Palliyeguru et al. (2010) found a higher incidence of sub-clinical NE in birds fed a 
potato protein diet in comparison to a soya diet although dietary analysis showed similar 
glycine levels in potato (9.4g/kg) and soya (9.0g/kg) diets. Dahiya et al. (2007b) found 
decrease in ileal and caecal populations of C. perfringens fed diets with high methionine 
concentrations. In agreement with studies (Palliyeguru et al., 2010; Dahiya et al., 
2007b), the present Phd project provide further confirmation of probable involvement of 
other factors as the results clearly demonstrate that the changes in C. perfringens levels 
are not adequately explained by the level of dietary amino acids which also do not 
appear to significantly affect the incidence of sub-clinical NE.  
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Figure 9.1: Indispensable (essential) amino acid composition of different grower diets used in experiment 2. 
Arg. Arginine; His: Histidine: Ile: Iso-leucine; Leu: Leucine; Lys: Lysine; Met: Methionine; Phe: Phenylalanin; 
Thr: Threonine; Val: Valine. 
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Figure 9.2 : Dispensable (non-essential) amino acid composition of different grower diets used in experiment 2. 
Ala: Alanine; Asp: Aspartic acid; Cys: Cysteine; Glu: Glutamic acid; Gly: Glycine; Pro: Proline; Ser: Serine; Tyr: Tyrosine. 
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Figure 9.3: Indispensable (essential) amino acid composition of grower diets used in experiment 4 and experiment 5. 
Arg. Arginine; His: Histidine: Ile: Iso-leucine; Leu: Leucine; Lys: Lysine; Met: Methionine; Phe: Phenylalanine; Thr: Threonine; Val: Valine 
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Figure 9.4: Dispensable (Non-essential) amino acid composition of grower diets used in experiment 4 and experiment 5. 
Ala: Alanine; Asp: Aspartic acid; Cys: Cysteine; Glu: Glutamic acid; Gly: Glycine; Pro: Proline; Ser: Serine; Tyr: Tyrosine. 
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 Impact of low and high doses of C. perfringens 9.3
through in feed challenge on experimental 
induction of sub-clinical NE  
Experiments 4a and 4b, detailed in Chapter 5, drew on the information gained 
from the preceding experiments (Saleem et al., 2011a; Saleem et al., 2011b). Both 
experiments were designed to develop an experimental disease model for sub-clinical 
NE using wheat-based diets incorporating high amounts of fish meal. Birds were 
challenged; 
- With low in-feed doses of C. perfringens (102 cfu/g), together with 
higher doses of coccidial vaccine (Experiment 4a)  
- With higher and repeated in-feed doses of C. perfringens (109 cfu/g), 
together with higher doses of coccidial vaccine (Experiment 4b). 
As different broiler strains have varying levels of susceptibility to infectious 
diseases, possibly due to genetic differences (Lamont, 1998; Zekarias et al., 2002), 
experiment 4b compared two breeds (Ross 308 & Hubbard) in their resistance to 
induction of sub-clinical NE under the same experimental conditions.  
Experiment 4a failed to induce the disease. In experiment 4b lesions were seen in 
only a few birds. Both experiments applied some of the predisposing factors, such as 
incorporation of more than 50% of wheat in the diet (Branton et al., 1987; Riddell & 
Kong, 1992), and high levels of fish meal (30% on top of the basic diet) in the grower 
diet from days 7 to 16 (Prescott et al., 1978a). Diet was offered in the form of mash 
rather than pellets as Engberg et al. (2002) found higher numbers of C. perfringens in 
the caecum of birds fed a mash compared to a pelleted diet. These experiments showed 
that lower concentrations of C. perfringens in gavage (10
2
), predisposing factors like 
higher doses of coccidial vaccine and high levels of fish meal in the diet were unable to 
produce sub-clinical NE. The results also show that even excessively high challenges of 
C. perfringens with high levels of fishmeal diets and high doses of coccidial 
vaccination, may not result in consistent production of gross lesions of sub-clinical NE. 
Further study is required to determine whether the lower number of Hubbard birds with 
gross lesions (1 out of 15) compared to Ross birds (2 out of 15) indicates a higher level 
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of resistance to NE between these species. Although Prescott et al. (1978b) reported that 
high levels of fish meal in the diet may provoke NE, the failure to produce NE in these 
two experiments emphasizes that other factors than a fish meal addition to the diet are 
likely to be involved.  
 Experimental disease model for sub-clinical NE  9.4
NE is difficult to reproduce experimentally with C. perfringens alone although 
some authors (Collier et al., 2008; Park et al., 2008) reported lesions by challenge with 
C. perfringens alone. This research clearly shows that the presence of C. perfringens in 
the intestinal tract of broilers or inoculation of birds with relatively higher doses of C. 
perfringens does not always lead to the development of sub-clinical NE.  
It can be concluded that sub-clinical NE can be successfully induced under 
experimental conditions (Experiment 5 Chapter 7) by feeding broiler diets containing 
higher levels of fishmeal, using higher doses of paracox vaccine and gavaging C. 
perfringens for four consecutive days. Therefore the challenge model can be 
recommended for study of sub-clinical NE under controlled environmental conditions. 
However feeding higher levels of dietary proteins, feed withdrawal, higher levels of 
dietary wheat - each of these factors alone did not result in successful induction of the 
disease. Olkowski et al. (2006a) observed similar findings, although feed withdrawal 
periods were not mentioned in their study. Olkowski et al. (2006b) examined the 
responses of broilers to oral administration of C. perfringens isolated from field cases of 
NE. None of their challenged trials produced overt clinical signs of the disease. High 
dietary protein content of animal origin (fish meal or meat meal), fasting, a high wheat 
diet or abrupt change of diet form did not increase the risk of NE. Many birds showed 
pronounced changes in their intestinal tissue. Although all these changes appeared to be 
subtle when compared to field cases of NE, yet they had a significant, negative effect on 
the digestive physiology of the intestinal mucosa.  
In several of the previously described models of NE, birds were inoculated with 
a cocktail of various strains of C. perfringens (McReynolds et al., 2004b; McReynolds 
et al., 2008; Cooper et al., 2009). However, the model described in the present study 
only used one strain of C. perfringens. Some models described in the literature are 
based on populations of C. perfringens in the ileum and caecum rather that the presence 
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of necrotic lesions in the intestine (Wilkie et al., 2005). However, the model used in this 
thesis is based on lesions not mortality since lesions are a more sensitive indicator of 
disease. 
 Biochemical markers of sub-clinical NE  9.5
Under field conditions carcass rejection is the stage at which most cases of sub-
clinical NE are identified (Kaldhusdal & Lovland, 2000), although the numbers 
involved are not necessarily reflected in the statistics of economic loss. At present the 
degree of host responses to NE can only be assessed by scoring gross pathological 
lesions within the intestine, although there is currently no validated lesion scoring 
system to characterize the disease condition in poultry. In addition, identification is 
made more complex by the use of different lesion scoring systems (Shane et al., 1985; 
Prescott, 1979; Lovland et al., 2004). It has been suggested that sub-clinical NE cannot 
be diagnosed solely on gross observations (Olkowski et al., 2006a). 
The need to develop reliable tests to quantify the problem is widely recognised 
particularly in the absence of AGPs. A more objective and quantifiable approach would 
be to determine the levels of various acute phase proteins (APP) and measure the level 
of expression of different genes, up or down, regulated in response to C. perfringens 
challenge in the intestinal tract of broiler chickens. This work is the first to provide 
evidence on the identification of novel bio-markers for sub-clinical NE in terms of acute 
phase protein levels in blood as well as the up/down expression of different genes 
regulated in response to C. perfringens challenge in broilers.  
9.5.1 Acute phase proteins response to sub-clinical NE  
A host’s natural systemic reaction, to neutralize the effect of pathogen, trauma 
and immune disorder is alteration in the levels of APPs released as a result of an acute 
phase response (Murata et al., 2004; Chamanza et al., 1999). The response of three 
main APPs, Ceruloplasmin, PIT 54 and OTF in response to C. perfringens challenge 
was investigated to determine whether they can be used as diagnostic biochemical 
markers for sub-clinical NE in poultry (Chapter 8a). Greater insight into the 
pathogenesis of sub-clinical NE will also be provided by the host’s response in terms of 
APPs. The results showed that there was a marked increase in serum ceruloplasmin 
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concentration in chickens challenged with C. perfringens compared to unchallenged 
birds, although no differences were seen in PIT 54 and OVT.  
An elevation of ceruloplasmin concentration evidenced an APP response that 
was induced in broiler chickens experimentally infected with sub-clinical NE. 
Haptoglobin like protein; PIT 54 in chicken is still not completely elucidated. 
Determination of plasma Ceruloplasmin concentrations can help in early diagnosis of 
sub-clinical infection, possibly even prior to the actual appearance of necrotic lesions on 
intestinal walls. Further studies are needed to confirm levels of these APPs in sub-
clinical NE for use as a tool to monitor chicken health. A better understanding of the 
kinetics of APP in serum definitely improves knowledge of the kinetics of this disease. 
Experimental models of sub-clinical NE are increasingly required for studies of 
disease progress and the effect of novel interventions products. However reliable, easily 
quantifiable indicators of sub-clinical NE are not readily available. There is great 
variety in the scoring system(s) for disease characterization (Prescott, 1979; George et 
al., 1982; Lovland et al., 2004). Acute phase proteins, as an indicator of the host’s 
response to early inflammation can represent a potentially useful marker of bacterial 
infection (Chamanza et al., 1999). Economically important diseases, especially sub-
clinical forms which are difficult to detect by clinical signs or even by post-mortem 
examination, may be diagnosed by levels of APPs, since an acute phase response in 
chickens is linked to growth depression and decreased production (Klasing & Korver, 
1997). The effect of sub-clinical NE on the concentration of various APPs has not been 
assessed in broilers. The present model analyses the effect of experimental challenge on 
three important APPs and their relation to attempted induction of sub-clinical NE. 
The disease was successfully produced in the present study. The appearance of 
typical lesions of sub-clinical NE following C. perfringens challenge confirmed the 
presence of infection in the gut. The initial phase of an inflammatory process induced 
by infection, involves the release of acute phase proteins (Gruys et al., 1994). The 
present study indicates that serum levels of the positive acute phase protein 
ceruloplasmin increased in challenged birds compared to unchallenged controls 
probably due to gut lesions caused by bacterium. These findings are in agreement with 
previous studies which reported significant elevations of ceruloplasmin concentrations 
(Georgieva, 2010). Mazur-Gonkowska et al. (2004) found significant increases in 
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concentrations of ceruloplasmin in turkeys infected with E. coli, with levels remaining 
elevated until day 10 post infection, indicating that ceruloplasmin is an important APP 
in poultry response to bacterial infection. 
The purpose of experiments described in Chapter 8 was to identify potential 
biochemical markers in terms of APP and gene expression so that these can give an 
indication of the severity of sub-clinical NE in the absence of grossly visible gut lesions. 
The expression of these APPs has yet to be fully determined through further 
investigation in experimental models. It is noteworthy that a proportion of birds in the 
control, unchallenged groups developed lesions of sub-clinical NE. This could explain 
the difference in the levels of PIT 54 and OTF compared to ceruloplasmin (O’Reilly, 
Personnel communication). However this is the first study to measure/analyse the 
response of APPs in broiler chickens challenged with C. perfringens. In conclusion, our 
results show that ceruloplasmin may be considered as moderate APP in sub-clinical NE 
in chickens, as it increased around 3 fold, suggesting that monitoring serum 
ceruloplasmin concentration can indicate the presence of C. perfringens infection in 
poultry. However further research confirming its role and concentrations in sub-clinical 
NE in order to establish a cut-off point to allow the optimal balance of clinical 
specificity and sensitivity is  needed to provide a diagnostic and prognostic marker for 
flock health and welfare to ultimately help in better understanding of the 
pathophysiology of sub-clinical NE.  Determination of a receiver operator curve (roc) 
with well defined populations of healthy and subclinically infected would be required to 
determine the best cut-off point for diagnostic use (Jesnsen and Kjelgaard-Hansen, 
2006). 
9.5.2 Expression pattern of host gene in response to C. 
perfringens challenge 
Athanasiadou et al. (2011) have identified the pathways that regulate early host 
responses to C. perfringens toxin in the duodenum of broilers by using a genome-wide 
transcriptomic analysis and an in situ broiler gut loop model. In earlier work, qPCR 
confirmed a wide range of up to 11 genes associated with innate immune responses 
following genome-wide transcriptomic analysis of the duodenum of broilers infused 
with crude C. perfringens α-toxin, compared to controls (Athanasiadou et al., 2011). Six 
of the eleven genes confirmed by qPCR, were chosen for analysis. With the objective of 
obtaining a better understanding of the immune competence of two genetically different 
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commercial broiler species (Ross and Hubbard) the expressions of 6 gene transcripts 
were analysed in broilers experimentally challenged with C. perfringens (1.54 x 10
9
 
cfu/g of feed). 
Chapter 8 demonstrated there was no alteration in the expression level of 
different gene transcripts, fas, BL-A, GIMAP8 and NBL1, following challenge with 
higher in-feed doses of C. perfringens, even though these genes had been up and down 
regulated after infusion of crude toxin, indicating the difference of host response in term 
of gene expression, to toxin and C. perfringens per se, and/ or different stages in 
pathogenesis of C. perfringens infection. 
The present experiment showed no differential gene expression pattern for the 
genes analysed between the two different commercial species of broilers. Unfortunately 
very limited information is available on the effect of bird breed on susceptibility to NE 
(Hong et al., 2012). In one UK epidemiological study one, un-named breed of chicken 
was more susceptible than the other employed (Hermans & Morgan, 2007). Though not 
experimentally verified, Olkowski et al. (2006a) speculated that currently broiler breeds 
may be more resistant to NE than those used 30 or more years ago. That could provide a 
reason for the difficulties experienced in developing a model of NE for disease 
induction.  
Hong et al. (2012) found differential gene expression patterns for avian ß-
defensins when analysing Ross and Cobb broilers response following E. maxima and C. 
perfringens co-infection. However only 8 out of 14 ß-defensins of the genes 
investigated were expressed differentially in the jejunum of two broiler species. 
Sumners et al. (2012) documented that the established trend of pathogen susceptibility 
is not always followed by genetically divergent species in their resistance to C. 
perfringens infection. Broilers with a low antibody response have been observed to have 
a lower resistance to C. perfringens infection compared to broilers with a high antibody 
response. The low antibody response species were observed to have a lower up-
regulated expression of various cytokines, IFN-γ, IL-8, IL-15 during exposure to C. 
perfringens α-toxin (Sumners et al., 2012).  
However in the experiment (Chapter 6b) only a small number of birds (3/30) 
developed lesions. So it would be useful for further gene expression studies to be done 
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where higher numbers of birds develop gut lesions, in order for a better understanding 
of  the gene responses, whether they change or remain the same. Changes in host gene 
expression response can reflect cellular and molecular biological processes during host 
response to C. perfringens infection in broilers. More extensive gene expression 
analysis is necessary to further build on the work of this preliminary study so that an 
experimental disease model can be refined to provide a better understanding of host 
pathogen interactions. 
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10 CONCLUSION  
The present thesis confirms that NE develops when C. perfringens establishes 
and multiplies in the intestinal tract of chickens in the presence of multiple predisposing 
factors such as: feed withdrawal, IBD vaccination, coccidiosis and high levels of dietary 
fish meal. Sub-clinical NE is a complex multi-factorial disease so successful 
reproduction requires careful incorporation of all these factors that, this researcher’s 
experiments suggest, act synergistically in inducing grossly visible gut damage. 
The ideal model to study the pathogenesis of sub-clinical NE is one in which a 
statistically significant proportion of challenged birds develop grossly visible lesions, 
but without clinical signs or associated mortality. The disease model used in the present 
study incorporates the different predisposing factors that commercial poultry operations 
are likely to face on a day to day basis. Most of the challenged models used a mixture of 
C. perfringens strains to induce NE (McReynolds et al., 2005; McReynolds et al., 
2008), although only one strain was used in the present study. Ficken & Wages, (1997) 
suggested that factors such as coccidiosis, IBD and dietary stress along with high doses 
of C. perfringens would favour experimental induction of NE in chickens. The present 
study confirms this finding. More importantly this model will be more acceptable to 
animal welfare activists since there is no mortality associated with this C. perfringens 
challenge so there would be minimal ethical issues to consider. It is, however, 
recommended to repeat this experiment several times to establish the repeatability of the 
model. Of the predisposing factors tested by the present project, the role of coccidiosis 
is clearly crucial in the establishemnt of NE. Control of coccidia through anticoccidials 
or by vaccination may become more critical under commercial conditions particulary in 
those parts of the world that no longer use antimicrobial growth promoters. This 
research has indicated that control of coccidiosis is likely to be the most effective way 
of preventing NE. 
The overall findings of this thesis showed that, of the factors tested, feed 
withdrawal, co-infection with coccidiosis, stress and dietary ingredients (fish meal and 
CM) are the most important in the development of sub-clinical NE. Understanding of 
the disease would benefit from a challenge model that will enable further, more 
effective investigation to combat it.  
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11 FUTURE WORK /RECOMENDATIONS 
This thesis reports work, as often occurs during scientific research, that generates 
more questions than it answers. This creates scope for several avenues of further study. 
 Future work is required to confirm the reproducibility of the disease 
model (Experiment 5, Chapter 7).  
 Additional research is needed to determine the extent and involvement of 
the other contributory, predisposing factors. Such research could start 
from the final experiment (Chapter 7), successively removing individual 
predisposing factors in order to isolate the role of the crucial 
predisposing factor(s). 
 Continue to explore the differences between two genotypes in their 
differing susceptibility to NE.  
 Further study needs to be undertaken, keeping all variables constant, to 
determine whether feed or gavage is the most appropriate for an NE 
model. 
 Levels of APPs as a potential tool for early diagnosis of sub-clinical NE 
needs further study. Pathophysiology of APP in serum of chickens 
challenged with C. perfringens is necessary to characterize various 
molecular and biochemical events that lead to pathogenesis of this 
complex disease. 
 Future work on confirmation of these novel markers and then use of 
these markers to identify and test diet related strategies to control NE.  
 Once confirmed its reproducibility, the present model can be used for 
testing various potential strategies to combat NE include Probiotics or 
Direct fed microbials (Fuller, 1989; Fukata et al., 1991; Hofacre et al., 
1998a), Prebiotics (Gibson & Roberfroid 1995; Tako et al., 2008), Feed 
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enzymes (Ferket 1993; Choct et. al., 1999; Dahiya et al., 2006), Organic 
acid (Adam 2004; Koscher et al., 2004; Kmet' et al., 1993), Herbs 
(Dahiya et al., 2006), spices and essential oils (Wilkinson et al., 2003; 
Mitsch et al., 2004a; Timbermont et al., 2010; Abildgaard et al., 2010), 
Hen egg antibodies (Wilkie et al., 2006), Vaccination (Kulkarni et al., 
2007), and bacteriophages therapy (Miller et al., 2010). However, in this 
researcher's opinion, the first and most important potential alternative 
that needs to be considered is directly fed microbials (probiotics). There 
are several such products on the global market due to growing interest in 
the potential of novel probiotics to not only promote gut health but also 
prevent the rise of NE. However before they can be reliably regarded as 
a valuable solution to maintain healthy gut flora there is a crucial need 
for them to be tested for their impact on proliferation of C. perfringens. 
Combined with good management practices and careful incorporation of 
feed ingredients, the application of antibiotic alternatives have the 
potential to be effective in achieving some control of NE. This could 
optimise production without the costly impact inevitable if NE is not 
controlled. 
Using modern biotechnology tools, such as host gene analysis and APP, superior 
models for disease reproduction can be developed enabling resolution of the aetiology 
of this multifactorial disease. Ultimately this will lead to novel approaches to disease 
control, a gateway to gut health for all chickens within the industry. This thesis has 
confirmed the complexity of this disease. Although it is understandable that there is 
presently no clear single answer for the aetiology of NE, this thesis has clarified the 
importance of recognising the need for a holistic approach that looks at the whole range 
of predisposing factors involved in the pathology of the disease. 
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13 APPENDICES:  
 Appendix A 13.1
Haematoxylin and Eosin staining technique for histopathological 
sections 
Slides were placed in a slide holder for the purpose of staining. The stain was 
applied according to the following timetable 
Pure alcohol     2 minutes 
Industrial spirit (IMS)    1minute 
Gills Haemotoxylin      5minute 
Wash in water     1 minute 
Scotts tap water substitute (STWS)   10-20seconds  
Wash in water     10-15 seconds 
Eosin      10-15 seconds 
Wash in water     10 seconds 
Pure alcohol     1 minute 
Pure alcohol     1 minute 
Organic solvent    30 seconds 
The purpose of these steps was to remove any wax from the sections and rehydrate them 
to allow them to take up the stain. 
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 Appendix B 13.2
Gram staining technique for C. perfringens identification 
Gram staining technique for bacterial identification  
A gram stain for morphology was carried out 
Place the slide with bacterial smear made from TSC colony on a staining rack 
Stain the slide with crystal violet for 1 minute 
Pour off the stain  
Flood the slide with Gram’s iodine for 1 minute 
Pour off the iodine 
Decolorize by washing the slide briefly with acetone (2-3 seconds) 
Wash slide with water to remove the acetone 
Flood slide with counter stain 
Wash the slide with water 
Blot excess water.  
After drying, slides were examined under oil immersion and the structure and 
appearance of cells noted. Gram positive cultures will appear purple black in colour 
while Gram negative cultures appear pink. 
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 Appendix C 13.3
Growth strain 56 of C. perfringens on different media over different 
time  
The experiment described in this appendix was conducted to find out when the 
growth of C. perfringens is at its peak as well as determining which medium best 
supports the growth of C. perfringens strain 56 and the associated α-toxin to ensure  the 
best medium is used for growing C. perfringens to be used for the challenge studies. We 
studied two commonly used media for growing up C. perfringens, i.e. Brain heart 
infusion broth (BHI) and thioglycollate broth (TG), and bacterial counts were 
determined at 0, 2, 4, 8, 10, 12, and 24 hrs. 
Frozen beads of C. perfringens strain 56, isolated from the intestine of a broiler 
chicken with severe necrotic gut lesions were streaked onto the Tryptose sulphite 
cyclerserine (TSC) agar plate. These plates were invertedly incubated in an anaerobic 
jar with CO2 generating gas packs (AnaeroGen™, AN0025A, Oxoid Ltd, UK). The jar 
was placed in an incubator at 37°C for 24hrs before inoculation into sterile respective 
tubes in brain heart infusion (BHI) broth (CM 1032, Oxoid, Ltd, UK). After overnight 
incubation, 3 colonies (Figure 13.1) were taken from TSC agar plates and mixed with 
further (BHI) broth (Oxoid Ltd, UK). Up to 3-4 colonies from overnight cultures of 
TSC plates (Figure 13.1) were taken and inoculated into bijou bottles with BHI broth. 
Brain heart infusion broth was incubated at 37ºC, shaking at 60rmp anaerobically 
overnight (18-24hrs).  
Thirty two sterile tubes containing 100ml of respective media (BHI and TG) 
were used in an in vitro experiment. Each tube was inoculated with 0.2ml of BHI broth 
containing an actively growing culture of C. perfringens. At 0, 2, 4, 6, 8, 12 and 24 hour 
intervals two tubes were removed. After mixing, 1ml of media was taken and mixed 
with 9ml of maximum recovery diluent. For enumeration of C. perfringens, dilutions 
were plated on TSC agar plates, incubating the plates at 37°C overnight, prior to 
counting the number of black presumptive C. perfringens colonies. 
From the above in vitro experiment little difference was observed in C. 
perfringens counts on TSC agar plates suggesting there was also little difference the  
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between the growth of C. perfringens on BHI or TG media over the time periods. It was 
also observed that the C. perfringens count was at its peak between 8 -12 hrs. As the TG 
media is known to quickly deteriorate under aerobic conditions, it was decided to use an 
8-12 hrs BHI culture of C. perfringens for challenging birds in subsequent experiments. 
 
 
Figure 13.1: Growth of C. perfringens in different media. BHI: Brain heart 
infusion broth; TG, thioglycolate at different intervals of time. 
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 Appendix D 13.4
13.4.1 RLT BUFFER 
Add 10µl of β-merceptoethanol (β-ME) in 1ml of buffer RLT 
 
13.4.2 70% ETHANOL  
Add 70ml of ethanol in graduated flask and make up to 100 ml by adding distilled 
water. 
 
 
